МедУнивер - MedUniver.com Все разделы сайта Видео по медицине Книги по медицине Форум консультаций врачей  
Рекомендуем:
Педиатрия:
Педиатрия
Генетика в педиатрии
Детская аллергология и иммунология
Детская гастроэнтерология
Детская гематология
Детская гинекология
Детская дерматология
Детская и подростковая стоматология
Детская кардиология
Детская неврология
Детская нефрология
Детская онкология
Детская ортопедия
Детская оториноларингология
Детская офтальмология
Детская пульмонология
Детская реабилитация
Детская ревматология
Детская урология
Детская фармакология
Детская эндокринология
Инфекционные болезни у детей
Неонатология
Неотложные состояния детей
Подростковая медицина
Рост и развитие ребенка
Организация педиатрической помощи
Форум
 

Авторы трудов (статей) использованные при подготовке материалов по детской пульмонологии в педиатрии

В статьях на сайте использованы следующие сокращения:

  • °F — температура по Фаренгейту
  • °C — температура по Цельсию
  • 5-НТ — 5-гидроксииндолуксусная кислота мочи
  • АБ — антибиотик(и)
  • АБЛА — аллергический бронхолегочный аспергиллез
  • АБТ — антибактериальная терапия
  • АВ — атриовентрикулярный
  • АГ — артериальная гипертензия
  • АГн — антиген
  • АД — артериальное давление
  • АДГ — антидиуретический гормон
  • АДС — анатоксин дифтерийно-столбнячный
  • АДС-М — анатоксин дифтерийно-столбнячный (малые дозы)
  • АДФ — аденозиндифосфорная кислота, аденозиндифосфат
  • АКДС — анатоксин коклюшно-дифтерийно-столбнячный
  • АКТГ — адренокортикотропный гормон
  • АКШ — аортокоронарное шунтирование
  • АЛТ — аланинаминотрансфераза
  • амер. — американский
  • АМК — азот мочевины крови
  • АМФ — аденозинмонофосфорная кислота, аденозинмонофосфат
  • АНА — антинуклеарные антитела
  • анат. — анатомический
  • англ. — английский
  • АПФ — ангиотензин-превращающий фермент
  • АРВТ — антиретровирусная терапия
  • АРП — активность ренина в плазме крови
  • ACT — аспартатаминотрансфераза
  • АТл — антитело
  • АТФ — аденозинтрифосфорная кислота, аденозинтрифосфат
  • АуД — аутосомно-доминантный
  • АуР — аутосомно-рецессивный
  • АФП — α-фетопротеин
  • АФС — антифосфолипидный синдром
  • АХЭ — ацетилхолинэстераза
  • АЦХ — ацетилхолин
  • АЧТВ — активированное частичное тромбопластиновое время
  • БА — бронхиальная астма
  • БАД — биологически активная добавка
  • БАЛ — бронхоальвеолярный лаваж
  • БАР — биполярное аффективное расстройство (I или II типа)
  • БКК — большой круг кровообращения
  • БЛД — бронхолегочная дисплазия
  • БЛНПГ — блокада левой ножки пучка Гиса
  • БМСЭ — бюро медико-социальной экспертизы
  • БП — брюшная полость
  • БПНПГ — блокада правой ножки пучка Гиса
  • БРМ — базовые реанимационные мероприятия
  • БРНС — быстро разрешившееся необъяснимое событие
  • БЦЖ — бацилла Кальметта-Герена в т.ч. — в том числе
  • БФП - биофизический профиль плода
  • в. — век
  • в/ — внутри... в сложносоставных словах (напр. в/сосудистый, в/черепной и т.п.)
  • в/а — внутриартериально
  • в/в — внутривенно
  • в/к — внутрикожно
  • в/м — внутримышечно
  • вв. — века
  • в-во — вещество
  • ВВЭ — военно-врачебная экспертиза
  • ВГД — внутриглазное давление
  • ВГЧ — вирус герпеса человека
  • ВДП — верхние дыхательные пути
  • ВЖК — внутрижелудочковое кровоизлияние
  • ВЗК — воспалительные заболевания кишечника
  • ВЗОМТ—воспалительные заболевания органов малого таза
  • ВИП — вазоактивный интестинальный пептид
  • ВИЧ — вирус иммунодефицита человека
  • ВМП — высокотехнологичная медицинская помощь
  • ВМС — внутриматочное средство (спираль)
  • ВН — вирусная нагрузка
  • ВНС — вегетативная нервная система
  • ВОВ — Великая Отечественная война
  • ВОГМ — высокогорный отек головного мозга
  • ВОЗ — Всемирная организация здравоохранения
  • ВОЛ — высокогорный отек легких
  • ВОМК — врач, осуществляющий медицинский контроль
  • ВОП — врач общей практики
  • ВПВ — верхняя полая вена
  • ВПГ — вирус простого герпеса
  • ВПР — врожденные пороки развития
  • ВПС — врожденный порок сердца
  • ВПЧ — вирус папилломы человека
  • ВРТ — вспомогательные репродуктивные технологии
  • ВСО — водно-солевой обмен
  • ВЧД — внутричерепное давление
  • ВЧИВЛ — высокочастотная искусственная вентиляция легких (HFV)
  • ВЭБ — вирус Эпштейна-Барр
  • г — грамм
  • г. — год
  • Г-6-ФД — глюкозо-6-фосфатдегидрогеназа
  • ГАМК — гамма-аминомасляная кислота
  • ГБ — гипертоническая болезнь
  • ГБН — гемолитическая болезнь новорожденного
  • ГБО — гипербарическая оксигенация
  • ГЗТ — гиперчувствительность замедленного типа
  • гист. — гистологический
  • ГК — грудная клетка
  • ГКМП — гипертрофическая кардиомиопатия
  • ГКС — глюкокортикостероид(ы)
  • ГЛГ — гемофагоцитарный лимфогистиоцитоз
  • ГЛПС — геморрагическая лихорадка с почечным синдромом
  • ГМ — головной мозг
  • ГМ-КСФ — гранулоцитарно-макрофагальный колониестимулирующий фактор
  • ГМФ — гуанозинмонофосфат
  • ГнРГ — гонадотропин-рилизинг-гормон
  • ГНТ — гиперчувствительность немедленного типа
  • ГПОД — грыжа пищеводного отверстия диафрагмы
  • ГРДС — гипоксическая реакция дыхательной системы греч. — греческий
  • ГТФ — гуанозинтрифосфат
  • ГУС — гемолитико-уремический синдром
  • Гц — герц
  • ГЭБ — гематоэнцефалический барьер
  • ГЭР — гастроэзофагеальный рефлюкс
  • ГЭРБ — гастроэзофагеальная рефлюксная болезнь
  • дБ — децибел
  • ДВС — диссеминированное внутрисосудистое свертывание
  • ДГТ — дигидротестостерон
  • ДД — дифференциальная диагностика, дифференциально-диагностический
  • ДДБА — длительнодействующие β2-агонисты
  • ДДК — дифференциально-диагностический критерий (критерии)
  • ДДРМ - допустимый диапазон распределения макронутриентов
  • ДИ — доверительный интервал
  • ДК — диагностический критерий
  • ДКА — диабетический кетоацидоз
  • ДКМП — дилатационная кардиомиопатия
  • ДМЖП — дефект межжелудочковой перегородки
  • ДМПП — дефект межпредсердной перегородки
  • ДМС — добровольное медицинское страхование
  • ДН — дыхательная недостаточность
  • ДНК — дезоксирибонуклеиновая кислота
  • ДНТ — дефекты нервной трубки
  • ДО - дыхательный объем
  • ДОФА — дигидроксифенилаланин
  • ДП — дыхательные пути
  • ДПК — двенадцатиперстная кишка
  • ДПМ — дата последней менструации
  • ДПП - допустимый предел потребления
  • др. — другие
  • ДТП — дорожно-транспортное происшествие
  • ДЦП — детский церебральный паралич
  • ЕД — единица действия, единица
  • ЖВП — желчевыводящие пути
  • ЖДА — железодефицитная анемия
  • ЖЕЛ — жизненная емкость легких
  • ЖКБ — желчекаменная болезнь
  • ЖКК — желудочно-кишечное кровотечение
  • ЖКТ — желудочно-кишечный тракт
  • ЖНВЛП — жизненно необходимые и важные лекарственные препараты (список, перечень)
  • ЗВУР — задержка внутриутробного развития
  • ЗЛ — здоровые люди (лица)
  • ЗНО — злокачественное новообразование
  • ЗО — здравоохранение
  • ЗОЖ — здоровый образ жизни
  • ЗСН — застойная сердечная недостаточность
  • иАПФ — ингибиторы ангиотензин-превращающего фермента
  • ИБС — ишемическая болезнь сердца
  • ИВЛ — искусственная вентиляция легких
  • ИГКС — ингаляционные глюкокортикостероиды
  • ИЗЛ — интерстициальные заболевания легких
  • ИКП — иммунокомпрометированные пациенты
  • ИЛ — интерлейкин
  • ИЛДБ — интегрированное лечение детских болезней
  • ИМ — инфаркт миокарда
  • ИМАО — ингибитор(ы) моноаминоксидазы
  • ИМбпБТ — инфаркт миокарда без подъема сегмента ST
  • ИМП — инфекция мочевых (мочевыводящих) путей
  • ИМпЗТ — инфаркт миокарда с подъемом сегмента
  • ST ИМТ — индекс массы тела
  • ИОЛ — интраокулярная линза
  • ИПП — ингибиторы протонной помпы (протонного насоса)
  • ИППП — инфекции, передаваемые половым путем
  • ИСС — индивидуальные спасательные средства истор. — историческое итал. — итальянский
  • ИТП — идиопатическая тромбоцитопеническая пурпура
  • ИТШ — инфекционно-токсический шок ИФА — иммуноферментный анализ
  • КА — коронарная(ые) артерия(и)
  • кВ — киловольт
  • кг — килограмм
  • КДБА — короткодействующие β2-агонисты
  • КДД — конечно-диастолическое давление
  • КДО — конечно-диастолический объем
  • КДР — конечно-диастолический размер
  • кит. — китайский
  • ккал — килокалория
  • кл. — клетки, клеток
  • КМП — качество медицинской помощи
  • КоА — коэнзим А, кофермент А
  • КОЕ — колониеобразующая единица
  • КОК — комбинированные оральные контрацептивы
  • КПТ — когнитивно-поведенческая терапия
  • КР — клинические рекомендации
  • КСД — конечно-систолическое давление
  • КСО — конечно-систолический объем
  • КСР — конечно-систолический размер
  • КТ — компьютерная томография
  • КТВР — компьютерная томография высокого разрешения
  • КТГ — кардиотокография
  • КФК — креатинфосфокиназа
  • КЩС — кислотно-щелочное состояние
  • л — литр
  • л/о — ложноотрицательный
  • л/п — ложноположительный
  • ЛА — легочная артерия
  • лат. — латинский
  • ЛГ — лютеинизирующий гормон
  • ЛДГ — лактатдегидрогеназа
  • ЛЖ — левый желудочек
  • ЛОР — имеющий отношение к оториноларингологии (ЛОР-врач, ЛОР-органы)
  • ЛП — лекарственный препарат
  • ЛПВП — липопротеины высокой плотности
  • ЛПНП — липопротеины низкой плотности
  • ЛПОНП — липопротеины очень низкой плотности
  • ЛПУ — лечебно-профилактическое учреждение
  • ЛС — лекарственное средство
  • ЛУ — лимфатический узел, лимфоузлы
  • ЛФК — лечебная физкультура
  • м.б. — может (мог, могут, могли) быть
  • М/Ж — соотношение мужчин и женщин
  • максД — максимальная доза
  • максНД — максимальная начальная доза
  • максРД — максимальная разовая доза
  • максСД — максимальная суточная доза
  • МАНК — метод амплификации нуклеиновых кислот
  • МАО — моноаминоксидаза
  • МВП — мочевыводящие пути мг — миллиграмм
  • МДБ — мышечная дистрофия Беккера
  • МДД — мышечная дистрофия Дюшенна
  • МДМА — метилендиоксиметамфетамин
  • ME — международная единица
  • мед. — медицинский
  • мес — месяц
  • МЖ — молочная железа
  • МЖП — межжелудочковая перегородка
  • МЗ — министерство здравоохранения
  • мин — минут(а)
  • минД — минимальная доза
  • минСД — минимальная суточная доза
  • МКБ — мочекаменная болезнь
  • МКБ-10 — Международная классификация болезней 10-го пересмотра
  • МКБ-11 — Международная классификация болезней 11-го пересмотра
  • мкВ — микровольт
  • мкг — микрограмм
  • МКК — малый круг кровообращения
  • мкл — микролитр
  • мл — миллилитр
  • млн — миллион
  • млрд — миллиард
  • мм — миллиметр
  • мм рт.ст. — миллиметр ртутного столба ммоль — миллимоль
  • МНН — международное непатентованное наименование
  • МНО — международное нормализованное отношение
  • МО — медицинская организация
  • МП — медицинская помощь
  • МПС — мочеполовая система
  • МР — магнитно-резонансный
  • МР-венография — МРТ вен и синусов головного мозга
  • МРТ — магнитно-резонансная томография
  • мс — миллисекунда
  • МСКТ — мультиспиральная компьютерная томография
  • МСЭ — медико-социальная экспертиза
  • МТ — масса тела
  • мтДНК — митохондриальная дезоксирибонуклеиновая кислота
  • МТР — масса тела при рождении
  • МЭ - миалгический энцефаломиелит
  • н.э. — нашей эры
  • НА — нервная анорексия
  • НАД — никотинамидадениндинуклеотид
  • НАДН — никотинамидадениндинуклеотид (восстановленный)
  • НАДФ — никотинамидадениндинуклеотидфосфат
  • НАЖБП — неалкогольная жировая болезнь печени напр. — например
  • НБ — нервная булимия
  • НДО — негативный детский опыт
  • нед — недели
  • нем. — немецкий
  • нм — нанометр
  • НМИЦ — национальный медицинский исследовательский центр
  • НМП — неотложная (медицинская) помощь
  • НМТ — низкая масса тела
  • НПА — нормативно-правовой акт
  • НПВ — нижняя полая вена
  • НПВС — нестероидные противовоспалительные средства
  • НС — нервная система
  • НСТ - нестрессовый тест
  • НРП — нормы рациона питания
  • НСГ — нейросонография
  • НЭК — некротический энтероколит
  • НЯК — неспецифический язвенный колит
  • ОАК — общий анализ крови
  • ОАМ — общий анализ мочи
  • ОАП — открытый артериальный проток
  • ОБП — органы брюшной полости
  • ОГБ — острая горная болезнь
  • ОГМ — отек головного мозга
  • ОДН — острая дыхательная недостаточность
  • ОЖСС — общая железосвязывающая способность сыворотки
  • ОЗ — организация здравоохранения
  • ок. — около
  • ОКР — обсессивно-компульсивное расстройство
  • ОКС — острый коронарный синдром
  • ОЛЛ — острый лимфобластный лейкоз
  • ОМС — обязательное медицинское страхование
  • ОМТ — органы малого таза
  • ОНМК — острое нарушение мозгового кровообращения
  • ОНМП — отделение неотложной (медицинской) помощи
  • ОНМТ — очень низкая масса тела
  • ООЗ — органы (организации/управления) здравоохранения
  • ООН — Организация Объединенных Наций
  • ОПЖ — ожидаемая продолжительность жизни
  • ОПН — острая почечная недостаточность
  • ОПСС - общее периферическое сосудистое сопротивление
  • ОРВИ — острая респираторная вирусная инфекция
  • ОРДС — острый респираторный дистресс-синдром
  • ОРЗ — острое респираторное заболевание
  • ОРИТ — отделение реанимации и интенсивной терапии (ICU)
  • ОСВО — общее содержание воды в организме
  • ОФВ — объем форсированного выдоха
  • ОФВ1 — объем форсированного выдоха за 1-ю секунду
  • ОЦК — объем циркулирующей крови
  • п.з. — поле зрения (микроскопа)
  • п/к — подкожно
  • ПАВ — психоактивные вещества
  • ПВ — протромбиновое время
  • ПВК — периферический венозный катетер
  • ПВЛ — перивентрикулярная лейкомаляция
  • Пг — простагландин
  • ПГГ — программа государственных гарантий оказания гражданам РФ бесплатной медицинской помощи
  • ПДКВ — положительное давление конца выдоха (PEEP)
  • ПЖ — правый желудочек
  • ПЖЖ — поджелудочная железа
  • ПЖК — подкожно-жировая клетчатка (гиподерма)
  • ПКА — почечный канальцевый ацидоз
  • ПКМД — поясно-конечностная мышечная дистрофия
  • ПЛСГ — пятнистая лихорадка Скалистых гор
  • ПМДР — предменструальное дисфорическое расстройство
  • ПМК — пролапс митрального клапана
  • ПМС — предменструальный синдром
  • ПМСП — первичная медико-санитарная помощь
  • ПНЖК — полиненасыщенные жирные кислоты
  • ПОРИТ— педиатрическое отделение реанимации и интенсивной терапии
  • ПОТ — постуральная ортостатическая тахикардия
  • ППВ — пневмококковая полисахаридная вакцина
  • ППОАК — прямые пероральные антикоагулянты
  • ППТ — площадь поверхности тела
  • ПСА — простатоспецифический антиген
  • ПСВ — пиковая скорость выдоха
  • ПСВХ — прогрессирующий семейный внутрипеченоч-ный холестаз
  • ПТ — психотерапия
  • ПТВ — протромбиновое время
  • ПТГ — паратиреоидный гормон
  • ПТИ — протромбиновый индекс
  • ПТСР — посттравматическое стрессовое расстройство
  • ПФЭ — пищевой фолатный эквивалент
  • ПЦР — полимеразная цепная реакция
  • ПШГ — пурпура Шенлейна-Геноха
  • ПЩЖ — паращитовидные железы
  • ПЭТ — позитронно-эмиссионная томография р/ — раз в ... (с, мин, ч, сут и т.п.)
  • РА — ревматоидный артрит
  • РААС — ренин-ангиотензин-альдостероновая система разг. — разговорное разл. — различное
  • РАС — расстройство аутистического спектра
  • РДС — респираторный дистресс-синдром рим. — римский
  • РИФ — реакция иммунофлюоресценции
  • РКИ — рандомизированные клинические исследования
  • РКМП — рестриктивная кардиомиопатия
  • РИГА — реакция непрямой гемагглютинации
  • РН - ретинопатия недоношенных
  • РНК — рибонуклеиновая кислота
  • РНП - рекомендуемую норму потребления
  • РОГК — рентгенография (рентгенограмма) органов грудной клетки
  • РОЛСНС — рекомендации по оценке и лечению при сортировке в неотложных ситуациях
  • РПГА — реакция прямой гемагглютинации
  • р-р — раствор
  • р-ритель — растворитель
  • РРК — рецепторы ретиноевой кислоты
  • PPM — расширенные реанимационные мероприятия
  • РСВ — респираторно-синцитиальный вирус
  • РСД — расстройство стереотипных движений
  • РСК — реакция связывания комплемента
  • РСП - расчетная средняя потребность
  • РТГА — реакция торможения гемагглютинации
  • РТНГА — реакция торможения непрямой гемагглютинации
  • РФ — Российская Федерация
  • РХР — ретиноевые Х-рецепторы
  • РЧА — радиочастотная абляция
  • РЭС — ретикулоэндотелиальная система
  • с — секунда
  • св-во — свойство
  • САМ - синдром аспирации мекония
  • СВДС — синдром внезапной детской смерти
  • СГЯ — синдром гиперстимуляции яичников
  • СД — сахарный диабет
  • СД-1 — сахарный диабет 1-го типа
  • СД-2 — сахарный диабет 2-го типа
  • СДВГ — синдром дефицита внимания и гиперактивности
  • СЕ — субъединица
  • СЖК — свободные жирные кислоты
  • СЗД - служба защиты детей
  • СЗСТ — системное(ые) заболевание(я) соединительной ткани
  • СИЗ — средства индивидуальной защиты
  • СИОЗС— селективный ингибитор обратного захвата серотонина
  • СИОЗСН — селективные ингибиторы обратного захвата серотонина и норэпинефрина
  • СКА — серповидно-клеточная анемия
  • СКВ — серповидно-клеточная болезнь
  • СКВ — системная красная волчанка
  • СКФ — скорость клубочковой фильтрации
  • СЛР — сердечно-легочная реанимация
  • см — сантиметр
  • см вод.ст. — сантиметр водяного столба
  • СМЖ — спинномозговая жидкость
  • СМИ — средства массовой информации
  • СМО — страховая медицинская организация
  • СМП — скорая медицинская помощь
  • СМЭ — судебно-медицинская экспертиза
  • СН — сердечная недостаточность
  • СНСАДГ — синдром неадекватной секреции АДГ
  • СОАС — синдром обструктивного апноэ сна (во сне) совр. — современный
  • СОЭ — скорость оседания эритроцитов
  • СПИД — синдром приобретенного иммунодефицита
  • СПКЯ — синдром поликистозных яичников
  • СПОН — синдром полиорганной недостаточности
  • СРВ — С-реактивный белок
  • СРК — синдром раздраженного кишечника
  • СрСД — средняя суточная доза
  • ССВ — синдром Стерджа-Вебера
  • ССВР — синдром системной воспалительной реакции
  • ССЗ — сердечно-сосудистые заболевания
  • ССС — сердечно-сосудистая система
  • СССУ — синдром слабости синусового узла
  • СТ — Синдром Туретта
  • СТГ — соматотропный гормон
  • СТР — стойкое (хроническое) моторное или вокальное тикозное расстройство
  • сут — сутки
  • СХУ — синдром хронической усталости
  • т.д. — так далее
  • т.е. — то есть
  • т.к. — так как
  • т.о. — таким образом
  • т.п. — тому подобное
  • Т3 — трийодтиронин
  • Т4 — тироксин
  • ТАНК — тест амплификации нуклеиновых кислот
  • ТБС — тазобедренный сустав
  • ТГВ — тромбоз глубоких вен
  • ТГСК — трансплантация гемопоэтических стволовых клеток
  • ТИА — транзиторная ишемическая атака
  • ТИАБ — тонкоигольная аспирационная биопсия
  • ТМО — твердая мозговая оболочка
  • TH — торговое наименование лекарственных средств
  • ТПГГ — территориальная программа государственных гарантий оказания гражданам РФ бесплатной медицинской помощи
  • ТПМ — травматическое повреждение мозга
  • ТТ — температура тела
  • ТТГ — тиреотропный гормон
  • ТФР — трансформирующий фактор роста
  • ТЦА — трициклические антидепрессанты
  • тыс. — тысяча
  • ТЭД —транзиторная эритробластопения детского возраста
  • ТЭЛА — тромбоэмболия легочной артерии
  • ТЭО — тромбоэмболические осложнения
  • УЗДС — ультразвуковое дуплексное сканирование
  • УЗИ — ультразвуковое исследование
  • устар. — устаревшее
  • УФ — ультрафиолетовый
  • УФО — ультрафиолетовое облучение
  • ФАП — фельдшерско-акушерский пункт
  • ФВ — фракция выброса
  • ФВД — функции внешнего дыхания
  • ФЖЕЛ — форсированная жизненная емкость легких
  • ФЗ — Федеральный закон
  • физиол. — физиологический
  • ФК — функциональный класс
  • ФКС — фиброколоноскопия
  • ФКУ — фенилкетонурия
  • ФН — физическая нагрузка
  • ФИО — фактор некроза опухоли
  • ФОМС — федеральный фонд обязательного медицинского страхования
  • ФОС — фосфорорганические соединения
  • ФП — фибрилляция предсердий
  • фр. — французский
  • ФСГ — фолликулостимулирующий гормон
  • ФЭГДС — фиброэзофагогастродуоденоскопия
  • ХБП — хроническая болезнь почек
  • ХГЧ — хорионический гонадотропин человека
  • ХДН — хроническая дыхательная недостаточность
  • хим. — химическая
  • ХНЗЛ —хронические неспецифические заболевания легких
  • ХОБЛ — хроническая обструктивная болезнь легких
  • ХПН — хроническая почечная недостаточность
  • ХС — холестерин
  • ХСН — хроническая сердечная недостаточность
  • XT — химиотерапия
  • ЦВД — центральное венозное давление
  • ЦВК — центральный венозный катетер
  • ЦИК — циркулирующие иммунные комплексы
  • ЦМВ — цитомегаловирус
  • ЦНС — центральная нервная система
  • ЦОГ — циклооксигеназа
  • ЦПД — церебральное перфузионное давление
  • ЦСТС — церебральный сольтеряющий синдром ч — час
  • ЧД — частота дыхания
  • ЧДД — частота дыхательных движений
  • ЧКВ — чрескожное коронарное вмешательство
  • ЧМН — черепно-мозговые нервы
  • ЧМТ — черепно-мозговая травма
  • ЧН — черепные нервы
  • ЧС — чувствительность/специфичность (ЧС 97%/87%)
  • ЧСС — частота сердечных сокращений
  • ЧССП - частота сердечных сокращений плода
  • ЧТВ — частичное тромбопластиновое время
  • ШКГ — шкала комы Глазго
  • ШОП — шейный отдел позвоночника
  • ЩЖ — щитовидная железа
  • ГЦФ — щелочная фосфатаза
  • ЭАР — эквивалент активности ретинола
  • ЭДТА — этилендиаминтетрауксусная кислота (этилендиаминтетраацетат)
  • ЭКГ — электрокардиография
  • ЭКМО — экстракорпоральная мембранная оксигенация
  • ЭКО — экстракорпоральное оплодотворение
  • ЭКС — электрокардиостимулятор, элекгрокардиостимуляция
  • ЭМГ — электромиография
  • ЭМК — электронная медицинская карта
  • ЭМП — экстренная медицинская помощь
  • ЭНМП — экстренная и неотложная медицинская помощь
  • ЭНМТ — экстремально низкая масса тела
  • ЭТТ — эндотрахеальная трубка
  • ЭхоКГ — эхокардиография
  • ЭЭГ — электроэнцефалография
  • ЮДМ — ювенильный дерматомиозит
  • ЮИА — ювенильный идиопатический артрит
  • ЯБ — язвенная болезнь
  • АА — амилоид A (amyloid А)
  • ААР — Американская академия педиатрии (American Academy of Pediatrics)
  • ABC — алгоритм неотложной помощи «дыхательные пути-дыхание-кровообращение» (Airways-Breathing-Circulation)
  • АВСА3 — белковый член АТФ-связывающей кассеты А3
  • АВСВ11— ген АТФ-связывающей кассеты, 11-й член подсемейства В (ATP-binding cassette, sub-family В member 11)
  • АВСВ4 — ген АТФ-связывающей кассеты, 4-й член подсемейства В (ATP-binding cassette 4 gene)
  • АВСС2 — ген, кодирующий 2-й член подсемейства С АТФ-связывающих кассет (ATP-binding cassette sub-family С member 2)
  • ABCDE — алгоритм неотложной помощи «дыхательные пути-дыхание-кровообращение-неврологический статус-внешний вид» (Airways-Breathing-Circulation-Disability- Exposure)
  • ABCG5/G8 — гетеродимер переносчика АТФ-связывающей кассеты ABCG5 и ABCG8 (The heterodimer of ATP-binding cassette transporter ABCG5 and ABCG8)
  • AC — до еды (при назначениях) — ante cibum
  • АСЕР — Американская коллегия врачей неотложной помощи (American College of Emergency Physicians)
  • ACOG — Американская коллегия акушеров и гинекологов (American College of Obstetricians and Gynecologists)
  • AHA — Американская кардиологическая ассоциация (American Heart Association)
  • ALTE — очевидное опасное для жизни событие (apparent life-threatening event)
  • APLS — курсы расширенных реанимационных мероприятий в педиатрии, спонсируемые Американской академией педиатрии и Американской коллегией врачей неотложной помощи (Advanced Pediatric Life Support)
  • ARPKD — аутосомно-рецессивный поликистоз почек
  • ASCVD-риск — риск развития атеросклеротического сердечно-сосудистого заболевания (ArterioSclerotic Cardiovascular Disease, ASCVD)
  • AVPU — шкала для оценки уровня сознания («в ясном сознании»; «реакция на вербальные раздражители»; «реакция на боль»; «без сознания») (alert, verbal, pain, unresponsive)
  • BCS — митохондриальный шаперон BCS1 (mitochondrial chaperone BCS1)
  • BIN — биноминальная номенклатура «живой» природы
  • BiPAP — режим искусственной вентиляции легких с двумя уровнями положительного давления (bilevel positive airway pressure) = ВРАР
  • BNP — натрийуретический пептид В-типа — мозговой (В (brain)-type natriuretic peptide)
  • BRUE — быстро разрешившиеся необъяснимые события (Brief resolved unexplained events)
  • BSEP — насос выведения солей желчных кислот
  • CADASIL — церебральная аутосомно-доминантная артериопатия с подкорковыми инфарктами и лейкоэнцефалопатией (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy)
  • CAPS — криопирин-ассоциированный периодический синдром (cryopyrin-associated periodic syndrome)
  • CBIT — комплексное поведенческое воздействие при тиках (Comprehensive behavioral intervention for tics)
  • CD — кластеры дифференцировки (clusters of differentiation)
  • CDC — Центр по контролю и профилактике заболеваний, США (Center for Disease Control and Prevention)
  • CDG — врожденные нарушения гликозилирования (Congenital Disorder of Glycosylation)
  • CFTR — трансмембранный регулятор муковисцидоза (cystic fibrosis transmembrane regulator)
  • CH — гемолитический комплемент (hemolytic complement)
  • CLLS — шкала оценки острой горной болезни озера Луиз у детей (Childrens Lake Louise Score)
  • CMT — Шарко-Мари-Тута болезнь (Charcot-Marie-Tooth disease)
  • СРАР — постоянное положительное давление в дыхательных путях (Constant Positive Airway Pressure)
  • CYP — цитохром общий
  • DAF — фактор ускорения распада (decay-accelerating factor)
  • DGAT1 —диацилглицерин-1-ацилтрансфераза (diacylglycerol acyltransferase 1)
  • DHR — дигидрородамин (dihydrorhodamine)
  • DSM — Диагностическое и статистическое руководство по психическим расстройствам (Diagnostic and Statistical Manual of Mental Disorders)
  • EAST syndrome — эпилепсия, атаксия, сенсоневральная тугоухость и тубулопатия (epilepsy, ataxia, sensorineural hearing loss, and tubulopath)
  • EBM — доказательная медицина (Evidence based medicine)
  • EPCAM— молекула адгезии эпителиальных клеток (epithelial cell adhesion molecule)
  • ESC — Европейское общество кардиологии (European Society of Cardiology)
  • EXIT — лечение вне матки во время родов (Ex utero intrapartum treatment)
  • FAST — сфокусированная сонография брюшной полости при травме (focused assessment with sonography in trauma)
  • FDA — Комитет по контролю за лекарственными веществами и пищевыми добавками, США (Food and Drug Administration)
  • FFR — фракционный резерв кровотока (Fractional Flow Reserve)
  • FGF-23 — фактор роста фибробластов-23 (Fibroblast growth factor-23)
  • FIC 1 —семейный внутрипеченочный холестаз 1-го типа, болезнь Байлера (familial intrahepatic cholestasis)
  • FiO2 — фракция кислорода (во вдыхаемом воздухе, газовой смеси)
  • FISH — флуоресцентная in situ гибридизация (fluorescence in situ hybridization)
  • FLAIR — восстановление инверсии с ослаблением жидкости (fluid-attenuated inversion recovery)
  • FMF — семейная средиземноморская лихорадка (Familial Mediterranean fever)
  • GATA — gata-связывающий белок
  • HADH — гидроксилацил-КоА-дегидрогеназа (Hydro-xyacyl-Coenzyme A dehydrogenase)
  • HAV — вирус гепатита В (hepatitis A virus)
  • Hb — гемоглобин
  • HBcAg — сердцевинный антиген вируса гепатита В
  • HBeAg — антиген вируса гепатита В
  • HBsAg — поверхностный антиген вируса гепатита В
  • HBV — вирус гепатита В (hepatitis В virus)
  • HCV — вирус гепатита С (hepatitis С virus)
  • HDV — вирус гепатита D (hepatitis D virus)
  • HFNC — назальные канюли высокого потока (heated, high-flow nasal cannula)
  • Hib — гемофильная палочка типа В (Haemophilus influenzae В type)
  • HLA — лейкоцитарные антигены (главного комплекса гистосовместимости) человека (human leukocyte antigens)
  • HR — отношение рисков (hazard ratio)
  • HRT — терапия отмены привычки (Habit reversal therapy)
  • Ht — гематокрит
  • HTLV — Т-лимфотропный вирус человека (human T-lymphotropic virus)
  • Ig — иммуноглобулин
  • IgA — иммуноглобулин A
  • IgE — иммуноглобулин E
  • IgG — иммуноглобулин G
  • IgM — иммуноглобулин M
  • IL — интерлейкин
  • IPEX — Х-сцепленный синдром иммунной дисре-гуляции, полиэндокринопатии и энтеропатии (Immunedysregulation polyendocrinopathy enteropathy, X-linked)
  • IQ — коэффициент умственного развития (intelligence quotient)
  • JAK — янус-киназа (Janus kinase)
  • LFA — антиген, активирующий функцию лейкоцитов (Lymphocyte function-associated antigen)
  • LT — лейкотриен
  • MALT — лимфоидная ткань слизистой оболочки (mucosa-associated lymphoid tissue)
  • MASP — МСЛ-ассоциированная сериновая протеаза (MBL-associated serine protease)
  • MBL — маннозо-связывающий лектин (mannose-
  • binding lectin)
  • MCP — мембранный белок-кофактор (membrane cofactor protein)
  • MDR3 — белок множественной лекарственной устойчивости 3 (multidrug resistance protein 3)
  • MELAS — митохондриальная энцефалопатия, лактоацидоз и инсультоподобные эпизоды (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes)
  • MERRF — миоклоническая эпилепсия с рваными красными волокнами (Myoclonic epilepsy with ragged red fibers)
  • Mr — кажущаяся молекулярная масса
  • MRP — белок с множественной лекарственной устойчивостью (multidrug-resistant protein)
  • MRSA — метициллинрезистентный золотистый стафилококк
  • MSSA — метициллинчувствительный золотистый стафилококк
  • NB! — важно, обратить внимание (Nota bene)
  • NICE — Национальный институт здоровья и клинического совершенствования (качества медицинской помощи) Великобритании (National Institute for Health and Clinical Excellence)
  • NK — естественные клетки-киллеры (natural killer)
  • NMDA — N-метил-D-аспартат (N-methyl-D-aspartate)
  • NMDA — N-метил-D-аспартатные рецепторы
  • NNT — число больных, которых необходимо пролечить, чтобы достичь какого-то указанного эффекта (Number Need to Treatment)
  • OR — отношение шансов (odds ratio)
  • paCO2 — парциальное давление углекислого газа в артериальной крови
  • PALS — курсы расширенных реанимационных мероприятий в педиатрии (Pediatric Advanced Life Support)
  • PANDAS — аутоиммунное нейропсихиатрическое расстройство в детском возрасте, ассоциированное со стрептококковой инфекцией (Pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection)
  • PANS — острый нейропсихиатрический синдром в детском возрасте (Pediatric acute-onset neuropsychiatric syndrome)
  • paO2 — парциальное давление кислорода в артериальной крови
  • PAS — фуксинсернистая кислота, реактив Шиффа (periodic acid-Shiff)
  • PC — после еды (при назначениях) — post cibum рСO2 — парциальное давление углекислого газа
  • PCSK-9 — пропротеиновая конвертаза субтилизин-кекси-нового типа 9 (proprotein convertase subtilisin/ kexin type 9)
  • PFAPA — периодическая лихорадка с афтозным стоматитом, фарингитом и лимфаденитом (Periodic Fevers with Aphthous stomatitis, Pharyngitis and Adenitis)
  • PFIC — семейный внутрипеченочный холестаз (familial intrahepatic cholestasis)
  • Pg — простагландин
  • pH — водородный показатель
  • PIM — показатель летального исхода у детей (Pediatric Index of Mortality)
  • piO2 — парциальное давление кислорода во вдыхаемом
  • воздухе
  • рO2 — парциальное давление кислорода
  • POLG — субъединица ДНК-полимеразы у
  • PRISA II — оценка риска госпитализации у детей II (Pediatric Risk of Admission)
  • PRISM — риск летального исхода у детей (Pediatric Risk of Mortality)
  • PRN — при (по) необходимости (Pro re nata — при возникновении обстоятельств)
  • PRSS — ген сериновой протеазы
  • PS. — примечание (Post scriptum)
  • PUVA-терапия — псорален-ультрафиолет А-терапия (psoralen and ultraviolet А)
  • Q#H — каждые # часов (при назначениях) — quaque ... hora
  • QAM — каждое утро (при назначениях) — quaque ante meridiem
  • QPM — каждый вечер (при назначениях) — quaque post meridiem
  • RAG — ген, активирующий рекомбиназу
  • RePEAT— пересмотренный инструмент для оценки педиатрической неотложной медицинской помощи (Revised Pediatric Emergency Assessment Tool)
  • RF — ревматоидный фактор
  • Rh — резус(-фактор)
  • Rh«-» — резус-отрицательн(ый)
  • Rh«+» — резус-положительн(ый)
  • ROHHAD — быстро развивающееся ожирение с дисфункцией гипоталамуса, гиповентиляцией и спонтанной дисрегуляцией (rapid-onset obesity with hypothalamic dysfunction, hypoventilation and autonomic dysregulation)
  • RR — относительный риск (relative risk или risk ratio) RW — реакция Вассермана (reaction of Wassermann)
  • SaO2 — сатурация артериальной крови кислородом SatO2 — насыщение крови кислородом
  • ScvO2 — насыщение кислородом центральной венозной крови (Central venous oxygen saturation)
  • SD — стандартное отклонение (standart deviation) SFTPA — ген сурфактантного белка A
  • SFTPB — ген сурфактантного белка В
  • SFTPC — ген сурфактантного белка С
  • SPINK — ингибитор сериновой протеазы
  • SpO2 — насыщение (сатурация) гемоглобина кислородом spp. — виды (при родовом имени микроорганизмов)
  • Src. — источник информации, библиографическая ссылка (source)
  • STAT1 — сигнальный преобразователь и активатор транскрипции 1 (signal transducer and activator of transcription)
  • TA — международная анатомическая терминология TCR — T-клеточный рецептор (T-cell receptor)
  • TLRs — Толл-подобные рецепторы (Toll-like receptors) TNF — фактор некроза опухоли (tumor necrosis factor)
  • TORCH — токсоплазмоз, краснуха, цитомегаловирусная инфекция, герпес и другие инфекции (Toxoplasmosis, Other infections, Rubella, Cytomegalovirus Herpes simplex)
  • TPM — мутация тропомиозина (mutation of the tropomyosin)
  • TRAP — синдром обратной артериальной перфузии близнецов (twin reversed arterial perfusion)
  • TRAPS — периодический синдром, ассоциированный с рецептором фактора некроза опухоли (Tumor Necrosis Factor Receptor-Associated Periodic Syndrome)
  • ™ — торговая марка
  • URL — интернет-ссылка, адрес интернет-ресурса (Uniform Resource Locator)
  • VEGF — фактор роста эндотелия сосудов (Vascular Endothelial Growth Factor)
  • WPW — синдром Вольфа-Паркинсона-Уайта (Wolff-Parkinson-White)
  • XLA — Х-сцепленная агаммаглобулинемия (X-linked agammaglobulinemia)
  • aDG-RD — дистрофии, связанные с a-дистрогликанами (alpha dystroglycan-related dystrophies)
  • β-ХГЧ — β-субъединица хорионического гонадотропина человека

В ходе подготовки статей по детской пульмонологии в педиатрии для пользователей сайта МедУнивер использованы труды следующих авторов:

  1. Bush A: Update in pediatric lung disease 2008, Am J Respir Crit Care Med 179:637–649, 2009.
  2. Deutsch GH, Young LR, Deterding RR, et al: Diffuse lung disease in young children. Application of a novel classification scheme, Am J Respir Crit Care Med 176:1120–1128, 2007.
  3. Himes BE, Jiang X, Hu R, et al: Genome-wide association analysis in asthma subjects identifies SPATS2L as a novel bronchodilator response gene, PLoS Genet 8(7):e1002824, 2012.
  4. Hirsch W, Sorge I, Krohmer S, et al: MRI of the lungs in children, Eur J Radiol 68(2):278–288, 2008.
  5. Marri PR, Stern DA, Wright AL, et al: Asthma-associated differences in microbial composition of induced sputum, J Allergy Clin Immunol 131(2):346–352, e1–3, 2013.
  6. Morris A, Beck JM, Schloss PD, et al: Lung HIV Microbiome Project: comparison of the respiratory microbiome in healthy nonsmokers and smokers, Am J Respir Crit Care Med 187(10):1067–1075, 2013.
  7. Sanders DB, Li Z, Rock MJ, et al: The sensitivity of lung disease surrogates in detecting chest CT abnormalities in children with cystic fibrosis, Pediatr Pulmonol 47(6):567–573, 2012.
  8. Schechter MS: Snoring: investigations guidelines, Pediatr Pulmonol Suppl 26:172–174, 2004.
  9. Schechter MS: Section on Pediatric Pulmonology, Subcommittee on Obstructive Sleep Apnea Syndrome: technical report: diagnosis and management of childhood obstructive sleep apnea syndrome, Pediatrics 109:e69, 2002.
  10. Steele MP, Schwartz DA: Molecular mechanisms in progressive idiopathic pulmonary fibrosis, Annu Rev Med 64:265–276, 2013.
  11. Dhooria S, Madan K, Pattabhiraman V, et al: A multicenter study on the utility and safety of EBUS-TBNA and EUS-B-FNA in children, Pediatr Pulmonol 51:1031–1039, 2016. doi:10.1002/ppul.23415.
  12. Iftikhar IH, Musani AI: Narrow-band imaging bronchoscopy in the detection of premalignant airway lesions: a meta-analysis of diagnostic test accuracy, Ther Adv Respir Dis 9:207–216, 2015. doi:10.1177/1753465815589698.
  13. Laxmanan B, Egressy K, Murgu SD, et al: Advances in bronchial thermoplasty, Chest 150:694–704, 2016. doi:10.1016/j.chest.2016.03.012.
  14. Paradis TJ, Dixon J, Tieu BH: The role of bronchoscopy in the diagnosis of airway disease, J Thorac Dis 8:3826–3837, 2016. doi:10.21037/jtd.2016.12.68.
  15. Pavord ID, Thomson NC, Niven RM, et al: Safety of bronchial thermoplasty in patients with severe refractory asthma, Ann Allergy Asthma Immunol 111:402–407, 2013. doi:10.1016/j.anai.2013.05.002.
  16. Selzer AR, Murrell M, Shostak E: New trends in interventional pulmonology, Curr Opin Anaesthesiol 30:17–22, 2017. doi:10.1097/ACO.0000000000000414.
  17. Thomson NC, Rubin AS, Niven RM, et al: Long-term (5 year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trial, BMC Pulm Med 11:8, 2011. doi:10.1186/1471-2466-11-8.
  18. Carroll JL, Agarwal A: Development of respiratory control in infants, Paediatr Respir Rev 11:199–207, 2010.
  19. Kouis P, Papatheodorou SI, Yiallouros PK: Diagnostic accuracy of nasal nitric oxide for establishing diagnosis of primary ciliary dyskinesia: a meta-analysis, BMC Pulm Med 3(15):153, 2015. doi:10.1186/s12890-015-0147-3.
  20. Leigh MW, Hazucha MJ, Chawla KK, et al: Standardizing nasal nitric oxide measurement as a test for primary ciliary dyskinesia, Ann Am Thorac Soc 10(6):574–581, 2013. doi:10.1513/AnnalsATS.201305-110OC.
  21. Maniscalco M, Vitale C, Vatrella A, et al: Fractional exhaled nitric oxide-measuring devices: technology update, Med Devices (Auckl) 23(9):151–160, 2016. doi:10.2147/MDER.S91201.
  22. Rao DR, Phipatanakul W: An overview of fractional exhaled nitric oxide and children with asthma, Expert Rev Clin Immunol 12(5):521–530, 2016. doi:10.1586/1744666X.2016.1141049.
  23. Tang S, Xie Y, Yuan C, et al: Fractional exhaled nitric oxide for the diagnosis of childhood asthma: a systematic review and Meta-analysis, Clin Rev Allergy Immunol 2016. doi:10.1007/s12016-016-8573-4. [Epub ahead of print].
  24. West JB: Respiratory physiology: the essentials, ed 8, Baltimore, 2008, Lippincott Williams and Wilkins.
  25. Chang AB, Landau LI, Van Asperen PP, et al: Cough in children: definitions and clinical evaluation. Thoracic Society of Australia and New Zealand, Med J Aust 184:398–403, 2006.
  26. Chang AB, Oppenheimer JJ, Weinberger MM, et al: Use of management pathways or algorithms in children with chronic cough: CHEST Guildeline and Expert Panel Report, Chest 2017. doi:10.1016/j.chest.2016.12.025.
  27. Dickson JM, Richter GT, Meinzen-Derr J, et al: Secondary airway lesions in infants with laryngomalacia, Ann Otol Rhinol Laryngol 118:37–43, 2009.
  28. Everard ML: Recurrent lower respiratory tract infections’-going around in circles, respiratory medicine style, Paediatr Respir Rev 13(3):139–143, 2012.
  29. Ida JB, Thompson DM: Pediatric stridor, Otolaryngol Clin North Am 47:795–819, 2014.
  30. Kliegman RM, Greenbaum LA, Lyle PS: Practical strategies in pediatric diagnosis and therapy, ed 2, Philadelphia, 2004, WB Saunders, pp 16–42.
  31. Marchant JM, Masters LB, Taylor SM, et al: Utility of signs and symptoms of chronic cough in predicting specific cause in children, Thorax 61:694–698, 2006.
  32. Paul IM, Beiler J, McMonagle A, et al: Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents, Arch Pediatr Adolesc Med 161:1140–1146, 2007.
  33. Shields MD, Bush A, Everard ML, et al: Recommendations for the assessment and management of cough in children, Thorax 63(SupplIII):iii1–iii15, 2008.
  34. Singh RR, Tan V, Hanna MG, et al: Mutations in SCN4A: a rare but treatable cause of recurrent life-threatening laryngospasm, Pediatrics 134:e1447–e1450, 2014.
  35. Tutor JD, Gosa MM: Dysphagia and aspiration in children, Pediatr Pulmonol 47:321–337, 2012.
  36. Vertigan AE, Murad MH, Pringsheim T, et al: Somatic cough syndrome (previously referred to as psychogenic cough) and tic cough (previously referred to as habit cough) in adults and children, Chest 148:24–31, 2015
  37. Gaude GS: Hemoptysis in children, Indian Pediatr 47(3):245–254, 2010.
  38. Jindal A, Singhi S: Acute chest pain, Indian J Pediatr 78(10):1262–1267, 2011.
  39. Loughlin GM: Chest pain. In Loughlin GM, Eigen H, editors: Respiratory disease in children: diagnosis and management, Baltimore, 1994, Williams & Wilkins, pp 207–214.
  40. Rehman HU: Methemoglobinemia, West J Med 175(3):193–196, 2001.
  41. American Academy of Pediatrics Task Force on Sudden Infant Death Syndrome: SIDS and other sleep-related infant deaths: updated 2016 recommendations for a safe infant sleeping environment, Pediatrics 138(5):e2016238, 2016.
  42. Bejjani C, Machaalini R, Waters KA: The dorsal motor nucleus of the vagus (DMNV) in sudden infant death syndrome (SIDS): pathways leading to apoptosis, Resp Physiol Neurobiol 185:203–210, 2013.
  43. Cannon SC: Skeletal muscle channelopathy: a new risk for sudden infant death syndrome, Lancet 391:1457–1458, 2018.
  44. Davis AM, Glengarry J, Skinner JR: Sudden infant death: QT or not QT? That is no longer the question, Circ Arrhythm Electrophysiol 9:e003859, 2016.
  45. Feldman-Winter L, Goldsmith JP: Committee on fetus and newborn, Task force on sudden infant death syndrome: safe sleep and skin-to-skin care in the neonatal period for healthy term newborns, Pediatrics 138(3):e20161889, 2016.
  46. Ferrante L, Rognum TO, Vege A, et al: Altered gene expression and possible immunodeficiency in cases of sudden infant death syndrome, Pediatr Res 80:77–84, 2016.
  47. Fleming PJ, Blair P, Pease A: Sudden unexpected death in infancy: aetiology, pathophysiology, epidemiology and prevention, Arch Dis Child 100:984–988, 2015.
  48. Gao Y, Schwebel DC, Hu G: Infant mortality due to unintentional suffocation among infants younger than 1 year in the United States, 1999-2015, JAMA Pediatrics 172(4):388–390, 2018.
  49. Garcia AJ, Koschnitzky JE, Ramirez J-M: The physiological determinants of sudden infant death syndrome, Resp Physiol Neurobiol 189:288–300, 2013.
  50. Goldstein RD, Nields HM, Kinney HC: A new approach to the investigation of sudden unexpected death, Pediatrics 140(2):e20170024, 2017.
  51. Hunt CE, Darnall RA, McEntire BL, Hyma BA: Assigning cause for sudden unexpected infant death, Forensic Sci Med Pathol 11:283–288, 2015.
  52. Hunt NJ, Phillips L, Waters KA, Machaalani R: Proteomic MALDI-TOF/TOF-IMS examination of peptide expression in the formalin fixed brainstem and changes in sudden infant death syndrome, J Proteomics 138:48–60, 2016.
  53. Malloy MH: Prematurity and sudden infant death syndrome: United States 2005-2007, J Perinatol 33:470–477, 2013.
  54. Monnikko R, Wong L, Tester DJ, et al: Dysfunction of Nav1.4, a skeletal muscle voltage-gated sodium channel, in sudden infant death syndrome: a case-control study, Lancet 391:1483–1492, 2018.
  55. Matthews TJ, MacDorman MF, Thoma ME: Infant mortality statistics from the 2013 period linked birth/infant death data set. National vital statistics reports, vol 64, no. 9, Hyattsville, MD, 2015, National Center for Health Statistics.
  56. Moon RY, American Academy of Pediatrics Task Force on Sudden Infant Death Syndrome: SIDS and other sleep-related infant deaths: evidence base for 2016 updated recommendations for a safe infant sleeping environment, Pediatrics 138(5):e20162940, 2016.
  57. National Infant Sleep Position and Collaborative Home Infant Monitoring Evaluation: Public access.
  58. Pease AS, Fleming PJ, Hauck FR, et al: Swaddling and the risk of sudden infant death syndrome: a meta-analysis, Pediatrics 137(6):e20153275, 2016.
  59. Porzionato A, Macchi V, Stecco C, De Caro R: The carotid body in sudden infant death syndrome, Resp Physiol Neurobiol 185:194–201, 2013.
  60. Richardson HL, Horne RSC: Arousal from sleep pathways are affected by the prone sleeping position and preterm birth, Early Human Dev 89:705–711, 2013.
  61. Thach BT: Potential central nervous system involvement in sudden unexpected infant deaths and the sudden infant death syndrome, Compr Physiol 5:1061–1068, 2015.
  62. Randall BB, Paterson DS, Haas EA, et al: Potential asphyxia and brainstem abnormalities in sudden and unexpected death in infants, Pediatr 132:e1616–e1625, 2013.
  63. Yiallourou SR, Witcombe NB, Sands SA, et al: The development of autonomic cardiovascular control is altered by preterm birth, Early Hum Dev 89:145–152, 2013.
  64. Bass JL, Gartley T, Kleinman R: Unintended consequences of current breastfeeding initiatives, JAMA Pediatr 170(10):923–924, 2016.
  65. Becher JC, Bushan SS, Lyon AJ: Unexpected collapse in apparent healthy newborns—a prospective national study of a missing cohort of neonatal deaths and near-death events, Arch Dis Child Fetal Neonatal Ed 97:F30–F34, 2012.
  66. Feldman-Winter L, Goldsmith JP, AAP Committee On Fetus And Newborn, AAP Task Force On Sudden Infant Death Syndrome: Safe sleep and Skin-to-skin care in the neonatal period for healthy term newborns, Pediatrics 138(3):e20161889, 2016.
  67. Herlenius E, Kuhn P: Sudden unexpected postnatal collapse of newborn infants: a review of cases, definitions, risks, and preventative measures, Transl Stroke Res 4(2):236–247, 2013
  68. Moore ER, Bergman N, Anderson GC, Medley N: Early skin-to-skin contact for mothers and their healthy newborn infants, Cochrane Database Syst Rev (11):Art. No.: CD003519, 2016. doi:10.1002/14651858.CD003519.pub4.
  69. Nassi N, Piumelli R, Nardini V, et al: Sudden unexpected perinatal collapse and sudden unexpected early neonatal death, Early Hum Dev 89(Suppl 4):S25–S26, 2013.
  70. Pejovic NJ, Herlenius E: Unexpected collapse of healthy newborn infants: risk factors, supervision and hypothermia treatment, Acta Paediatr 102(7):680–688, 2013.
  71. Poets A, Steinfeldt R, Poets CF: Sudden deaths and severe apparent life-threatening events in term infants within 24 hours of birth, Pediatrics 127(4):e1073–e1076, 2011.
  72. Thach BT: Deaths and near deaths of healthy newborn infants while bed sharing on maternity wards, J Perinatol 34(4):275–279, 2014.
  73. Bonkowsky JL, Guenther E, Filloux FM, Srivastava R: Death, child abuse, and adverse neurological outcome of infants after an apparent life-threatening event, Pediatrics 122(1):125–131, 2008.
  74. Brand DA, Altman RL, Purtill K, Edwards KS: Yield of diagnostic testing in infants who have had an apparent life-threatening event, Pediatrics 115(4):885–893, 2005.
  75. Claudius I, Keens T: Do all infants with apparent life-threatening events need to be admitted?, Pediatrics 119:679, 2007.
  76. Freed GE, Steinschneider A, Glassman M, Winn K: Sudden infant death syndrome prevention and an understanding of selected clinical issues, Pediatr Clin North Am 41(5):967–990, 1994.
  77. Green M: Vulnerable child syndrome and its variants, Pediatr Rev 8(3):75–80, 1986.
  78. Hoffman HJ, Damus K, Hillman L, Krongrad E: Risk factors for SIDS. Results of the national institute of child health and human development SIDS cooperative epidemiological study, Ann N Y Acad Sci 533:13, 1988.
  79. Kiechl-Kohlendorfer U, Hof D, Peglow UP, et al: Epidemiology of apparent lifethreatening events, Arch Dis Child 90(3):297–300, 2005.
  80. Mitchell EA, Thompson JM: Parental reported apnoea, admissions to hospital and sudden infant death syndrome, Acta Paediatr 90(4):417–422, 2001.
  81. Monti MC, Borrelli P, Nosetti L, et al: Incidence of apparent life-threatening events and post-neonatal risk factors, Acta Paediatr 106(2):204–210, 2017.
  82. Putnam-Hornstein E, Schneiderman JU, Cleves MA, et al: A prospective study of sudden unexpected infant death after reported maltreatment, J Pediatr 164:142, 2014.
  83. Ramanathan R, Corwin MJ, Hunt CE, et al: Cardiorespiratory events recorded on home monitors: comparison of healthy infants with those at increased risk for SIDS, JAMA 285(17):2199–2207, 2001.
  84. Tieder JS, Altman RL, Bonkowsky JL, et al: Management of apparent life-threatening events in infants: a systematic review, J Pediatr 163(1):94–99, 2013.
  85. Tieder JS, Bonkowsky JL, Etzel RA, et al: Brief resolved unexplained events (formerly apparent Life-threatening events) and evaluation of Lower-risk infants, Pediatrics 137(5):2016.
  86. Willinger M, Keens TG, Collaborative Home Infant Monitoring Evaluation (CHIME) Study Group: Cardiorespiratory events recorded on home monitors: comparison of healthy infants with those at increased risk for SIDS, JAMA 285(17):2199–2207, 2001.
  87. Ologlu H: Congenital isolated absence of the nasal membranous septum, J Craniofac Surg. 24(3):e294–e295, 2013.
  88. Hale CL, Niederriter AN, Green GE, Martin DM: Atypical phenotypes associated with pathogenic CHD7 variants and a proposal for broadening CHARGE syndrome clinical diagnostic criteria, Am J Med Genet A 170(2):344–354, 2016.
  89. Harley EH: Pediatric congenital nasal masses, Ear Nose Throat J 70:28–32, 1991.
  90. Jacob SB, Chandran SK: Congenital midline nasal masses, Surg Tech Otolaryngol Neck Surg Pediatr Otolaryngol Surg 53:2014.
  91. Kwong KM: Current updates on choanal atresia, Front Pediatr 3:2015.
  92. Moreddu E, Le Treut-Gay C, Triglia JM, Nicollas R: Congenital nasal pyriform aperture stenosis: elaboration of a management algorithm from 25 years of experience, Int J Pediatr Otorhinolaryngol 83:7–11, 2016.
  93. Moses MA, Green BC, Cugno S, et al: The management of midline frontonasal dermoids: a review of 55 cases at a tertiary referral center and a protocol for treatment, Plast Reconstr Surg 135(1):187–196, 2015.
  94. Newman JR, Harmon P, Shirley WP, et al: Operative management of choanal atresia: a 15-year experience, JAMA Otolaryngol Head Neck Surg 139(1):71–75, 2013.
  95. Saafan ME: Endoscopic management of congenital bilateral posterior choanal atresia: value of using stents, Eur Arch Otorhinolaryngol 270(1):129–134, 2013.
  96. Saettele M, Alexander A, Markovich B, et al: Congenital midline nasofrontal masses, Pediatr Radiol 42:1119–1124, 2012.
  97. Strychowsky JE, Kawai K, Moritz E, et al: To stent or not to stent? A meta-analysis of endonasal congenital bilateral choanal atresia repair, Laryngoscope 126(1):218–227, 2016.
  98. Wong MTY, Sch?lvinck EH, Lambeck AJA, van Ravenswaaij-Arts CMA: CHARGE syndrome: a review of the immunological aspects, Eur J Hum Genet 23:1451–1459, 2015.
  99. Bakshi SS, Coumare VN, Priya M, Kumar S: Long-term complications of button batteries in the nose, J Emerg Med 50(3):485–487, 2016.
  100. Bernius M, Perlin D: Pediatric ear, nose, and throat emergencies, Pediatr Clin North Am 53:195–214, 2006.
  101. Craig SS, Cheek JA, Seith RW, West A: Removal of ENT foreign bodies in children, Emerg Med Australas 27(2):145–147, 2015.
  102. Friedman EM: Removal of foreign bodies from the ear and nose, N Engl J Med 374(7):e7, 2016.
  103. Haddad J Jr, et al: Foreign bodies of the ear, nose and pharynx. In Burg FD, Gershon A, Ingelfinger JR, editors: Current pediatric therapy, ed 17, Philadelphia, 2002, WB Saunders, p 23.
  104. Oh H, Min HJ, Yang HS, Kim KS: Is radiologic evaluation necessary to find out foreign bodies in nasal cavity?, J Craniofac Surg 27(1):e62–e64, 2016.
  105. Scholes MA, Jensen EL: Presentation and management of nasal foreign bodies at a tertiary children’s hospital in an American metro area, Int J Pediatr Otorhinolaryngol 88:190–193, 2016.
  106. Calder N, Kang S, Fraser L, Kunanandam T, Montgomery J, Kubba H. A double-blind randomized controlled trial of management of recurrent nosebleeds in children. Otolaryngol Neck Surg. 2009;140(5):670–674.
  107. Davies K, Batra K, Mehanna R, Keogh I. Pediatric epistaxis: epidemiology, management impact on quality of life. Int J Pediatr Otorhinolaryngol. 2014;78(8):1294–1297.
  108. Elden L, Reinders M, Witmer C: Predictors of bleeding disorders in children with epistaxis: value or preoperative tests and clinical screening, Int J Pediatr Otorhinolaryngol 76:767–771, 2012.
  109. Johnson N, Faria J, Behar P. A comparison of bipolar electrocautery and chemical cautery for control of pediatric recurrent anterior epistaxis. Otolaryngol Neck Surg. 2015;153(5):851–856.
  110. Kamble P, Saxena S, Kumar S. Nasal bacterial colonization in cases of idiopathic epistaxis in children. Int J Pediatr Otorhinolaryngol. 2015;79(11):1901–1904.
  111. Korkmaz M, ?etinkol Y, Korkmaz H, Batmaz T. Nasal bacterial colonization in pediatric epistaxis: the role of topical antibacterial treatment. Balkan Med J. 2016;33(2):212–215.
  112. Mulla O, Prowse S, Sanders T, et al: Epistaxis, BMJ 344:e1097, 2012.
  113. Vosler PS, Kass JI, Wang EW, Snyderman CH. Successful implementation of a clinical care pathway for management of epistaxis at a tertiary care center. Otolaryngol Neck Surg. 2016;155(5):879–885.
  114. Zahed R, Jazayeri MHM, Naderi A, et al: Topical tranexamic acid compared with anterior nasal packing for treatment of epistaxis in patients taking antiplatelet drugs: randomized controlled trial. Acad Emerg Med. 25(3):261–266, 2018.
  115. Beer H, Southern KW, Swift AC: Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis, Cochrane Libr 2015.
  116. Kelles M, Toplu Y, Yildirim I, Okur E: Antrochoanal polyp: clinical presentation and retrospective comparison of endoscopic sinus surgery and endoscopic sinus surgery plus mini-caldwell surgical procedures, J Craniofac Surg 25(5):1779-1781, 2014.
  117. Oakley GM, Curtin K, Orb Q, et al: Familial risk of chronic rhinosinusitis with and without nasal polyposis: genetics or environment, Int Forum Allergy Rhinol 5:276-282, 2015. Wiley Online Library.
  118. Scadding GK, Durham SR, Mirakian R, et al: British society for allergy and clinical immunology: BSACI guidelines for the management of rhinosinusitis and nasal polyposis, Clin Exp Allergy 38:260-275, 2008.
  119. Settipane RA, Peters AT, Chiu AG: Nasal polyps, Am J Rhinol Allergy 27(3s):S20-S25, 2013.
  120. Stokes PJ, Rimmer J: The relationship between serum vitamin D and chronic rhino-sinusitis: a systematic review, Am J Rhinol Allergy 30(1):23-28, 2016.
  121. Van Zele T, et al: Oral steroids and doxycycline: two different approaches to treat nasal polyps, J Allergy Clin Immunol 125:1069-1076, 2010.
  122. Wei CC, Adappa ND, Cohen NA: Use of topical nasal therapies in the management of chronic rhinosinusitis, Laryngoscope 123(10):2347-2359, 2013.
  123. Albalawi ZH, Othman SS, Alfaleh K: Intranasal ipratroprium bromide for the common cold, Cochrane Database Syst Rev (6):CD008231, 2013.
  124. Ballengee CR, Turner RB: Supportive treatment for children with the common cold, Curr Opin Pediatr 26:114-118, 2014.
  125. Bell EA, Tunkel DE: Over-the-counter cough and cold medications in children: are they helpful?, Otolaryngol Head Neck Surg 142:647, 2010.
  126. Chonmaitree T, Revai K, Grady JJ, et al: Viral upper respiratory tract infection and otitis media complication in young children, Clin Infect Dis 46:815-823, 2008.
  127. Cohen HA, Rozen J, Kristal H, et al: Effect of honey on nocturnal cough and sleep quality: a double-blind, randomized, placebo-controlled study, Pediatrics 130:465-471, 2012.
  128. Das RR, Singh M: Oral zinc for the common cold, JAMA 311:1440-1442, 2014.
  129. Deckx L, De Sutter AI, Guo L, et al: Nasal decongestants in monotherapy for the common cold, Cochrane Database Syst Rev (10):CD009612, 2016.
  130. Eggo RM, Scott JG, Galvani AP, Meyers LA: Respiratory virus transmission dynamics determine timing of asthma exacerbation peaks: evidence from a population-level model, Proc Natl Acad Sci USA 113:2194-2199, 2016.
  131. Green JL, Wang GS, Reynolds KM, et al: Safety profile of cough and cold medication use in pediatrics, Pediatrics 139(6):e20163070, 2017.
  132. Hampton LM, Nguyen DB, Edwards JR, et al: Cough and cold medication adverse events after market withdrawal and labeling revision, Pediatrics 132:1047-1054, 2013.
  133. Hemila H, Chalker E: Vitamin C for preventing and treating the common cold (review), Cochrane Database Syst Rev (1):CD000980, 2013.
  134. Jefferson T, Del Mar C, Dooley L, et al: Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review, BMJ 339:792-793, 2009.
  135. Kenealy T, Arroll B: Antibiotics for the common cold and acute purulent rhinitis, Cochrane Database Syst Rev (6):CD000247, 2013.
  136. Kim SY, Chang YJ, Cho HM, et al: Non-steroidal anti-inflammatory drugs for the common col, Cochrane Database Syst Rev (6):CD006362, 2013.
  137. Linder JE, Kraft DC, Mohamed YA, et al: HRV-C is not a new virus: age, season, and year are associated with HRV species in a 21-year prospective pediatric cohort study, J Allergy Clin Immunol 1(131):69-77, e6, 2013.
  138. Lowry JA, Leeder JS: Over-the-counter medications: update on cough and cold preparations, Pediatr Rev 36:286-297, 2015.
  139. Malesker MA, Callahan-Lyon P, Ireland B, et al: Pharmacologic and nonpharmacologic treatment ofor acute cough associated with the common cold, Chest 152(5): 1021-1037, 2017.
  140. Miceli S, Greco M, Monaco S, et al: Effect of multiple honey doses on non-specific acute cough in children. An open randomized study and literature review, Allergol Immunopathol (Madr) 2014. S0301-0546(14):00129-3.
  141. National Institute for Health and Clinical Excellence: Prescribing of antibiotics for self limiting respiratory tract infections in adults and children in primary care, 2008.
  142. Nordt SP, Vivero LE, Cantrell FL: Not just a drop in the bucket—inversion of oxymetazoline nasal decongestant container increases potential for severe pediatric poisoning, J Pediatr 168:240-241, 2016.
  143. Pappas DE, Hendley JO, Hayden FG, et al: Symptom profile of common colds in school-aged children, Pediatr Infect Dis J 27:8, 2008.
  144. Pappas DE, Hendley JO: The common cold and decongestant therapy, Pediatr Rev 32:47, 2011.
  145. Paul IM, Beiler JS, King TS, et al: Vapor rub, petrolatum, and no treatment for children with nocturnal cough and cold symptoms, Pediatrics 126:1092-1099, 2010.
  146. Science M, Maguire JL, Russell ML, et al: Low serum 25-hydroxyvitamin D level and risk of upper respiratory tract infection in children and adolescents, Clin Infect Dis 57(3):392-397, 2013.
  147. Singh M, Das RR: Zinc for the common cold, Cochrane Database Syst Rev (6):CD001364, 2013.
  148. Singh M, Singh M: Heated, humidified air for the common cold, Cochrane Database Syst Rev (6):CD001728, 2013.
  149. Smith SM, Schroeder K, Fahey T: Over-the-counter (OTC) medications for acute cough in children and adults in ambulatory settings, Cochrane Database Syst Rev (8):CD001831, 2012.
  150. Talbot HK, Shepherd BE, Crowe JE Jr, et al: The pediatric burden of human coronaviruses evaluated for twenty years, Pediatr Infect Dis J 28:682-686, 2009.
  151. The Medical Letter: Oral phenylephrine for nasal congestion, Med Lett 57(1484):174, 2015.
  152. Thompson M, Vodicka TA, Blair PS, et al: Duration of symptoms of respiratory tract infections in children: systematic review, BMJ 347:f7027, 2013.
  153. Turner RB, Fuls JL, Rodgers ND, et al: A randomized trial of the efficacy of hand disinfection for prevention of rhinovirus infection, Clin Infect Dis 54(10):1422-1426, 2012.
  154. World Health Organization: Cough and cold remedies for the treatment of acute respiratory infections in young children, 2001.
  155. Ah-see KL, MacKenzie J, Ah-See KW: Management of chronic rhinosinusitis, BMJ 345:e7054, 2012
  156. Chow AW, Benninger MS, Brook I, et al: IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults, CLIN INFECT DIS 54:e72-e112, 2012
  157. Coffinet L, Chan KH, Abzug MJ, et al: Immunopathology of chronic rhinosinusitis in young children, J Pediatr 154:757-758, 2009
  158. Cronin MJ, Khan S, Saeed S: The role of antibiotics in the treatment of acute rhinosinusitis in children: a systematic review, Arch Dis Child 98:299-303, 2013.
  159. De Muri DP, Eickhoff JC, Gern JC, Wald ER: Clinical and virological characteristics of acute sinusitis in children, Clin Infect Dis 2019. doi:10.1093/cid/ciz023/5289266
  160. De Muri GP, Wald ER: Acute bacterial sinusitis in children, N Engl J Med 367:1128-1134, 2012.
  161. De Muri GP, Wald ER: Complications of acute bacterial sinusitis in children, Pediatr Infect Dis J 30:701-702, 2011
  162. Gerber JS, Ross RK, Bryan M, et al: Association of broad- vs narrow-spectrum antibiotics with treatment failure, adverse events, and quality of life in children with acute respiratory tract infections, JAMA 318(23):2325-2336, 2017
  163. Goytia VK, Giannoni CM, Edwards MS: Intraorbital and intracranial extension of sinusitis: comparative morbidity, J Pediatr 158:486-491, 2011
  164. Harris AM, Hicks LA, Qaseem A, et al: Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American college of physicians and the centers for disease control and prevention, Ann Intern Med 164(6):425-434, 2016
  165. Head K, Chong LY, Piromchai P, et al: Systematic and topical antibiotics for chronic rhinosinusitis (review), Cochrane Database Syst Rev (4):Art No. CD011994, 2016
  166. Hersh AL, Jackson MA, Hicks LA, et al: Principles of judicious antibiotic prescribing for upper respiratory tract infections in pediatrics, Pediatrics 132:1146-1154, 2013. Hicks CW, Weber JG, Reid JR, et al: Identifying and managing intracranial complications of sinusitis in children: a retrospective series, Pediatr Infect Dis J 30:222-226, 2011
  167. Kristo A, Uhari M, Luotonen J, et al: Paranasal sinus findings in children during respiratory infection evaluated with magnetic resonance imaging, Pediatrics 111:e586-e589, 2003.
  168. Kristo A, Uhari M: Timing of rhinosinusitis complications in children, Pediatr Infect Dis J 28:769-771, 2009
  169. Little P, Stuart B, Mullee M, et al: Effectiveness of steam inhalation and nasal irrigation for chronic or recurrent sinus symptoms in primary care: a pragmatic randomized controlled study, CMAJ 188(13):940-949, 2016
  170. Patel NA, Garber D, Hu S, Kamat A: Systematic review and case report: intracranial complications of pediatrics sinusitis, Int J Pediatr Otorhinolaryngol 86:200-212, 2016
  171. Piatt JH: Intracranial suppuration complicating sinusitis among children: an epidemiological and clinical study, J Neurosurg Pediatr 7:567-574, 2011
  172. Rosenfeld RM: Acute sinusitis in adults, N Engl J Med 375(10):962-970, 2016.
  173. Shaikh N, Wald ER, Jeong JH, et al: Predicting responses to antimicrobial therapy in children with acute sinusitis, J Pediatr 164:536-541, 2014
  174. Sivaswamy L, Ang J: Intracranial complications of sinusitis, J Pediatr 195:306, 2018. Talbot G, Kennedy D, Scheld W, et al: Rigid nasal endoscopy versus sinus puncture and aspiration for microbiologic documentation of acute bacterial maxillary sinusitis, Clin Infect Dis 33:1668-1675, 2001
  175. Vaidyanathan S, Barnes M, Williamson P, et al: Treatment of chronic rhinosinusitis with nasal polyposis with oral steroids followed by tropical steroids, Ann Intern Med 154:293-302, 2011
  176. Wald ER, Applegate KE, Bordley C, et al: Clinical practice guideline for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years, Pediatrics 132:e262-e280, 2013.
  177. Aertgeerts B, Agoritsas T, Siemieniuk RAC, et al: Corticosteroids for sore throat: a clinical practice guideline, BMJ 358:j4090, 2017.
  178. American Academy of Pediatrics: Group a streptococcal infections. In Kimberlin DW, Brady MT, Jackson MA, et al, editors: Red book: 2015 report of the committee on infectious diseases, ed 30, Elk Grove Village, IL, 2015, American Academy of Pediatrics, pp 732-744.
  179. Byington CL, Ampofo K, Stockmann C, et al: Community surveillance of respiratory viruses among families in the Utah better identification of Germs-longitudinal viral epidemiology (BIG-LoVE) study, Clin Infect Dis 61:1217-1224, 2015.
  180. Centor RM, Atkinson TP, Ratliff AE, et al: The clinical presentation of Fusobacterium- positive and streptococcal-positive pharyngitis in a University health clinic, Ann Intern Med 162:241-247, 2015.
  181. Cohen DM, Russo ME, Jaggi P, et al: Multicenter clinical evaluation of the novel alere i strep a isothermal nucleic acid amplification test, J Clin Microbiol 53:2258-2261, 2015.
  182. Felsenstein S, Faddoul D, Sposto R, et al: Molecular and clinical diagnosis of group a streptococcal pharyngitis in children, J Clin Microbiol 52:3884-3889, 2014.
  183. Fine AM, Nizet V, Mandl KD: Large-scale validation of the centor and McIsaac scores to predict group a streptococcal pharyngitis, Arch Intern Med 172:847-852, 2012.
  184. Gerber MA, Baltimore RS, Eaton CB, et al: Prevention of acute rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis (American heart association scientific statement), Circulation 119:1541-1551, 2009.
  185. Harrist A, Van Houten C, Shulman ST, et al: Group a streptococcal pharyngitis misdiagnosis at a rural urgent-care clinic, Wyoming, March 2015, MMWR 64(50&51): 1383-1385, 2016.
  186. Hayward GN, Hay AD, Moore MV, et al: Effect of oral dexamethasone without immediate antibiotics vs placebo on acute sore throat in adults—a randomized clinical trial, JAMA 317(15):1535-1543, 2017.
  187. Henson AM, Carter D, Todd K, et al: Detection of Streptococcus pyogenes by use of illumigene group a streptococcus assay, J Clin Microbiol 51:4207-4209, 2013.
  188. Hersh AL, Jackson MA, Hicks LA: Principles of judicious antibiotic prescribing for upper respiratory tract infections in pediatrics, Pediatrics 132:1146-1154, 2013.
  189. Hysmith ND, Kaplan EL, Cleary PP, et al: Prospective longitudinal analysis of immune responses in pediatric subjects following pharyngeal acquisition of Group A streptococci, J Pediatr Infect Dis Soc 6(2):187-196, 2017.
  190. Kuppalli K, Livorsi D, Talati NJ, et al: Lemierre's syndrome due to Fusobacterium necrophorum, Lancet Infect Dis 12:808-815, 2012.
  191. Mullarkey C: Soothing a sore throat: the efficacy and safety of steroids in acute pharyngitis, Ir J Med Sci 180:837-840, 2011.
  192. Paradise JL, Bluestone CD, Bachman RZ, et al: Efficacy of tonsillectomy for recurrent throat infection in severely affected children: results of parallel randomized and nonrandomized clinical trials, N Engl J Med 310:674-683, 1984.
  193. Sadeghirad B, Siemienuik RA, Brignardello-Petersen R, et al: Corticosteroids for treatment of sore throat: systematic review and meta-analysis of randomized trials, BMJ 358:j3887, 2017.
  194. Shaikh N, Swaminathan N, Hooper EG: Accuracy and precision of the signs and symptoms of streptococcal pharyngitis in children: a systematic review, J Pediatr 160:487-493, 2012.
  195. Shapiro DJ, Lindgren CE, Neuman MI, Fine AM: Viral features and testing for streptococcal pharyngitis, Pediatrics 139(5):e20163403, 2017.
  196. Shulman ST, Bisno AL, Clegg HW, et al: Clinical practice guideline for the diagnosis and management of group a streptococcal pharyngitis: 2012 update by the infectious diseases society of America, Clin Infect Dis 55(10):e86-e102, 2012.
  197. Tanz RR, Shulman ST: Chronic pharyngeal carriage of group a streptococci, Pediatr Infect Dis J 26:175-176, 2007.
  198. Tanz RR, Zheng XT, Carter DM, et al: Caution needed: molecular diagnosis of pediatric group A streptococcal pharyngitis, J Pediatr Infect Dis Soc 7:e145-e147, 2018.
  199. Van Driesl ML, De Sutter AIM, Keber N, et al: Different antibiotic treatments for group a streptococcal pharyngitis, Cochrane Database Syst Rev (4):CD004406, 2013.
  200. Wessels MR: Streptococcal pharyngitis, N Engl J Med 364:648-655, 2011.
  201. Abdel-Haq N, Quezada M, Asmar BI: Retropharyngeal abscess in children: the rising incidence of methicillin-resistant Staphylococcus aureus, Pediatr Infect Dis J 31:696-699, 2012.
  202. Adil E, Tarshish Y, Roberson D, et al: The public health impact of pediatric deep neck space infections, Otolaryngol Head Neck Surg 153:1036-1041, 2015.
  203. Bandarkar AN, Adeyiga AO, Fordham MT, et al: Tonsil ultrasound: technical approach and spectrum of pediatric peritonsillar infections, Pediatr Radiol 46:1059-1067, 2016.
  204. Bolton M, Wang W, Hahn A, et al: Predictors for successful treatment of pediatric deep neck infections using antimicrobials alone, Pediatr Infect Dis J 32:1034-1036, 2013.
  205. Constantino TG, Satz WA, Dehnkamp W, et al: Randomized trial comparing intraoral ultrasound to landmark-based needle aspiration in patients with suspected peritonsilar abscess, Acad Emerg Med 19:626-631, 2012.
  206. Fordham MT, Rock AN, Bandarkar S, et al: Transcervical ultrasonography in the diagnosis of pediatric peritonsillar abscess, Laryngoscope 125:799-2804, 2015.
  207. Vural C, Gungor A, Comerci S: Accuracy of computerized tomography in deep neck infections in the pediatric population, Am J Otolaryngol 24:143-148, 2003.
  208. Woods CR, Cash ED, Smith AM, et al: Retropharyngeal and parapharyngeal abscesses among children and adolescents in the United States: epidemiology and management trends, 2003-2012, J Pediatric Infect Dis Soc 3:259-268, 2016.
  209. Wright CT, Stocks RSM, Armstrong DL, et al: Pediatric mediastinitis as a complication of methicillin-resistant Staphylococcus aureus retropharyngeal abscess, Arch Otolaryngol Head Neck Surg 134:408-413, 2008.
  210. Amoils M, Chang KW, Saynina O, et al: Postoperative complications in pediatric tonsillectomy and adenoidectomy in ambulatory vs inpatient settings, JAMA Otolaryngol Head Neck Surg 142(4):344-350, 2016.
  211. Baugh RF, Archer SM, Mitchell RB, et al: Clinical practice guideline: tonsillectomy in children, Otolaryngol Head Neck Surg 144(1 Suppl):S1-S30, 2011.
  212. Bonuck KA, Freeman K, Henderson J: Growth and growth biomarker changes after adenotonsillectomy: systematic review and meta-analysis, Arch Dis Child 94:83-91, 2009.
  213. Borgstrom A, Nerfeldt P, Friberg D: Adenotonsillotomy versus adenotonsillectomy in pediatric obstructive sleep apnea: an RCT, Pediatrics 139(4):e20163314, 2017.
  214. Brigger MT, Cunningham MJ, Hartnick CJ: Dexamethasone administration and postoperative bleeding risk in children undergoing tonsillectomy, Arch Otolaryngol Head Neck Surg 136(8):766-772, 2010. doi:10.1001/archoto.2010.133. PMID: 20713751.
  215. Burton MJ, Glasziou PP: Tonsillectomy or adeno-tonsillectomy versus non-surgical treatment for chronic/recurrent acute tonsillitis, Cochrane Database Syst Rev (1):CD001802, 2009.
  216. Buskens E, van Staaij B, van den Akker J, et al: Adenotonsillectomy or watchful waiting in patients with mild to moderate symptoms of throat infections or adenotonsillar hypertrophy, Arch Otolaryngol Head Neck Surg 133:1083-1088, 2007.
  217. De Luca Canto G, Pacheco-Pereira C, Aydinoz S, et al: Adenotonsillectomy complications: a meta-analysis, Pediatrics 136(4):702-718, 2015.
  218. Gallagher TQ, Hill C, Ojha S, et al: Perioperative dexamethasone administration and risk of bleeding following tonsillectomy in children, JAMA 308:1221-1226, 2012.
  219. Goodman DC, Challener GJ: Tonsillectomy: a procedure in search of evidence, J Pediatr 160:716-718, 2012.
  220. Isaacson G: Tonsillectomy care for the pediatrician, Pediatrics 130(2):324-334, 2012. Kelly LE, Rieder M, van den Anker J, et al: More codeine fatalities after tonsillectomy in North American Children, Pediatrics 129:e1343-e1347, 2012.
  221. Kuehn BM: FDA: no codeine after tonsillectomy for children, JAMA 309:1100, 2013. Marcus CL, Moore RH, Rosen CL, et al: A randomized trial of adenotonsillectomy for childhood sleep apnea, N Engl J Med 368:2366-2376, 2013.
  222. Mitchell RB: Adenotonsillectomy for obstructive sleep apnea in children: outcome evaluated by pre- and postoperative polysomnography, Laryngoscope 117:1844-1854, 2007.
  223. Mitchell RB, Archer SM, Ishman SL, et al: Clinical practice guideline: tonsillectomy in children (update), Otolaryngol Head Neck Surg 160(1S):S1-S42, 2019.
  224. Mudd PA, Thottathil P, Giordano T, et al: Association between ibuprofen use and severity of surgically managed post-tonsillectomy hemorrhage, JAMA Otolaryngol Head Neck Surg 143(7):712-717, 2017. doi:10.1001/jamaoto.2016.3839. Published online May 4, 2017.
  225. Oomen KP, Modi VK, Stewart MG: Evidence-based practice: pediatric tonsillectomy, Otolaryngol Clin North Am 45(5):1071-1081, 2012.
  226. Plante J, Turgeon AF, Zarychanski R, et al: Effect of systemic steroids on posttonsillectomy bleeding and reinterventions: meta-analysis of randomized controlled trials, BMJ 345:e5389, 2012.
  227. Sun GH, Auger KA, Aliu O, et al: Posttonsillectomy hemorrhage in children with von Willebrand disease or hemophilia, JAMA Otolaryngol Head Neck Surg 139:245-249, 2013.
  228. Van den Aardweg MTA, Boonacker CWB, Rovers MM, et al: Effectiveness of adenoidectomy in children with recurrent upper respiratory tract infections: open randomized controlled trial, BMJ 343:d5154, 2011.
  229. Wetmore RF: Surgical management of the tonsillectomy and adenoidectomy patient, World J Otorhinolaryngol Head Neck Surg 3(3):176-182, 2017. doi:10.1016/j. wjorl.2017.01.001. Notes: Online publication complete: 3-Mar-2017.
  230. Zautner AE: Adenotonsillar disease, Recent Pat Inflamm Allergy Drug Discov 6(2):121-129, 2012.
  231. Bjornson C, Russell K, Vandermeer B, et al: Nebulized epinephrine for croup in children, Cochrane Database Syst Rev (10):CD006619, 2013.
  232. Garbutt JM, Conlon B, Sterkel R, et al: The comparative effectiveness of prednisolone and dexamethasone for children with croup: a community-based randomized trial, Clin Pediatr (Phila) 52(11):1014-1021, 2013.
  233. Hiebert JC, Zhao YD, Willis EB, et al: Bronchoscopy findings in recurrent croup: a systemic review and meta-analysis, Int J Pediatr Otorhinolaryngol 90:86-90, 2016.
  234. Moore M, Little P: Humidified air inhalation for treating croup: a systematic review and meta-analysis, Fam Pract 24(4):295-301, 2007.
  235. Walner DL, Ouanounou S, Donnelly LF, et al: Utility of radiographs in the evaluation of pediatric upper airway obstruction, Ann Otol Rhinol Laryngol 108:378-383, 1999.
  236. Weber JE, Chudnofsky CR, Younger JG, et al: A randomized comparison of heliumoxygen mixture (Heliox) and racemic epinephrine for the treatment of moderate to severe croup, Pediatrics 107:E96, 2001.
  237. Senior BA, Radkowski D, MacArthur C, et al: Changing patterns in pediatric epiglottis: a multi-institutional review, 1980 to 1992, Laryngoscope 104:1314-1322, 1994.
  238. Verbruggen K, Halewyck S, Deron P, et al: Epiglottitis and related complications in adults. Case reports and review of the literature, B-ENT 8(2):143-148, 2012.
  239. Virk JS, Pang J, Okhovat S, et al: Analysing lateral soft tissue neck radiographs, Emerg Radiol 19(3):255-260, 2012.
  240. Graf J, Stein F: Tracheitis in pediatric patients, Semin Pediatr Infect Dis 17:11–13, 2006.
  241. Huang YL, Peng CC, Chiu NC, et al: Bacterial tracheitis in pediatrics: 12 year experience at a medical center in Taiwan, Pediatr Int 51:110–113, 2009.
  242. Tebruegge M, Pantazidou A, Thorburn K, et al: Bacterial tracheitis: a multi-centre perspective, Scand J Infect Dis 41:548–557, 2009.
  243. Lyons M, Vlastarakos PV, Nikolopoulos TP: Congenital and acquired developmental problems of the upper airway in newborns and infants, Early Hum Dev 88(12):951-955, 2012.
  244. Ryan G, Somme S, Crombleholme TM: Airway compromise in the fetus and neonate: prenatal assessment and perinatal management, Semin Fetal Neonatal Med 21:230-239, 2016.
  245. Zoumalan R, Maddalozzo J, Holinger LD: Etiology of stridor in infants, Ann Otol Rhinol Laryngol 116:329-334, 2007.
  246. Bedwell J, Zalzal G: Laryngomalacia, Semin Pediatr Surg 25(3):119-122, 2016.
  247. Carter J, et al: International Pediatric ORL Group (IPOG) Laryngomalacia Consensus Recommendations.
  248. D'Agostino JA, Passarella M, Martin AE, Lorch SA: Use of gastroesophageal reflux medications in premature infants after NICU discharge, Pediatrics 138(6):e20161977, 2016.
  249. Dickson JM, Richter GT, Derr JM, et al: Secondary airway lesions in infants with laryngomalacia, Ann Otol Rhinol Laryngol 118:37-43, 2009.
  250. Schroeder J, Tharrar K, Poznanovic S, et al: Aspiration following CO2 laser assisted supraglattoplasty, Int J Pediatr Otorhinolaryngol 77:985-990, 2008.
  251. Thompson D: Abnormal integrative function in laryngomalacia, Laryngoscope 117(6 Pt 2 Suppl 114):1-33, 2007.
  252. Thompson DM: Laryngomalacia: factors that influence disease severity and outcomes of management, Curr Opin Otolaryngol Head Neck Surg 18(6):564-570, 2010.
  253. Myer C.M., O'Conner D.M., Cotton R.T.: Proposed grading system for subglottic stenosis based on endotracheal tube sizes, Ann Otol Rhinol Laryngol 103(4 Pt 1):319-323, 1994.
  254. Sandu K, Monnier P: Cricotracheal resection, Otolaryngol Clin North Am 41:988-998, 2008.
  255. Schroeder JW Jr, Holinger LD: Congenital laryngeal stenosis, Otolaryngol Clin North Am 41:865-875, 2008.
  256. Zur K, Carrol L: Recurrent laryngeal nerve reinnervation in children: acoustic and endoscopic characteristics Pre-intervention and Post-intervention. A comparison of treatment options, Laryngoscope Supp 125(11):S1-S15, 2015.
  257. Ambrosiom A, Magit A: Respiratory distress of the newborn: congenital laryngeal atresia, Int J Pediatr Otorhinolaryngol 76(11):1685-1687, 2012.
  258. McElhinney DB, Jacobs I, McDonald-McGinn DM, et al: Chromosomal and cardiovascular anomalies associated with congenital laryngeal web, Int J Pediatr Otorhinolaryngol 66(1):23-27, 2002.
  259. Shah J, White K, Dohar J: Vocal characteristics of congenital anterior glottic webs in children: a case report, Int J Pediatr Otorhinolaryngol 79(6):941-945, 2015.
  260. Durr ML, Meyer NK, Huoh KC, et al: Airway hemangiomas in PHACE syndrome, Laryngoscope 122:2323-2329, 2012.
  261. Hardison S, Wan W, Dodson KM: The use of propranolol in the treatment of subglottic hemangiomas: a literature review and Meta-analysis, Int J Pediatr Otorhinolaryngol 90:175-180, 2016.
  262. Rahbar R, et al: The biology and management of subglottic hemangioma: past, Present, Future, Laryngoscope 114(11):1880-1891, 2004.
  263. Saetti R, Silvestrini M, Cutrone C, et al: Treatment of congenital subglottic hemangiomas: our experience compared with reports in the literature, Arch Otolaryngol Head Neck Surg 134(8):848-851, 2008.
  264. Siegel B, Mehta D: Open airway surgery for subglottic hemangioma in the era of propranolol: is it still indicated, Int J Pediatr Otorhinolaryngol 79(7):1124-1127, 2015.
  265. Civantos FJ, Holinger LD: Laryngoceles and saccular cysts in infants and children, Arch Otolaryngol Head Neck Surg 118:296-300, 1992.
  266. Kirse DJ, Rees CJ, Celmer AW, et al: Endoscopic extended ventriculotomy for congenital saccular cysts of the larynx in infants, Arch Otolaryngol Head Neck Surg 132(7):724-728, 2006.
  267. Parkes WJ, Propst EJ: Advances in the diagnosis, Management, and treatment of neonates with laryngeal disorders, Semin Fetal Neonatal Med 2016.
  268. Alexander NS, et al: Postoperative observation of children after endoscopic type I posterior laryngeal cleft repair, Otolaryngol Head Neck Surg 152(1):153-158, 2015.
  269. Moungthong G, Holinger LD: Laryngotracheoesophageal clefts, Ann Otol Rhinol Laryngol 106:1002-1011, 1997.
  270. Rahbar R, Roullon I, Roger G, et al: The presentation and management of laryngeal cleft, Arch Otolaryngol Head Neck Surg 132:1335-1341, 2006.
  271. Shehab ZP, Bailey CM: Type IV laryngotracheoesophageal clefts—recent 5 year experience at great ormond street hospital for children, Int J Pediatr Otorhinolaryngol 60(1):1-9, 2001.
  272. Backer CL, Monge MC, Popescu AR, et al: Vascular rings, Semin Pediatr Surg 25(3):165-175, 2016.
  273. Backer CM, Mavroudis C, Gerber ME, et al: Tracheal surgery in children: an 18-year review of four techniques, Eur J Cardiothorac Surg 19:777-784, 2001.
  274. Hannemann K, Newman B, Chan F: Congenital variants and anomalies of the aortic arch, Radiographics 37(1):32-51, 2017.
  275. Hofferberth SG, Watters K, Rahbar R, Fynn-Thompson F: Management of congenital tracheal stenosis.
  276. Ywakim R, El-Hakim H: Congenital tracheal stenosis managed conservatively: systematic review of the literature, J Otolaryngol Head Neck Surg 41(4):288-302, 2012.
  277. Barnes NA, Pilling DW: Bronchopulmonary foregut malformations: embryology, radiology and quandary, Eur Radiol 13(12):2659-2673, 2003.
  278. Hills S, Maddalozzo J: Congenital lesions of epithelial origin, Otolaryngol Clin North Am 48(1):209-223, 2015.
  279. American Academy of Pediatrics: Committee on injury, violence, and poison prevention: prevention of choking among children, Pediatrics 125:601-607, 2010.
  280. Archarya K: Rigid bronchoscopy in airway foreign bodies: value of the clinical and radiological signs, Int Arch Otorhinolaryngol 20:196-201, 2016.
  281. Chapin MM, Rochette LM, Annest JL, et al: Nonfatal choking on food among children 14 years or younger in the United States, 2001-2009, Pediatrics 132:275-281, 2013.
  282. Foltran F, Ballali S, Passali FM, et al: Foreign bodies in the airways: a meta-analysis of published papers, Int J Pediatr Otorhinolaryngol 76S:S12-S19, 2012.
  283. Friedman EM, Anthony MD: A five-year analysis of airway foreign body management: toward a better understanding of negative bronchoscopies, Ann Otol Rhinol Laryngol 125(7):591-595, 2016.
  284. Lowe DA, Vasquez R, Maniaci V: Foreign body aspiration in children, Clin Ped Emerg Med 16(3):140-148, 2015.
  285. Maraynes M, Agoritsas K: Inhaled foreign bodies in pediatric patients: proven management techniques in the emergency department, Pediatr Emerg Med Pract 12(10):1-14, 2015.
  286. Rodriguez H, Passali GC, Gregori D, et al: Management of foreign bodies in the airway and oesophagus, Int J Pediatr Otorhinolaryngol 76(Suppl 1):S84-S91, 2012.
  287. Benjamin B, Holinger LD: Laryngeal complications of endotracheal intubation, Ann Otol Rhinol Laryngol 117(Suppl 200):1-20, 2008.
  288. Ida JB, Thompson DM: Pediatric stridor, Otolaryngol Clin North Am 47(5):795-819, 2014.
  289. Markovitz BP, Randolph AG, Khemanu RG: Corticosteroids for the prevention and treatment of post-extubation stridor in neonates, children and adults, Cochrane Database Syst Rev (2):CD001000, 2008.
  290. Rizzi MD, Thorne MC, Zur KB, et al: Laryngotracheal reconstruction with posterior cartilage grafts, Otolaryngol Head Neck Surg 140:348-353, 2009.
  291. Anton-Pacheco JL, Cabezali D, Tejedor R, et al: The role of airway stenting in pediatric tracheobronchial obstruction, Eur J Cardiothorac Surg 33:1069-1075, 2008.
  292. Boogaard R, Huijsmans SH, Pijnenburg MW, et al: Tracheomalacia and bronchomalacia in children: incidence and patient characteristics, Chest 128:3391-3397, 2005.
  293. Carden KA, Boiselle PM, Waltz DA, et al: Tracheomalacia and tracheobronchomalacia in children and adults: an in-depth review, Chest 127:984-1005, 2005.
  294. Kompare M, Weinberger M: Protracted bacterial bronchitis in young children: association with airway malacia, J Pediatr 160:88-92, 2012.
  295. Mahajan AK, Folch E, Khandhar SJ, et al: The diagnosis and management of airway complications following lung transplantation, Chest 2017. pii: S0012-3692(17)30265-9.
  296. Masters IB, Zimmerman PV, Pandeya N, et al: Quantified tracheobronchomalacia disorders and their clinical profiles in children, Chest 133:461-467, 2008.
  297. McNamara VM, Crabbe DC: Tracheomalacia, Paediatr Respir Rev 5:147-154, 2004. Morrison RJ, Hollister SJ, Niedner MF: Mitigation of tracheobronchomalacia with 3d-printed personalized medical devices in pediatric patients, Sci Transl Med 7(285):285ra64, 2015.
  298. Sanchez MO, Greer MC, Masters IB, et al: A comparison of fluoroscopic airway screening with flexible bronchoscopy for diagnosing tracheomalacia, Pediatr Pulmonol 47:63-67, 2012.
  299. Anton-Pacheco JL, Cabezali D, Tejedor R, et al: The role of airway stenting in pediatric tracheobronchial obstruction, Eur J Cardiothorac Surg 33:1069–1075, 2008.
  300. Boogaard R, Huijsmans SH, Pijnenburg MW, et al: Tracheomalacia and bronchomalacia in children: incidence and patient characteristics, Chest 128:3391–3397, 2005.
  301. Carden KA, Boiselle PM, Waltz DA, et al: Tracheomalacia and tracheobronchomalacia in children and adults: an in-depth review, Chest 127:984–1005, 2005.
  302. Kompare M, Weinberger M: Protracted bacterial bronchitis in young children: association with airway malacia, J Pediatr 160:88–92, 2012.
  303. Mahajan AK, Folch E, Khandhar SJ, et al: The diagnosis and management of airway complications following lung transplantation, Chest 2017. pii: S0012-3692(17)30265-9.
  304. Masters IB, Zimmerman PV, Pandeya N, et al: Quantified tracheobronchomalacia disorders and their clinical profiles in children, Chest 133:461–467, 2008.
  305. McNamara VM, Crabbe DC: Tracheomalacia, Paediatr Respir Rev 5:147–154, 2004.
  306. Morrison RJ, Hollister SJ, Niedner MF: Mitigation of tracheobronchomalacia with 3d-printed personalized medical devices in pediatric patients, Sci Transl Med 7(285):285ra64, 2015.
  307. Sanchez MO, Greer MC, Masters IB, et al: A comparison of fluoroscopic airway screening with flexible bronchoscopy for diagnosing tracheomalacia, Pediatr Pulmonol 47:63–67, 2012.
  308. Bauman N, McCarter R, Guzzetta P, et al: Propranolol vs prednisolone for symptomatic proliferating infantile hemangiomas: a randomized clinical trial, JAMA Otolaryngol Head Neck Surg 140(4):323, 2014.
  309. Drolet BA, et al: Initiation and use of propranolol for infantile hemangioma: a report of a consensus conference, Pediatrics 131:128-140, 2013. PMID 23266923.
  310. England R, Banerjee D, Shawber C, et al: Propranolol action is mediated via the beta-2 adrenergic receptor in hemangioma stem cells, Plast Reconstr Surg 131(5):62, 2013.
  311. Hoff SR, Rastatter JC, Richter GT: Head and neck vascular lesions, Otolaryngol Clin North Am 48(1):29-45, 2015.
  312. Behr GG, Johnson C: Vascular anomalies: hemangiomas and beyond—part 1, Fast-flow lesions, AJR Am J Roentgenol 200(2):414-422, 2013.
  313. Behr GG, Johnson CM: Vascular anomalies: hemangiomas and beyond—part 2, Slow-flow lesions, AJR Am J Roentgenol 200(2):423-436, 2013.
  314. Hoff SR, Rastatter JC, Richter GT: Head and neck vascular lesions, Otolaryngol Clin North Am 48(1):29-45, 2015.
  315. Desai DP, Holinger LD, Gonzalez-Crussi F: Tracheal neoplasms in children, Ann Otol Rhinol Laryngol 107(9 Pt 1):790-796, 1998.
  316. Pugnale MJ, Maresh A, Sinha P, et al: Pediatric tracheal tumor masked by a history of travel: case report and literature review, Laryngoscope 125:1004-1007, 2015. doi:10.1002/lary.24968.
  317. Al-Qahtani SR, et al: Endobronchial tumors in children: institutional experience and literature review, J Pediatr Surg 38(5):733-736, 2003.
  318. Alansari K, Toaimah FH, Khalafalla H, et al: Caffeine for the treatment of apnea in bronchiolitis: a randomized trial, J Pediatr 177:204-2011, 2016.
  319. American Academy of Pediatrics: Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection, Pediatrics 134(2):415-418, 2014.
  320. Badgett RG, Vindhyal M, Stirnaman JT, et al: A living systematic review of nebulized hypertonic saline for acute bronchiolitis in infants, JAMA pediatrics 169(8):788-789, 2015.
  321. Byington CL, Wilkes J, Korgenski K, Sheng X: Respiratory syncytial virus-associated mortality in hospitalized infants and young children, Pediatrics 135(1):e24-e31, 2015.
  322. Cunningham S, Nair H, Campbell H: Deciphering clinical phenotypes in acute viral lower respiratory tract infection: bronchiolitis is not an island, Thorax 71(8):679-680, 2016.
  323. Cunningham S, Rodriguez A, Adams T, et al: Oxygen saturation targets in infants with bronchiolitis (BIDS): a double-blind, randomised, equivalence trial, Lancet 386:1041-1048, 2015.
  324. Essouri S, Baudin F, Chevret L, et al: Variability of care in infants with severe bronchiolitis: less-invasive respiratory management leads to similar outcomes, J Pediatr 188:156-162, 2017.
  325. Fernandes RM, Andrade MG, Constant C, et al: Acute viral bronchiolitis: physician perspectives on definition and clinically important outcomes, Pediatr Pulmonol 51(7):724-732, 2016.
  326. Fernandes RM, Bialy LM, Vandermeer B, et al: Glucocorticoids for acute viral bronchiolitis in infants and young children, Cochrane Database Syst Rev (6):CD004878, 2013.
  327. Florin TA, Plint PC, Zorc JJ: Viral bronchiolitis, Lancet 389:211-224, 2017.
  328. Franklin D, Babl FE, Schlapbach LJ, et al: A randomized trial of high-flow oxygen therapy in infants with bronchiolitis, N Engl J Med 378(12):1121-1130, 2018.
  329. Gadomski AM, Scribani MB: Bronchodilators for bronchiolitis, Cochrane Database Syst Rev (6):CD001266, 2014.
  330. Hall CB, Weinberg GA, Blumkin AK, et al: Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age, Pediatrics 132(2):e341-e348, 2013.
  331. Hartling L, Bialy LM, Vandermeer B, et al: Epinephrine for bronchiolitis (review), Cochrane Database Syst Rev (12):CD003123, 2011.
  332. Hasegawa K, Mansbach JM, Camargo CA Jr: Infectious pathogens and bronchiolitis outcomes, Expert Rev Anti Infect Ther 12(7):817-828, 2014.
  333. Hasegawa K, Tsugawa Y, Brown DF, et al: Trends in bronchiolitis hospitalizations in the United States, 2000-2009, Pediatrics 132(1):28-36, 2013.
  334. Henderson J, Granell R, Heron J, et al: Associations of wheezing phenotypes in the first 6 years of life with atopy, lung function and airway responsiveness in mid-childhood, Thorax 63(11):974-980, 2008.
  335. Kepreotes E, Whitehead B, Attia J, et al: Hihg-flow warm humidified oxygen versus standard low-flow nasal cannula oxygen for moderate bronchiolitis (HFWHO RCT): an open, phase 4, randomised controlled trial, Lancet 389(930):939, 2017.
  336. Mahant S, Parkin PC: Apnea in bronchiolitis: challenges of studying an uncommon complication of a common condition, J Pediatr 177:11-12, 2016.
  337. Mansbach JM, Clark S, Teach SJ, et al: Children hospitalized with rhinovirus bronchiolitis have asthma-like characteristics, J Pediatr 172:202-204, 2016.
  338. Mansbach JM, Piedra PA, Teach SJ, et al: Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis, Arch Pediatr Adolesc Med 166:700-706, 2012.
  339. McCulloh R, Koster M, Ralston S, et al: Use of intermittent vs continuous pulse oximetry for nonhypoxemic infants and young children hospitalized for bronchiolitis, JAMA Pediatr 169(10):898-904, 2015.
  340. Meissner HC: Viral bronchiolitis in children, N Engl J Med 374(1):62-72, 2016.
  341. Pignotti MS, Carmela Leo M, Pugi A, et al: Consensus conference on the appropriateness of palivizumab prophylaxis in respiratory syncytial virus disease, Pediatr Pulmonol 51(10):1088-1096, 2016.
  342. Principi T, Coates AL, Parkin PC, et al: Effect of oxygen desaturations on subsequent medical visits in infants discharged from the emergency department with bronchiolitis, JAMA Pediatr 170(6):602-608, 2016.
  343. Ralston SL, Lieberthal AS, Meissner HC, et al: Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis, Pediatrics 134:e1474-e1502, 2014.
  344. Ren CL, Esther CR Jr, Debley JS, et al: Official American thoracic society clinical practice guidelines: diagnostic evaluation of infants with recurrent or persistent wheezing, Am J Respir Crit Care Med 194(3):356-373, 2016.
  345. Stern DA, Morgan WJ, Halonen M, et al: Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study, Lancet 372(9643):1058-1064, 2008.
  346. Thompson M, Vodicka TA, Blair PS, et al: Duration of symptoms of respiratory tract infections in children: systematic review, BMJ 347:f7072, 2013.
  347. Zhang L, Mendoza-Sassi PA, Klassen TP, Wainwright C: Nebulized hypertonic saline for acute bronchiolitis: a systematic review, Pediatrics 136(4):687-701, 2015.
  348. Craven V, Everard ML: Protracted bacterial bronchitis: reinventing an old disease, Arch Dis Child 98:72-76, 2013.
  349. Jones LL, Hashim A, McKeever T, et al: Parental and household smoking and the increased risk of bronchitis, bronchiolitis and other lower respiratory infections in infancy: systematic review and meta-analysis, Respir Res 12:5, 2011.
  350. Shields MD, Bush A, Everard ML, et al: On behalf of the British thoracic society cough guideline group. Recommendations for the assessment and management of cough in children, Thorax 63:iii1-iii15, 2008.
  351. Zgherea D, Pagala S, Mendiratta M, et al: Bronchoscopic findings in children with chronic wet cough, Pediatrics 129(2):e364-e369, 2012.
  352. Dori Y, Itkin M: Etiology and new treatment options for patients with plastic bronchitis, J Thorac Cardiovasc Surg 152(2):e49-e50, 2016.
  353. Dori Y, Keller MS, Rychik J, Itkin M: Successful treatment of plastic bronchitis by selective lymphatic embolization in a fontan patient, Pediatrics 134(2):e590-e595, 2014.
  354. Eberlein MH, Drummond MB, Haponik EF: Plastic bronchitis: a management challenge, Am J Med Sci 335:163-169, 2008.
  355. Kunder R, Kunder C, Sun HY, et al: Pediatric plastic bronchitis: case report and retrospective comparative analysis of epidemiology and pathology, Case Rep Pulmonol 2013:649365, 2013.
  356. Lubcke NL, Nussbaum VM, Schroth M: Use of aerosolized tissue plasminogen activator in the treatment of plastic bronchitis, Ann Pharmacother 47(3):e13, 2013.
  357. Panchabhai TS, Mukhopadhyay S, Sehgal S, et al: Plugs of the air passages: a clini- copathologic review, Chest 150(5):1141-1157, 2016.
  358. Perez Ruiz E, Lopez Castillo MC, Caro Aguilera P, Perez Frias J: Management and treatment of pediatric plastic bronchitis, Arch Bronconeumol 2017 Feb 23.
  359. Rubin BK: Plastic bronchitis, Clin Chest Med 37:405-408, 2016.
  360. Seear M, Hui H, Magee F, et al: Bronchial casts in children: a proposed classification based on nine cases and a review of the literature, Am J Respir Crit Care Med 155:364-370, 1987.
  361. Ugaki S, Lord DJE, Sherwood MC, Winlaw DS: Lymphangiography is a diagnostic and therapeutic intervention for patients with plastic bronchitis after the Fontan operation, J Thorac Cardiovasc Surg 152(2): e47-e49, 3, 2016.
  362. Chao MC, Karamzadeh AM, Ahuja G: Congenital lobar emphysema: an otolaryngologic perspective, Int J Pediatr Otorhinolaryngol 69:549-554, 2005.
  363. Chen IC, Chen YW, Lin SH, et al: Usefulness of combination of pulmonary ventilation and perfusion scintigraphy on the diagnosis of children with unilateral hyperlucent lung, Nucl Med Commun 32:1052-1059, 2011.
  364. Damle NA, Mishra R, Wadhwa JK: Classical imaging triad in a very young child with Swyer-James syndrome, Nucl Med Mol Imaging 46:115-118, 2012.
  365. Guidry C, McGahren ED: Pediatric chest 1: developmental and physiologic conditions for the surgeon, Surg Clin North Am 92:615-643, 2012.
  366. Horak E, Bodner J, Gassner I, et al: Congenital cystic lung disease: diagnostic and therapeutic considerations, Clin Pediatr (Phila) 42:251-261, 2003.
  367. Hwang J, Min BJ, Seo WH: Thoracoscopic imaging of Swyer-james-macleod syndrome in an adolescent patient, J Pediatr 163:2013, 1524.
  368. Karnak I, Senocak ME, Ciftci AO, et al: Congenital lobar emphysema: diagnostic and therapeutic considerations, J Pediatr Surg 34:1347-1351, 1999.
  369. Kim CK, Koh JY, Han YS, et al: Swyer-James syndrome with finger clubbing after severe measles infection, Pediatr Int 50:413-415, 2008.
  370. MacLeod WM: Abnormal transradiancy of one lung, Thorax 9:147-153, 1954.
  371. Mei-Zahar M, Konen O, Manson D, et al: Is congenital lobar emphysema a surgical disease? J Pediatr Surg 41:1058-1061, 2006.
  372. Mets OM, Roothaan SM, Bronsveld I, et al: Emphysema is common in lungs of cystic fibrosis lung transplantation patients: A histopathological and computer tomography study, PLoS ONE 10(6):e0128062, 2015.
  373. Mura M, Zompatori M, Mussoni A, et al: Bullous emphysema versus diffuse emphysema: a functional and radiologic comparison, Respir Med 99:171-178, 2005.
  374. Sunavaia AJ, Thacker HP, Khann JN: Left pulmonary artery hypoplasia presenting with unilateral hyperluscent lung, J Assoc Physicians India 59:179-181, 2011.
  375. Swyer PR, James GCW: A case of unilateral pulmonary emphysema, Thorax 8:133-136, 1952.
  376. Ulku R, Onat S, Ozelik C: Congenital lobar emphysema: differential diagnosis and therapeutic approach, Pediatr Int 50:658-661, 2008.
  377. Wasilewska E, Lee EY, Eisenberg RL: Unilateral hyperlucent lung in children, AJR Am J Roentgenol 198:W400-W414, 2012.
  378. Wong KS, Liu HP, Cheng KS, et al: Pathological case of the month. Primary bullous emphysema with spontaneous pneumothorax, Arch Pediatr Adolesc Med 154:845-856, 2000.
  379. Chapman KR, Burdon JG, Pitulaine E, et al: Intravenous augmentation treatment and lung density in severe alpha 1 antitrypsin deficiency (RAPID): a randomized, double-blind, placebo-controlled trial, Lancet 386:360-368, 2015.
  380. Chiuchiolo MJ, Crystal RG: Gene therapy for alpha-1 antitrypsin deficiency lung disease, Ann Am Thorac Soc 13(Suppl 4):S352-S369, 2016.
  381. Escribano A, Amor M, Pastor S, et al: Decreased glutathione and low catalase activity contribute to oxidative stress in children with alpha-1 antitrypsin deficiency, Thorax 70:82-83, 2015.
  382. Franciosi AN, McCarthy C, McElvaney NG: The efficacy and safety of inhaled human alpha-1 antitrypsin in people with alpha-1 antitrypsin-related emphysema, Expert Rev Respir Med 9:143-151, 2015.
  383. Kueppers F, Sanders C: State-of-the-art testing for alpha-1 antitrypsin deficiency, Allergy Asthma Proc 38:108-114, 2017.
  384. Sandhaus RA, Turino G, Brantly ML, et al: The diagnosis and management of alpha-1 antitrypsin deficiency in the adult, Chronic Obstr Pulm Dis (Miami) 3:668-682, 2016.
  385. Tanash HA, Nystedt-Duzakin M, Montero LC, et al: The Swedish alpha 1-antitrypsin screening study: health status and lung and liver function at age 34, Ann Am Thorac Soc 12:807-812, 2015.
  386. Teckman J, Pardee E, Howell RR, et al: Appropriateness of newborn screening for alpha 1-antitrypsin deficiency, J Pediatr Gastroenterol Nutr 58:199-203, 2014.
  387. Aguilar PR, Michelson AP, Isakow W: Obliterative bronchiolitis, Transplantation 100:272-283, 2016.
  388. Barker AF, Bergeron A, Rom WN, et al: Obliterative bronchiolitis, N Engl J Med 370:1820-1828, 2014.
  389. Champs NS, Lasmar LM, Camargos PA, et al: Post-infectious bronchiolitis obliterans in children, J Pediatr (Rio J) 87(3):187-198, 2011.
  390. Epler GR: Bronchiolitis obliterans organizing pneumonia, Arch Intern Med 161:158-164, 2001.
  391. Fischer GB, Sarria EE, Mattiello R, et al: Post infectious bronchiolitis obliterans in children, Paediatr Respir Rev 11:233-239, 2010.
  392. Fullmer JJ, Fan LL, Dishop MK, et al: Successful treatment of bronchiolitis obliterans in a bone marrow transplant patient with tumor necrosis factor-a blockade, Pediatrics 116:767-770, 2005.
  393. Kurland G, Michelson P: Bronchiolitis obliterans in children, Pediatr Pulmonol 39:193-208, 2005.
  394. Moonnumakal SP, Fan LL: Bronchiolitis obliterans in children, Curr Opin Pediatr 20:272-278, 2008.
  395. Todd JL, Palmer SM: Bronchiolitis obliterans syndrome, Chest 140:502-508, 2011.
  396. Weber DJ, Wilkes DS: The role of autoimmunity in obliterative bronchiolitis after lung transplantation, Am J Physiol Lung Cell Mol Physiol 304(5):L307-L311, 2013.
  397. Bramson RT, Cleveland R, Blickman JG, et al: Radiographic assessment of follicular bronchitis in children, AJR Am J Roentgenol 166:1447–1450, 1996.
  398. Kinane BT, Mansell AL, Zwerdling RG, et al: Follicular bronchitis in the pediatric population, Chest 104:1183–1186, 1993.
  399. Castellana G, Castellana G, Gentile M, et al: Pulmonary alveolar microlithiasis: review of the 1022 cases reported worldwide, Eur Respir Rev 24(138):607-620, 2015.
  400. Corut A, Senyigit A, et al: Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possible associated with testicular microlithiasis, Am J Hum Genet 79:650-656, 2006.
  401. Saito A, McCormick FX: Pulmonary alveolar microlithiasis, Clin Chest Med 37:441-448, 2016.
  402. Dillman JR, Sanchez R, Ladino-Torres MF, et al: Expanding upon the unilateral hyperlucent hemithorax in children, Radiographics 31(3):723–741, 2011.
  403. Kim K, Min KH, Park SJ, et al: Right pulmonary agenesis in a 12-year-old girl, Am J Respir Crit Care Med 184(6):742–743, 2011.
  404. Pierron C, Sigal-Cinqualbre A, Lambert V, et al: Left pulmonary artery sling with right lung aplasia, J Pediatr Surg 46(11):2190–2194, 2011.
  405. Parikh DH, Rasiah SV: Congenital lung lesions: postnatal management and outcome, Semin Pediatr Surg 24(4):160-167, 2015.
  406. Puligandla PS, Laberge JM: Congenital lung lesions, Clin Perinatol 39(2):331-347, 2012.
  407. Vergani P: Prenatal diagnosis of pulmonary hypoplasia, Curr Opin Obstet Gynecol 24(2):89-94, 2012.
  408. Baird R, Puligandla PS, Laberge JM: Congenital lung malformations: informing best practice, Semin Pediatr Surg 23(5):270-277, 2014.
  409. Kotecha S, Barbato A, Bush A, et al: Antenatal and postnatal management of congenital cystic adenomatoid malformation, Paediatr Respir Rev 13(3):162-170, quiz 170-171, 2012.
  410. Singh R, Davenport M: The argument for operative approach to asymptomatic lung lesions, Semin Pediatr Surg 24(4):187-195, 2015.
  411. Abbey P, Das CJ, Pangtey GS, et al: Imaging in bronchopulmonary sequestration, J Med Imaging Radiat Oncol 53(1):22-31, 2009.
  412. Adzick NS: Management of fetal lung lesions, Clin Perinatol 36(2):363-376, 2009.
  413. Chien KJ, Huang TC, Lin CC, et al: Early and late outcomes of coil embolization of pulmonary sequestration in children, Circ J 73:938-942, 2009.
  414. Lee BS, Kim JT, Kim EA, et al: Neonatal pulmonary sequestration: clinical experience with transumbilical arterial embolization, Pediatr Pulmonol 43:404-414, 2008.
  415. Chowdhury MM, Chakraborty S: Imaging of congenital lung malformations, Semin Pediatr Surg 24(4):168-175, 2015.
  416. Fievet L, D'Journo XB, Guys JM, et al: Bronchogenic cyst: best time for surgery? Ann Thorac Surg 94(5):1695-1699, 2012.
  417. Maurin S, Hery G, Bourliere B, et al: Bronchogenic cyst: clinical course from antenatal diagnosis to postnatal thoracoscopic resection, J Minim Access Surg 9(1):25-28, 2013.
  418. Boland J.M., Tazelaar H.D., Colby T.V., et al: Diffuse pulmonary lymphatic disease presenting as interstitial lung disease in adulthood: report of 3 cases, Am J Surg Pathol 36(10):1548-1554, 2012.
  419. Melee P, Sridhar S: Congenital pulmonary lymphangiectasia: an unusual presentation of nonimmune hydrops in a preterm infant, Adv Neonatal Care 12(3):166-171, 2012.
  420. Yuan SM: Congenital pulmonary lymphangiectasia, J Perinat Med 2017. [Epub ahead of print].
  421. Maeda T, Sato R, Luthe SK, Russell MC: Spontaneous intercostal lung hernia, Am J Med 2017. [Epub ahead of print].
  422. Zia Z, Bashir O, Ramjas GE, et al: Intercostal lung hernia: radiographic and MDCT findings, Clin Radiol 68(7):e412-e417, 2013.
  423. Kim MJ, Kim SH, Hwang IK, et al: Presence of bilirubin in bronchobiliary fistula easily confirmed with urinary dipstick test and treated with embolization, Korean J Intern Med 32(1):182-185, 2017.
  424. Sachdev A, Chugh K, Krishana A, et al: Congenital tracheobiliary fistula: a case report with review of literature, Pediatr Surg Int 27(8):899-905, 2011.
  425. Baumann A, Audibert G, Mertes PM, et al: Neurogenic pulmonary edema, Acta Anaesthesiol Scand 51:447-455, 2007.
  426. Berthiaume Y, Matthay M: Alveolar fluid clearance and acute lung injury, Respir Physiol Neurobiol 159(3):350-359, 2007.
  427. Fremont RD, Matthay MA, Ware LB, et al: Postobstructive pulmonary edema: a case for hydrostatic mechanisms, Chest 131(6):1742-1746, 2007.
  428. Hornik C, Meliones J: Pulmonary edema and hypoxic respiratory failure, Pediatr Crit Care Med 17(8):S178-S181, 2016.
  429. Masip J, Roque M, Sanchez B, et al: Noninvasive ventilation in acute cardiogenic pulmonary edema, JAMA 294:3124-3130, 2005.
  430. Matthay MA, Ware LB, Zimmerman GA: The acute respiratory distress syndrome, J Clin Invest 122(8):2731-2740, 2012.
  431. Mehta VM, Har-El G, Goldstein NA: Postobstructive pulmonary edema after laryngospasm in the otolaryngology patient, Laryngoscope 116:1693-1696, 2006.
  432. Mutlu GM, Sznajder JI: Mechanisms of pulmonary edema clearance, Am J Physiol Lung Cell Mol Physiol 289:L685-L695, 2005.
  433. O'Brodovich H: Pulmonary edema in infants and children, Curr Opin Pediatr 17:381-384, 2005.
  434. Peter JV, Moran JL, Phillips-Hughes J, et al: Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema: a meta-analysis, Lancet 367:1155-1162, 2006.
  435. West JB: High altitude medicine, Am J Respir Crit Care Med 186(12):1229-1237, 2012.
  436. Brady M, Kinn S, Ness V, et al: Preoperative fasting for preventing perioperative complications in children, Cochrane Database Syst Rev (4):CD005285, 2009.
  437. Bronstein AC, Spyker DA, Cantilena LR Jr, et al: 2009 annual report of the American association of poison control Centers' national poison data system (NPDS): 27th annual report, Clin Toxicol (Phila) 48:979, 2010.
  438. Colombo JL, Thomas HM: Aspiration syndromes. In Taussig LM, Landau LI, editors: Pediatric respiratory medicine, ed 2, Philadelphia, 2008, Mosby/Elsevier, pp 337-345.
  439. Johr M: Anaesthesia for the child with a full stomach, Curr Opin Anaesthesiol 20:201-203, 2007.
  440. LaMantia AS, Moody SA, Maynard TM, et al: Hard to swallow: developmental biological insights into pediatric dysphagia, Dev Biol 409(2):329-342, 2016.
  441. Makrygianni EA, Palamidou F, Kaditis AG: Respiratory complications following hydrocarbon aspiration in children, Pediatr Pulmonol 51:560-569, 2016.
  442. Mandell LA, Niederman MS: Aspiration pneumonia, N Engl J Med 380(7):651-662, 2019. Mickiewicz M, Gomez HF: Hydrocarbon toxicity: general review and management guidelines, Air Med J 20:8-11, 2001.
  443. Raghavendran K, Nemzek J, Napolitano LM, et al: Aspiration-induced lung injury, Crit Care Med 39(4):818-826, 2011.
  444. Tutor JD, Gosa MM: Dysphagia and aspiration in children, Pediatr Pulmol 47(4):321-337, 2012.
  445. Hoving MF, Brand PL: Causes of recurrent pneumonia in children in a general hospital, J Paediatr Child Health 49(3):E208-E212, 2013.
  446. LaMantia AS, Moody SA, Maynard TM, et al: Dev Biol 402(2):329-342, 2016.
  447. Kyzima Strowd L, Pillsbury D, Valley T, et al: Dysphagia dietary guidelines and the rheology of nutritional feeds and barium test feeds, Chest 133(6):1397-1401, 2008.
  448. Makrygianni EA, Palamidou F, Kaditis AG: Respiratory complications following hydrocarbon aspiration in children, Pediatr Pulmonol 51:560-569, 2016.
  449. Raghavendran K, Nemzek J, Napolitano LM, et al: Asiration-induced lung injury, Crit Care Med 39(4):818-826, 2011.
  450. Reilly BK, Katz ES, Misono AS, et al: Utilization of lipid laden macrophage index in evaluation of aerodigestive disorders, Laryngoscope 121(5):1055-1059, 2011.
  451. Srivastava R, Downey EC, O'Gorman M, et al: Impact of fundoplication versus gastrojejunal feeding tubes on mortality and in preventing aspiration pneumonia in young children with neurologic impairment who have gastroesophageal reflux disease, Pediatrics 123:338-345, 2009.
  452. Tutor JD, Gosa MM: Dysphagia and aspiration in children, Pediatr Pulmonol 47(4):321-337, 2012.
  453. Wallis C, Ryan M: Assessing the role of aspiration in pediatric lung disease, Pediatr Allergy Immunol Pulmonol 25(3):2012.
  454. Weir K, McMahon S, Barry L, et al: Clinical signs and symptoms of oropharyngeal aspiration and dysphagia in children, Eur Respir J 33:604-611, 2009.
  455. Weir K, McMahon S, Chang AB: Restriction of oral intake of water for aspiration lung disease in children, Cochrane Database Syst Rev (9):CD005303, 2012.
  456. Weir KA, McMahon S, Taylor S, et al: Oropharyngeal aspiration and silent aspiration in children, Chest 140(3):589-597, 2011.
  457. Buchvald F, Petersen BL, Damgaard K, et al: Frequency, treatment, and functional outcome in children with hypersensitivity pneumonitis, Pediatr Pulmonol 46: 1098-1107, 2011.
  458. Douglass JA, Sandrini A, Holgate S, et al: Allergic bronchopulmonary aspergillosis and hypersensitivity pneumonitis. In Adkinson NF, editor: Middleton's allergy principles and practice, Philadelphia, NY, 2014, Elsevier, pp 1000-1013.
  459. Girard M, Israel-Assayag E, Cormier Yl: Impaired function of regulatory T-cells in hypersensitivity pneumonitis, Eur Respir J 37:632-639, 2011.
  460. Hanak V, Golbin JM, Hartman TE, et al: High-resolution CT findings of parenchymal fibrosis correlate with prognosis in hypersensitivity pneumonitis, Chest 134:133, 2008.
  461. Hanak V, Golbin JM, Ryu JH: Causes and presenting features in 85 consecutive patients with hypersensitivity pneumonitis, Mayo Clin Proc 82:812, 2007.
  462. Lacasse Y, Girard M, Cormier Y: Recent advances in hypersensitivity pneumonitis, Chest 142(1):208-217, 2012.
  463. Selman M, Pardo A, King TE Jr: Hypersensitivity pneumonitis: insights in diagnosis and pathobiology, Am J Respir Crit Care Med 186:314, 2012.
  464. Brooks SM, Weiss MA, Bernstein IL: Reactive airways dysfunction syndrome (RADS). Persistent asthma syndrome after high level irritant exposures, Chest 88:376, 1985.
  465. Kelly KJ: Immune and inflammatory lung disease. In Kliegman RM, Stanton B, St Geme J, Schor NJ, editors: Nelson textbook of pediatrics, Philadelphia, PA, 2015, Elsevier/Saunders, pp 2067-2088.
  466. Kelly KJ, Wang ML, Klancnik M, et al: Prevention of IgE sensitization in healthcare workers, J Occup Environ Med 53(8):934-940, 2011.
  467. Lemiere C, Vandenplas O: Occupational allergy and asthma. In Adkinson NF, editor: Middleton's allergy principles and practice, Philadelphia, PA, 2014, Elsevier, pp 970-985.
  468. Levy BS, Wegman DH, Baron SL, editors: Occupational and environmental health: recognizing and preventing disease and injury, Philadelphia, PA, 2006, Lippincott Williams & Wilkins.
  469. Tarlo SM, Balmes J, Balkissoon R, et al: Diagnosis and management of work-related asthma: American College of chest physicians consensus statement, Chest 134:1S-41S, 2008.
  470. Vandenplas O, Wiszniewska M, Raulf M, et al: EAACI position paper: irritant-induced asthma, Allergy 69(9):1141-1153, 2014.
  471. Case studies in environmental medicine: beryllium toxicity. Agency for Toxic Substances & Disease Registry website.
  472. Chase NM, Verbsky JW, Hintermeyer MK, et al: Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID), J Clin Immunol 33:30, 2013.
  473. Culver DA: Sarcoidosis, Immunol Allergy Clin North Am 32(4):487-511, 2012.
  474. Dai S, Murphy GA, Crawford F, et al: Crystal structure of HLA-DP2 and implications for chronic beryllium disease, Proc Natl Acad Sci USA 107:7425, 2010.
  475. Falta MT, Pinilla C, Mack DG, et al: Identification of beryllium-dependent peptides recognized by CD4+ T cells in chronic beryllium disease, J Exp Med 210:1403, 2013.
  476. Guillevin L, Pagnoux C, Karras A, et al: Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis, N Engl J Med 371(19):1771-1780, 2014.
  477. Hiemstra TF, Walsh M, Mahr A, et al: Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial, JAMA 304(21):2381-2388, 2010.
  478. Jayne DR, Gaskin G, Rasmussen N, et al: Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis, J Am Soc Nephrol 18(7):2180-2188, 2007.
  479. Maier LA, Barkes BQ, Mroz M, et al: Infliximab therapy modulates an antigen-specific immune response in chronic beryllium disease, Respir Med 106:2012, 1810.
  480. Maier LA, Martyny JW, Liang J, et al: Recent chronic beryllium disease in residents surrounding a beryllium facility, Am J Respir Crit Care Med 177:1012, 2008.
  481. Martin AK, Mack DG, Falta MT, et al: Beryllium-specific CD4+ T cells in blood as a biomarker of disease progression, J Allergy Clin Immunol 128:1100, 2011.
  482. Myers JL, Tazelaar HD: Challenges in pulmonary fibrosis: 6—problematic granulomatous lung disease, Thorax 63(1):78-84, 2008.
  483. Pagnoux C, Mahr A, Hamidou MA, et al: Azathioprine or methotrexate maintenance for ANCA-associated vasculitis, N Engl J Med 359(26):2790, 2008.
  484. Pott GB, Palmer BE, Sullivan AK, et al: Frequency of beryllium-specific, TH1-type cytokine-expressing CD4+ T cells in patients with beryllium-induced disease, J Allergy Clin Immunol 115:1036, 2005.
  485. Sneller MC, Fontana JR, Shelhamer JH: Immunologic nonasthmatic diseases of the lung. In Adkinson NF, editor: Middleton's allergy principles and practice, Philadelphia, PA, 2014, Elsevier, pp 1014-1031.
  486. Sood A, Beckett WS, Cullen MR: Variable response to long-term corticosteroid therapy in chronic beryllium disease, Chest 126:2004, 2000.
  487. Stone JH, Merkel PA, Spiera R, et al: Rituximab versus cyclophosphamide for ANCA- associated vasculitis, N Engl J Med 363(3):221-232, 2010.
  488. Van Dyke MV, Martyny JW, Mroz MM, et al: Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers, Am J Respir Crit Care Med 183:2011, 1680.
  489. Brackel CLH, Ropers FG, Vermaas-Fricot SFN, et al: Acute eosinophilic pneumonia after recent start of smoking, Lancet 385:1150, 2015.
  490. Cottin V, Cordier JF: Eosinophilic lung diseases, Immunol Allergy Clin North Am 32(4):557-586, 2012.
  491. Erasmus JJ, McAdams HP, Rossi SE: High-resolution CT of drug-induced lung disease, Radiol Clin North Am 40:61, 2002.
  492. Gibson PG: Allergic bronchopulmonary aspergillosis, Semin Respir Crit Care Med 27:185, 2006.
  493. Simon H, Rothenberg ME, Bochner BS, et al: Refining the definition of hypereosinophilic syndrome, J Allergy Clin Immunol 126:45, 2010.
  494. Uchiyama H, Suda T, Nakamura Y, et al: Alterations in smoking habits are associated with acute eosinophilic pneumonia, Chest 133:1174, 2008.
  495. American thoracic society/European respiratory society international multidisciplinary consensus society: classification of the idiopathic interstitial pneumonias, Am J Respir Crit Care Med 165:277-304, 2002.
  496. Brody AS: Imaging consideration: interstitial lung disease in children, Radiol Clin North Am 43:391-403, 2005.
  497. Clement A, Eber E: Interstitial lung diseases in infants and children, Eur Respir J 31:658-666, 2008.
  498. Dempsey OJ, Kerr KM, Remmen H, et al: How to investigate a patient with suspected interstitial lung disease, BMJ 340:1294-1299, 2010.
  499. Deterding R: Evaluating infants and children with interstitial lung disease, Semin Respir Crit Care Med 28:333-341, 2007.
  500. Deutsch GH, Young LR, Deterding RR, et al: Diffuse lung disease in young children: application of a novel classification scheme, Am J Respir Crit Care Med 176:1120-1128, 2007.
  501. Dishop MK: Paediatric interstitial lung disease: classification and definitions, Paediatr Respir Rev 12:230-237, 2011.
  502. Doan ML, Guillerman RP, Dishop MK, et al: Clinical, radiological and pathological features of ABCA3 mutations in children, Thorax 63:366-373, 2008.
  503. Eldridge WB, Zhang Q, Faro A, et al: Outcomes of lung transplantation for infants and children with genetic disorders of surfactant metabolism, J Pediatr 184:157-164, 2017. Fan LL, Dishop MK, Galambos C, et al: Diffuse lung disease in biopsied children 2 to 18 years of age. Application of the chILD classification scheme, Ann Am Thorac Soc 12(10):1498-1505, 2015.
  504. Fischer A, du Bois R: Interstitial lung disease in connective tissue disorders, Lancet 380:689-698, 2012.
  505. Griese M: Pulmonary alveolar proteinosis: a comprehensive clinical perspective, Pediatrics 140(2):e20170610, 2017.
  506. Griese M, Lorenz E, Hengst M, et al: Surfactant proteins in pediatric interstitial lung disease, Pediatr Res 79(1):34-41, 2016.
  507. Gupta A, Zheng SL: Genetic disorders of surfactant protein dysfunction: when to consider and how to investigate, Arch Dis Child 102:84-90, 2017.
  508. Hamvas A, Cole FS, Nogee LM: Genetic disorders of surfactant proteins, Neonatology 91:311-317, 2007.
  509. Hepping N, Griese M, Lohse P, et al: Successful treatment of neonatal respiratory failure caused by a novel surfactant protein C p.Cys121gly mutation with hydroxychloroquine, J Perinatol 33:492-494, 2013.
  510. Huaringa AJ, Francis WH: Pulmonary alveolar proteinosis: a case report and world literature review, Respirol Case Rep 4(6):e00201, 2016.
  511. Hunninghake GM, Hatabu H, Okajima Y, et al: MUC5b promoter polymorphism and interstitial lung abnormalities, N Engl J Med 368:2192-2200, 2013.
  512. Kuo CS, Desai TJ: Cellular mechanisms of alveolar pathology in childhood interstitial lung diseases: current insights from mouse genetics, Curr Opin Pediatr 27:3410347, 2015.
  513. Kuo CS, Young LR: Interstitial lung disease in children, Curr Opin Pediatr 26:320-327, 2014.
  514. Langston C, Dishop MK: Diffuse lung disease in infancy: a proposed classification applied to 259 diagnostic biopsies, Pediatr Dev Pathol 9:173-180, 2009.
  515. Lazor R, Bigay-Game L, Cottin V, et al: Alveolar hemorrhage in anti-basement membrane antibody disease: a series of 28 cases, Medicine (Baltimore) 86:181, 2007.
  516. Levy JB, Hammad T, Coulthart A, et al: Clinical features and outcome of patients with both ANCA and anti-GBM antibodies, Kidney Int 66:2004, 1535.
  517. Lopez-Andreu JA, Hidalgo-Santos A, Fuentes-Castello MA, et al: Delayed presentation and prolonged survival of a child with surfactant protein B deficiency, J Pediatr 190:268-270, 2017.
  518. Pedchenko V, Bondar O, Fogo AB, et al: Molecular architecture of the goodpasture autoantigen in anti-GBM nephritis, N Engl J Med 363:343, 2010.
  519. Rabach I, Poli F, Zennaro F, et al: Is treatment with hydroxychloroquine effective in surfactant protein C deficiency?, Arch Bronconeumol 49(5):213-215, 2013.
  520. Soares JJ, Deutsch GH, Moore PE, et al: Childhood interstitial lung diseases: an 18-year retrospective analysis, Pediatrics 132:684-691, 2013.
  521. Spagnolo P, Bush A: Interstitial lung disease in children younger than 2 years, Pediatrics 137(6):e20152725, 2016.
  522. Vece TJ, Fan LL: Diagnosis and management of diffuse lung disease in children, Paediatr Respir Rev 12(4):238-242, 2011.
  523. Brody AS, Guillerman RP, Hay TC, et al: Neuroendocrine cell hyperplasia of infancy: diagnosis with high-resolution CT, AJR Am J Roentgenol 194:238-244, 2010.
  524. Cutz E: Hyperplasia of pulmonary neuroendocrine cells in infancy and childhood, Semin Diagn Pathol 32:420-437, 2015.
  525. Deutsch GH, Young LR, Deterding RR, et al: Diffuse lung disease in young children: application of a novel classification scheme, Am J Respir Crit Care Med 176:1120-1128, 2007.
  526. Houin PR, Deterding RR, Young LR: Exacerbations in neuroendocrine cell hyperplasia of infancy are characterized by increased air trapping, Pediatr Pulmonol 51:E9-E12, 2016.
  527. Kerby GS, Wagner BD, Popler J, et al: Abnormal infant pulmonary function in young children with neuroendocrine cell hyperplasia of infancy, Pediatr Pulmonol 48:1008-1015, 2013.
  528. Langston C, Dishop MK: Diffuse lung disease in infancy: a proposed classification applied to 259 diagnostic biopsies, Pediatr Dev Pathol 12:421-437, 2009.
  529. Lukkarinen H, Pelkonen A, Lohi J, et al: Neuroendocrine cell hyperplasia of infancy: a prospective follow-up of nine children, Arch Dis Child 98:141-144, 2013.
  530. Nevel RJ, Garnett ET, Worrell JA, et al: Persistent lung disease in adults with NKX2.1 mutation and familial neuroendocrine cell hyperplasia of infancy, Ann Am Thorac Soc 13:1299-1304, 2016.
  531. Popler J, Wagner BD, Tarro HL, et al: Bronchoalveolar lavage fluid cytokine profiles in neuroendocrine cell hyperplasia of infancy and follicular bronchiolitis, Orphanet J Rare Dis 8:175, 2013.
  532. Young LR, Brody AS, Inge TH, et al: Neuroendocrine cell distribution and frequency distinguish neuroendocrine cell hyperplasia of infancy from other pulmonary disorders, Chest 139:1060-1071, 2011.
  533. Fan Leland L, et al: Diffuse lung disease in biopsied children 2 to 18 years of age.
  534. Application of the child classification scheme, Ann Am Thorac Soc 12(10):1498-1505, 2015.
  535. Hansell DM, Bankier AA, MacMahon H, et al: Fleischner society: glossary of terms for thoracic imaging 1, Radiology 246(3):697-722, 2008.
  536. King Jr Talmadge E, et al: A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis, N Engl J Med 370(22):2083-2092, 2014.
  537. Lederer DJ, Martinez FJ: Idiopathic pulmonary fibrosis, N Engl J Med 378(19):1811-1822, 2018.
  538. Meyer KC: Pulmonary fibrosis, part 1: epidemiology, pathogenesis, and diagnosis, Expert Rev Respir Med 11(5):343-359, 2017.
  539. Richeldi L, et al: Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis, N Engl J Med 370(22):2071-2082, 2014.
  540. Richeldi L, Collard HR, Jones MG: Idiopathic pulmonary fibrosis, Lancet 389:2017.
  541. Vij R, Strek ME: Diagnosis and treatment of connective tissue disease-associated interstitial lung disease, Chest 143(3):814-824, 2013.
  542. Ambroggio L, Taylor JA, Tabb LP, et al: Comparative effectiveness of empiric [3 -lactam monotherapy and ?-lactam-macrolide combination therapy in children hospitalized with community-acquired pneumonia, J Pediatr 161:1097-1103, 2012.
  543. Angoulvant F, Levy C, Grimprel E, et al: Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children, Clin Infect Dis 58:918-924, 2014.
  544. Baumann P, Baer G, Bonhoeffer J, et al: Procalcitonin for diagnostics and treatment decisions in pediatric lower respiratory tract infections, Frontiers Pediatr 5:183, 2017.
  545. Biondi E, McCulloh R, Alverson B, et al: Treatment of mycoplasma pneumonia: a systematic review, Pediatrics 133:1081-1090, 2014.
  546. Blaschke AJ, Heyrend C, Byington CL, et al: Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema, Pediatr Infect Dis J 30:289-294, 2011.
  547. Bradley JS, Arguedas A, Blumer JL, et al: Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia, Pediatr Infect Dis J 26:868-878, 2007.
  548. Bradley JS, Byington CL, Shah SS, et al: The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the pediatric infectious diseases society and the infectious diseases society of America, Clin Infect Dis 53(7):617-630, 2011.
  549. Centers for Disease Control and Prevention: Hantavirus pulmonary syndrome in five pediatric patients, four states, 2009, MMWR Morb Mortal Wkly Rep 58:1409-1412, 2009.
  550. Centers for Disease Control and Prevention: Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine—United States, 1997-2006, MMWR Morb Mortal Wkly Rep 58:1-4, 2009.
  551. Chisti MJ, Salam MA, Smith JH, et al: Bubble continuous positive airway pressure for children with severe pneumonia and hypoxaemia in Bangladesh: an open, randomized controlled trial, Lancet 386:1057-1065, 2015.
  552. Cohen E, Mahant S, Dell SD, et al: The long-term outcomes of pediatric pleural empyema, Arch Pediatr Adolesc Med 166:999-1004, 2012.
  553. De Schutter I, De Wachter E, Crokaert F, et al: Microbiology of bronchoalveolar lavage fluid in children with acute nonresponding or recurrent community-acquired pneumonia: identification of nontypeable Haemophilus influenzae as a major pathogen, Clin Infect Dis 52:1437-1444, 2011.
  554. Dickson RP, Erb-Downward JR, Huffnagle GB: Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis, Lancet Respir Med 2(3):238-246, 2014.
  555. Dowell SF, Kupronis BA, Zell ER, et al: Mortality from pneumonia in children in the United States, 1939 through 1996, N Engl J Med 342(19):1399-1407, 2000.
  556. Flood RG, Badik J, Aronoff SC: The utility of serum C-reactive protein in differentiating bacterial from nonbacterial pneumonia in children, Pediatr Infect Dis J 27:95-99, 2008.
  557. Griffin MR, Mitchel E, Moore MR, et al: Declines in pneumonia hospitalizations of children aged <2 years associated with use of pneumococcal conjugate vac- cines—Tennessee, 1998-2012, MMWR Morb Mortal Wkly Rep 63(44):995-998, 2014.
  558. Haider BA, Saeed MA, Bhutta ZA: Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months, Cochrane Database Syst Rev (16):CD005976, 2008.
  559. Hazir T, Fox LM, Nisar YB, et al: Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomized equivalency trial, Lancet 371:49-56, 2008.
  560. Hsieh YC, Wang CW, Lai SH, et al: Necrotizing pneumococcal pneumonia with bronchopleural fistula among children in Taiwan, Pediatr Infect Dis J 30:740-744, 2011.
  561. Insa R, Marin M, Martin A, et al: Systematic use of universal 16s rRNA gene polymerase chain reaction (PCR) and sequencing for processing pleural effusions improves conventional culture techniques, Medicine (Baltimore) 91:103-110, 2012.
  562. Kusel MMH, de Klerk NH, Holt PG, et al: Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life: a birth cohort study, Pediatr Infect Dis J 25:680-686, 2006.
  563. Llamas-Alvarez AM, Tenza-Lozano EM, Latour-Perez J: Accuracy of lung ultrasonography in the diagnosis of pneumonia in adults, Chest 151(2):374-382, 2017.
  564. McClurg RP, Roth DM, Vigar M, et al: Waterborne disease outbreaks associated with environmental and undetermined exposures to water — United States, 2013-2014, MMWR 66(44):1222-1225, 2017.
  565. Muscedre J: Which antibiotic for hospital acquired pneumonia caused by MRSA?, BMJ 348:10, 2014.
  566. Myers AL, Hall M, Williams DJ, et al: Prevalence of bacteremia in hospitalized pediatric patients with community-acquired pneumonia, Pediatr Infect Dis J 32:736-740, 2013.
  567. Pereda MA, Chavez MA, Hooper-Miele CC, et al: Lung ultrasound for the diagnosis of pneumonia in children: a meta-analysis, Pediatrics 135(4):714-722, 2015.
  568. Prina E, Ranzani OT, Torres A: Community-acquired pneumonia, Lancet 386:1097-1108, 2015.
  569. Rahman NM, Maskell NA, West A, et al: Intrapleural use of tissue plasminogen activator and DNase in pleural infection, N Engl J Med 365:518-526, 2011.
  570. Rours GIJG, Hammerschlag MR, Van Doorman GJJ, et al: Chlamydia trachomatis respiratory infection in Dutch infants, Arch Dis Child 94:705-707, 2009.
  571. Ruuskanen O, Lahti E, Jennings LC, et al: Viral pneumonia, Lancet 377:1264-1274, 2011. Schroeder AR, Ralston SL: Viral resting for pediatric respiratory infections—why precise diagnoses do not always translate to patient benefit, JAMA 318(5):472-473, 2017. Schuetz P, Wirz Y, Sager R, et al: Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections (review), Cochrane Database System Rev (10):Art. No.: CD007498, 2017.
  572. Schuetz P, Wirz Y, Sager R, et al: Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis, Lancet 18(1):95-107, 2018.
  573. Scicluna BP, Klein Klouwenberg PM, van Vught LA, et al: A molecular biomarker to diagnose community-acquired pneumonia on intensive care unit admission, Am J Respir Crit Care Med 192:826-835, 2015.
  574. Schuetz P, Christ-Crain M, Thomann R, et al: Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections, JAMA 302:1059-1066, 2009.
  575. Self WH, Wunderink RG, Williams DJ, et al: Staphylococcus aureus community-acquired pneumonia: prevalence, clinical characteristics, and outcomes, CID 63:300-309, 2016.
  576. Shah SS, Bachur RG, Simel DL, Neuman MI: Does this child have pneumonia? The rational clinical examination systematic review, JAMA 318(5):462-471, 2017.
  577. Shah SS, DiCristina CM, Bell LM, et al: Primary early thoracoscopy and reduction in length of hospital stay and additional procedures among children with complicated pneumonia, Arch Pediatr Adolesc Med 162:675-681, 2008.
  578. Shah SS, Dugan MH, Bell LM, et al: Blood cultures in the emergency department evaluation of childhood pneumonia, Pediatr Infect Dis J 30:475-479, 2011.
  579. Shah VP, Tunik MG, Tsung JW: Prospective evaluation of point-of-care ultrasonography for the diagnosis of pneumonia in children and young adults, Arch Pediatr Adolesc Med 167:119-125, 2013.
  580. Sorde R, Falco V, Lowak M, et al: Current and potential usefulness of pneumococcal urinary antigen detection in hospitalized patients with community-acquired pneumonia to guide antimicrobial therapy, Arch Intern Med 171(2):166-172, 2011.
  581. Srinivasan MG, Ndeezi G, Mboijana CK, et al: Zinc adjunct therapy reduces case fatality in severe childhood pneumonia: a randomized double blind placebo-controlled trial, BMC Med 10:14, 2012.
  582. United Nations Children's Fund: One is too many—ending child deaths from pneumonia and diarrhoea.
  583. Uranga A, Espana PP, Bilbao A, et al: Duration of antibiotic treatment in community- acquired pneumonia—a multicenter randomized clinical trial, JAMA Intern Med 176(9):1257-1265, 2016.
  584. van der Poll T, Opal SM: Pathogenesis, treatment, and prevention of pneumococcal pneumonia, Lancet 374:1543-1554, 2009.
  585. van Houten CB, de Groot JAH, Klein A, et al: A host-protein based assay to differentiate between bacterial and viral infections in preschool children (OPPORTUNITY): a double-blind, multicentre, validation study, Lancet Infect Dis 2016. pii: S1473-3099(16)30519-9.
  586. Varshney T, Mok E, Shapiro AJ, et al: Point-of-care lung ultrasound in young children with respiratory tract infections and wheeze, Emerg Med J 33(9):603-610, 2016.
  587. Viasua D, Di Yacovo S, Garcia-Vidal C, et al: Community-acquired Legionella pneumophila pneumonia. A single-center experience with 214 hospitalized sporadic cases over 15 years, Medicine (Baltimore) 92:51-60, 2013.
  588. Wacogne I, Negrine RJS: Are follow up chest x ray examinations helpful in the management of children recovering from pneumonia?, Arch Dis Child 88:457-458, 2003.
  589. Wilcox ME, Chong CAKY, Stanbrook MB, et al: Does this patient have an exudative pleural effusion? The rational clinical examination systematic review, JAMA 311:2422-2431, 2014.
  590. Williams DJ, Edwards KM, Self WH, et al: Effectiveness of 3-lactam monotherapy vs macrolide combination therapy for children hospitalized with pneumonia, JAMA Pediatr 171(12):1184-1191, 2017.
  591. Williams DJ, Hall M, Shah SS, et al: Narrow vs broad-spectrum antimicrobial therapy for children hospitalized with pneumonia, Pediatrics 132:e1141-e1148, 2013.
  592. Williams DJ, Shah SS: Community-acquired pneumonia in the conjugate vaccine era, Pediatr Infect Dis J 1(4):314-328, 2012.
  593. World Health Organization and Maternal and Child Epidemiology Estimation Group (MCEE): Estimates for 2000-2015: child causes of death.
  594. Zaas AK, Burke T, Chen M, et al: A host-based RT-PCR gene expression signature to identify acute respiratory viral infection, Sci Transl Med 5:1-9, 2013.
  595. Gulati C, Satlin M, Magro C, Kyriakos K: Two systemic lupus erythematosus patients with severe pleurisy: similar presentations, different causes, Arthritis Care Res 65(6):1005-1013, 2013
  596. Cashen K, Peterson TL: Pleural effusions and pneumothoraces, Pediatr Rev 38(4):170-179, 2017
  597. Hendaus M, Janahi I: Parapneumonic effusion in children: an Up-to-date review, Clin Pediatr (Phila) 55(1):10-18, 2016
  598. Bhatnagar R, Maskell N: Treatment of complicated pleural effusions in 2013, Clin Chest Med 34(2013):47-62, 2013
  599. Cashen K, Peterson TL: Pleural effusions and pneumothoraces, Pediatr Rev 38(4):170-179, 2017
  600. Das D: Age and sex distribution in malignant and tuberculous serous effusions: A study of 127 patients and review of the literature, Geriatr Gerontol Int 15:1143-1150, 2015
  601. Grisaru-Soen G, Eisenstadt M, Paret G, et al: Pediatric parapneumonic empyema: risk factors, clinical characteristics, microbiology, and management, Pediatr Emerg Care 29:425-429, 2013
  602. Hansen SJ, Havens PL, Simpson PM, et al: Intrapleural alteplase decreases parapneumonic effusion volume in children more than saline irrigation, Pediatr Pulmonol 50:1328-1335, 2015
  603. Hendaus M, Janahi I: Parapneumonic effusion in children: an Up-to-date review, Clin Pediatr (Phila) 55(1):10-18, 2016
  604. Shen KR, Bribriesco A, Crabtree T, et al: The American association for thoracic surgery consensus guideline for management of empyema, J Thorac Cardiovasc Surg 153(6):e129-e146, 2017
  605. Tagarro A, Otheo E, Baquero-Artgao F, et al: Dexamethasone for parapneumonic pleural effusion: a randomized, double-blind, clinical trial, J Pediatr 185:117-123, 2017
  606. Yu D, Buchvald F, Brandt B, Nielsen K: Seventeen-year study shows rise in parapneumonic effusion and empyema with higher treatment failure after chest tube drainage, Acta Pediatrica 103:93-99, 2014
  607. Banjar HH: A review of 151 cases of pediatric noncystic fibrosis bronchiectasis in a tertiary care center, Ann Thorac Med 2(1):3-8, 2007.
  608. Bonavita J, Naidich DP: Imaging of bronchiectasis, Clin Chest Med 33(2):233-248, 2012. Brower KS, Del Vecchio MT, Aronoff SC: The etiologies of non-CF bronchiectasis in childhood: a systematic review of 989 subjects, BMC Pediatr 14:299-306, 2014.
  609. Gao YH, Guan WJ, Xu G, et al: Macrolide therapy in adults and children with non-CF bronchiectasis: a systematic reviw and meta-analysis, PLoS ONE 9(3):e90047, 2014.
  610. Goyal V, Grimwood K, Marchant J, et al: Pediatric bronchiectasis: no longer an orphan disease, Pediatr Pulmonol 51:450-469, 2016.
  611. Gudbjartsson T, Gudmundsson G: Middle lobe syndrome: a review of clinicopathological features, diagnosis and treatment, Respiration 84:80-86, 2012.
  612. Hnin K, Nguyen C, Crason KV, et al: Prolonged antibiotics for non-cystic fibrosis bronchiectasis in children and adults (review), Cochrane Database of Syst Rev 8:2015.
  613. Hodge G, Upham JW, Change AB, et al: Increased peripheral blood pro-inflammatory/ cytotoxic lymphocytes in children with bronchiectasis, PLoS ONE 10(8):e0133695, 2015.
  614. Kapur N, Mackay IM, Sloots TP, et al: Respiratory viruses in exacerbation of non-cyrtic fibrosis bronchiectasis in children, Arch Dis Child 99:749-753, 2014.
  615. Lee AL, Button BM, Tannenbaum EL: Airway clearance techniques in children and adolescents with chronic suppurative lung disease and bronchiectasis, Front Pediatr 5:2, 2017.
  616. Rashid A, Nanjappa S, Greene JN: Infectious causes of right middle lobe syndrome, Cancer Control 24(1):60-65, 2017.
  617. Romagnoli V, Priftis KN, de Benedictis FM: Middle lobe syndrome in children today, Pediatr resp Rev 15:188-193, 2014.
  618. Snijders D, Calgaro S, Bertozzi I, et al: Bronchiectasis in children, Int J Immunopathol Pharmacol 26(2):529-534, 2013.
  619. Alsubie H, Fitzgerald DA: Lung abscess in children, J Ped Infect Dis 4:27-35, 2009.
  620. Choi MS, Chun JH, Lee KS, et al: Clinical experience of lung abscess in children: 15 year experience at two university hospitals, Korean J Pediatr 58(12):476-483, 2015.
  621. Goyadi P, Srikanth KP, Vaidya PC, et al: Primary lung abscess in early infancy, Indian Pedtr 52(3):241-242, 2015.
  622. Hogan MJ, Marshalleck FE, Sidhu MK, et al: Quality improvement guidelines for pediatric abscess and fluid drainage, Pediatr Radiol 42:1527-1535, 2012.
  623. Madhani K, McGrath E, Guglani L: A 10-year retrospective review of pediatric lung abscesses from a single center, Ann Thorac Med 11:191-196, 2016.
  624. Rahman A, Rman M: Clindamycin in treatment of lung abscess in children, Amer J Drug Delivery Therapeutics 1(1):1-8, 2014.
  625. Ruffini E, De Petris L, Candeloni P, et al: Lung abscess in a child secondary to Mycoplasma pneumonia infection, Ped Med Chir (Med Surg Ped) 36:87-89, 2014.
  626. Saxena A, Vatkar A, Chaudhary P, et al: Lung abscess in children: current perspective, J Dent and Med Sciences 14(3):13-14, 2015.
  627. Alton EWFW, Armstrong DK, Ashby D, et al: Repeated nebulization of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomized, double-blind, placebo-controlled, phase 2b trial, Lancet Respir Med 3(9):684-691, 2015. Erratum in: Lancet Respir Med Sep;3(9):e33, 2015.
  628. Aslam AA, Higgins C, Sinha IP, Southern KW: Ataluren and similar compounds (specific therapies for premature termination condon class 1 mutations) for cyctic fibrosis (review), Cochrane Database Syst Rev (1):Art No. CD012040, 2017.
  629. Assis DN, Freedman SD: Gastrointestinal disorders in cystic fibrosis, Clin Chest Med 37(1):109-118, 2016.
  630. Bell SC, De Boeck K, Amaral MD: New pharmacological approaches for cystic fibrosis: promises, progress, pitfalls, Pharmacol Ther 145:19-34, 2015.
  631. Borowitz D, Parad RB, Sharp JK, et al: Cystic fibrosis foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator—related metabolic syndrome during the first two years of life and beyond, J Pediatr 155:S106-S116, 2009.
  632. Cogen JD, Oron AP, Gibson RL, et al: Characterization of inpatient cystic fibrosis pulmonary exacerbations, Pediatrics 139(2):e20162642, 2017.
  633. Cohen-Cymberknoh M, Shoseyov D, Kerem E: Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life, Am J Respir Crit Care Med 183(11):1463-1471, 2011.
  634. Colombo C, Ellemunter H, Houwen R, et al: Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients, J Cyst Fibros 10(Suppl 2):S24-S28, 2011.
  635. Cutting GR: Treating specific variants causing cystic fibrosis, JAMA 318(21):2130-2131, 2017.
  636. Davies JC, Moskowitz SM, Brown C, et al: VX-659-tezacaftor-ivacaftor in patients with cystic fibrosis and one or two Phe508del allels, N Engl J Med 379(17):1599-1610, 2018.
  637. Elborn JS: Cystic fibrosis, Lancet 388:2519-2531, 2016.
  638. Faro A, Weymann A: Transplantation, Pediatr Clin North Am 63(4):709-734, 2016. Farrell PM, White TB, Derichs N, et al: Cystic fibrosis diagnostic challenges over 4 decades: historical perspectives and lesson learned, J Pediatr 181S:S16-S26, 2017.
  639. Farrell PM, White TB, Ren CL, et al: Diagnosis of cystic fibrosis: consensus guidelines from the cystic fibrosis foundation, J Pediatr 181S:S4-S15, e11, 2017.
  640. Groves T, Robinson P, Wiley V, et al: Long-term outcomes of children with intermediate sweat chloride values in infancy, J Pediatr 166:1469-1474, 2015.
  641. Keating D, Marigowda G, Burr L, et al: VX-445-tezacaftor-ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles, N Engl J Med 379(17):1612-1620, 2018.
  642. Levy H, Nugent M, Schneck K, et al: Refining the continuum of CFTR-associated disorders in the era of newborn screening, Clin Genet 89(5):539-549, 2016.
  643. Nichols DP, Chmiel JF: Inflammation and its genesis in cystic fibrosis, Pediatr Pulmonol 50(Suppl 40):S39-S56, 2015.
  644. Ooi CY, Durie PR: Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis, J Cyst Fibros 11:355-362, 2012.
  645. Quon BS, Rowe SM: New and emerging targeted therapies for cystic fibrosis, BMJ 352:i859, 2016.
  646. Ramos KJ, Sack CS, Mitchell KH, et al: Cystic fibrosis is associated with adverse neonatal outcomes in Washington State, 1996-2013, J Pediatr 180:206-211, 2017.
  647. Ren CL, Borowitz DS, Gonska T, et al: Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome and cystic fibrosis screen positive inconclusive diagnosis, J Pediatr 181S:S45-S51, 2017.
  648. Rowe SM, Daines C, Ringshausen FC, et al: Tezacaftor-ivacaftor in residual-function heterozygotes with cystic fibrosis, N Engl J Med 377(21):2024-2034, 2017.
  649. Solomon GM, Marshall SG, Ramsey BW, Rowe SM: Breakthrough therapies: cystic fibrosis (CF) potentiators and correctors, Pediatr Pulmonol 50:S3-S13, 2015.
  650. Solomon M, Bozic M, Mascarenhas MR: Nutritional issues in cystic fibrosis, Clin Chest Med 37(1):97-107, 2016.
  651. Sosnay PR, Raraigh KS, Gibson RL: Molecular genetics of cystic fibrosis transmembrane conductance regulator: genotype and phenotype, Pediatr Clin North Am 63(4):585-598, 2016.
  652. Stalvey MS, Pace J, Niknian M, et al: Growth in prepubertal children with cystic fibrosis treated with ivacaftor, Pediatrics 139(2):e20162522, 2017.
  653. Stephenson AL, Sykes J, Stanojevic S, et al: Survival comparison of patients with cystic fibrosis in Canada and the United States, Ann Intern Med 166(8):537-546, 2017.
  654. Stoltz DA, Meyerholz DK, Welsh MJ: Origins of cystic fibrosis lung disease, N Engl J Med 372(4):351-362, 2015.
  655. Taylor-Cousar JL, Munck A, McKone EF, et al: Tezacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del, N Engl J Med 377(21):2013-2022, 2017.
  656. The Medical Letter Lumacftor/ivacaftor (orkambi) for cystic fibrosis, Med Lett Drugs Ther 58(1491):41-42, 2016.
  657. The Medical Letter: Tezacaftor/ivacaftor (Symdeko) for cystic fibrosis, Med Lett Drugs Ther 60(1558):174-176, 2018.
  658. Thomas JM, Durak A, Sterling A, et al: Aquagenic wrinkling of the palms: a diagnostic clue to cystic fibrosis carrier status and non-classic disease, Lancet 389:846, 2017.
  659. Welsh SK, Gross JE, Larson NS, et al: False-negative sweat chloride testing in a child with cystic fibrosis and undiagnosed hypohidrotic ectodermal dysplasia, Clin Pediatr (Phila) 53(12):1203-1205, 2014.
  660. Wilschanski M, Duris PR: Patterns of GI disease in adulthood associated with mutations in the CFTR gene, Gut 56:1153-1163, 2007.
  661. Behan L, Dimitrov BD, Kuehni CE, et al: PICADAR: a diagnostic predictive tool for primary ciliary dyskinesia, Eur Respir J 47:1103-1112, 2016.
  662. Davis SD, Ferkol TW, Rosenfeld M, et al: Clinical features of childhood primary ciliary dyskinesia by genotype and ultrastructural phenotype, Am J Respir Crit Care Med 191:316-324, 2015.
  663. Ferkol T, Leigh M: Pediatric ciliopathies: the central role of cilia in a spectrum of pediatric disorders, J Pediatr 160:366-371, 2012.
  664. Horani A, Brody SL, Ferkol T: Picking up speed: advances in the genetics of primary ciliary dyskinesia, Pediatr Res 75:158-164, 2014.
  665. Knowles MR, Daniels LA, Davis SD, et al: Primary ciliary dyskinesia. Recent advances in diagnostics, genetics, and characterization of clinical disease, Am J Respir Crit Care Med 188:913-922, 2013.
  666. Leigh MW, Ferkol TW, Davis SD, et al: Clinical features and associated likelihood of primary ciliary dyskinesia in children and adolescents, Ann Am Thorac Soc. 13:1305-1313, 2016.
  667. Leigh MW, Hazucha MJ, Chawla KK, et al: Standardizing nasal nitric oxide measurement as a diagnostic test for primary ciliary dyskinesia, Ann Am Thorac Soc. 10:574-581, 2013.
  668. Leigh MW, Pittman JE, Carson JL, et al: Clinical and genetic aspects of primary ciliary dyskinesia and Kartagener syndrome, Genet Med 11:473-487, 2009.
  669. Lobo J, Zariwala MA, Noone PG: Primary ciliary dyskinesia, Semin Respir Crit Care Med 36(2):169-179, 2015.
  670. Lucas JS, Barbato A, Collins SA, et al: European respiratory society guidelines for diagnosis of primary ciliary dyskinesia, Eur Respir J 49(1):1601090, 2017.
  671. Milla CE: The evolving spectrum of ciliopathies and respiratory disease, Curr Opin Pediatr 28:339-347, 2016.
  672. Noone PG, Leigh MW, Sannuti A, et al: Primary ciliary dyskinesia: diagnostic and phenotypic features, Am J Respir Crit Care Med 169:459-467, 2004.
  673. Shapiro AJ, Zariwala MA, Ferkol T, et al: Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD Foundation consensus recommendations based on state of the art review, Pediatr Pulmonol 51:115-132, 2016.
  674. Bullard JE, Wert SE, Whitsett JA, et al: ABCA3 mutations associated with pediatric interstitial lung disease, Am J Respir Crit Care Med 172:1026-1031, 2005.
  675. Carre A, Szinnai G, Castanet M, et al: Five new TTF1/NKX2.1 mutations in brainlung-thyroid syndrome: rescue by PAX8 synergism in one case, Hum Mol Genet 18:2266-2276, 2009.
  676. Cheong N, Zhang H, Madesh M, et al: ABCA3 is critical for lamellar body biogenesis in vivo, J Biol Chem 282(33):23811-23817, 2007.
  677. Deutsch GH, Young LR, Deterding RR, et al: Diffuse lung disease in young children: application of a novel classification scheme, Am J Respir Crit Care Med 176:1120-1128, 2007.
  678. Eldridge WB, Zhang Q, Faro A, et al: Outcomes of lung transplantation for infants and children with genetic disorders of surfactant metabolism, J Pediatr 184:157-164, 2017.
  679. Fitzgerald ML, Xavier R, Haley KJ, et al: ABCA3 inactivation in mice causes respiratory failure, loss of pulmonary surfactant, and depletion of lung phosphotidylglycerol, J Lipid Res 48(3):621-632, 2006.
  680. Garmany TH, Wambach JA, Heins HB, et al: Population and disease-based prevalence of the common mutations associated with surfactant deficiency, Pediatr Res 63:645-649, 2008.
  681. Hamvas A, Deterding RR, Wert SE, et al: Heterogeneous pulmonary phenotypes associated with mutations in the thyroid transcription factor gene NKX2-1, Chest 144(3):794-7804, 2013.
  682. Kleinlein B, Griese M, Liebisch G, et al: Fatal neonatal respiratory failure in an infant with congenital hypothyroidism due to haploinsufficiency of the NKX2-1 gene: alteration of pulmonary surfactant homeostasis, Arch Dis Child Fetal Neonatal Ed 96:F453-F456, 2011.
  683. Kroner C, Reu S, Teusch V, et al: Genotype alone does not predict the clinical course of SFTPC deficiency in paediatric patients, Eur Respir J 46:197-206, 2015.
  684. Kroner C, Wittmenn T, Reu S, et al: Lung disease caused by ABCA3 mutations, Thorax 72:213-220, 2017.
  685. Lek M, Karczewski KJ, Minikel EV, et al: Analysis of protein-coding genetic variation in 60,706 humans, Nature 536(7616):285-291, 2016.
  686. Liptzin DR, Patel T, Deterding RR: Chronic ventilation in infants with surfactant protein C mutations; an alternative to lung transplantation, Am J Respir Crit Care Med 191(11):1338-1340, 2015.
  687. Matsumura Y, Ban N, Inagaki N: Aberrant catalytic cycle and impaired lipid transport into intracellular vesicles in ABCA3 mutants associated with nonfatal pediatric interstitial lung disease, Am J Physiol Lung Cell Mol Physiol 295:698-707, 2008.
  688. Nogee LM, Dunbar AE III, Wert SE, et al: A mutation in the surfactant protein C gene associated with familial interstitial lung disease, N Engl J Med 344:573-579, 2001.
  689. Nogee LM, Wert SE, Proffit SA, et al: Allelic heterogeneity in hereditary surfactant protein B (SP-B) deficiency, Am J Respir Crit Care Med 161:973-981, 2000.
  690. Palomar LM, Nogee LM, Sweet SC, et al: Long-term outcomes after infant lung transplantation for surfactant protein B deficiency related to other causes of respiratory failure, J Pediatr 149:548-553, 2006.
  691. Wambach JA, Casey AM, Fishman MP, et al: Genotype-phenotype correlation for infants and children with ABCA3 mutations, Am J Respir Crit Care Med 189:1538-1543, 2014.
  692. Wambach J, Wegner D, DePass K, et al: Single ABCA3 mutations and risk for neonatal respiratory distress syndrome, Pediatrics 130:e1575-e1582, 2012.
  693. Wang Y, Kuan PJ, Xing C, et al: Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer, Am J Hum Genet 84:52-59, 2009.
  694. Barilli A, Rotoli BM, Visigalli R, et al: Impaired phagocytosis in macrophages from patients affected by lysinuric protein intolerance, Mol Genet Metab 105:585-589, 2012.
  695. De Blic J: Pulmonary alveolar proteinosis in children, Paediatr Respir Rev 5:316-322, 2004.
  696. Griese M, Zarbock R, Costabel U, et al: GATA2 deficiency in children and adults with pulmonary alveolar proteinosis and hematologic disorders, BMC Pulm Med 15:87, 2015.
  697. Hadchouel A, Wieland T, Griese M, et al: Biallelic mutations of Methionyl-tRNA synthetase cause a specific type of pulmonary alveolar proteinosis prevalent on Reunion Island, Am J Hum Genet 96:826-831, 2015.
  698. Kitamura T, Uchida K, Tanaka N, et al: Serological diagnosis of idiopathic pulmonary alveolar proteinosis, Am J Respir Crit Care Med 162:658-662, 2000.
  699. Martinez-Moczygemba M, Doan ML, Elidemir O, et al: Pulmonary alveolar proteinosis caused by deletion of the GM-CSFR gene in the X chromosome pseudoautosomal region 1, J Exp Med 205:2711-2716, 2008.
  700. Price A, Manson D, Cutz E, et al: Pulmonary alveolar proteinosis associated with anti-GM-CSF antibodies in a child: successful treatment with inhaled GM-CSF, Pediatr Pulmonol 41:367-370, 2006.
  701. Seymour JF, Presneill JJ, Schoch OD, et al: Therapeutic efficacy of granulocytemacrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis, Am J Respir Crit Care Med 163:524-531, 2001.
  702. Suzuki T, Arumugam P, Sakagami T, et al: Pulmonary macrophage transplantation therapy, Nature 514:450-454, 2014.
  703. Suzuki T, Maranda B, Sakagami T, et al: Hereditary pulmonary alveolar proteinosis caused by recessive CSF2RB mutations, Eur Respir J 37:201-204, 2011.
  704. Suzuki T, Sakagami T, Rubin BK, et al: Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA, J Exp Med 205:2703-2710, 2008.
  705. Suzuki T, Sakagami T, Young LR, et al: Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy, Am J Respir Crit Care Med 182:1292-1304, 2010.
  706. Suzuki T, Trapnell BC: Pulmonary alveolar proteinosis syndrome, Clin Chest Med 37:431-440, 2016.
  707. Tanaka T, Motoi N, Tsuchihashi Y, et al: Adult-onset hereditary pulmonary alveolar proteinosis caused by a single-base deletion in CSF2RB, J Med Genet 48:205-209, 2011.
  708. Uchida K, Beck DC, Yamamoto T, et al: GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis, N Engl J Med 356:567-578, 2007.
  709. Van Meel E, Wegner DJ, Cliften P, et al: Rare recessive loss-of-function methionyl- tRNA synthetase mutations presenting as a multi-organ phenotype, BMC Med Genet 14:106, 2013.
  710. Chen CC, McManemy JK, Vece TJ, Cruz AT: Idiopathic pulmonary hemosiderosis presenting as anemia, Failure to thrive and jaundice in a toddler, Pediatr Emer Care 32:237-239, 2016.
  711. Chin CIC, Kohn SL, Keens TG, et al: A physician survey reveals differences in management of idiopathic pulmonary hemosiderosis, Orphanet J Rare Dis 10:98, 2015.
  712. Eldem I, Ileri T, Ince E, et al: Idiopathic pulmonary hemosiderosis with allergic asthma diagnosis in a pediatric patient, J Pediatr Hematol Oncol 37:e435-e437, 2015.
  713. Flanagan F, Glackin L, Slattery DM: Successful treatment of idiopathic pulmonary capillaritis with intravenous cyclophosphamide, Pediatr Pulmon 48:303-305, 2013.
  714. Franks TJ, Koss MN: Pulmonary capillaritis, Curr Opin Pulm Med 6:430-435, 2000. Fullmer JJ, Langston C, Dishop MK, Fan LL: Pulmonary capillaritis in children: a review of eight cases with comparison to other alveolar hemorrhage syndromes, J Pediatr 146:376-381, 2005.
  715. Glisenti P, Rakusa J, Albrecht R, Luedi M: Negative pressure pulmonary oedema with haemorrhage after 5-minute avalanche burial, Lancet 388:2321-2322, 2016.
  716. Godfrey S: Pulmonary hemorrhage/hemoptysis in children, Pediatr Pulmonol 37:476-484, 2004.
  717. Hendricks GFM, Somers K, Vandenplas Y: Lane-hamilton syndrome: case report and review of the literature, Eur J Pediatr 170:1597-1602, 2011.
  718. Hoca NT, Dayioglu D, Ogretensoy M: Pulmonary hemosiderosis in association with celiac disease, Lung 184:297-300, 2006.
  719. Huang SH, Lee PY, Niu CK: Treatment of pediatric idiopathic pulmonary hemosiderosis with low-dose cyclophosphamide, Ann Pharmacother 37:1618-1621, 2003.
  720. Ioachimescu OC, Sieber S, Kotch A: Idiopathic pulmonary hemosiderosis revisited, Eur Respir J 24:162-170, 2004.
  721. Ioachimescu OC, Stoller JK: Diffuse alveolar hemorrhage: diagnosing it and finding the cause, Cleve Clin J Med 75:258, 260, 264-265, 2008.
  722. Lara AR, Schwarz MI: Diffuse alveolar hemorrhage, Chest 137(5):1164-1171, 2010. LeClainche L, LeBourgeois M, Fauroux B, et al: Long term outcome of idiopathic pulmonary hemosiderosis in children, Medicine (Baltimore) 79:318-326, 2000.
  723. Luo XQ, Ke ZY, Huang LB, et al: Maintenance therapy with dose adjusted 6-mercapto- purine in idiopathic pulmonary hemosiderosis, Pediatr Pulmonol 43:1067-1071, 2008. Moissidi SI, Chaidaroon D, Vichyanond P, et al: Milk-induced pulmonary disease in infants (heiner syndrome), Pediatr Allergy Immunol 16:545-562, 2005.
  724. Neumayr TM, Watson AM, Wylam ME, Ouellette Y: Surfactant treatment of an infant with acute idiopathic pulmonary hemorrhage, Pediatr Crit Care Med 9:e4, 2008.
  725. Susarla SC, Fan LL: Diffuse alveolar hemorrhage syndromes in children, Curr Opin Pediatr 19:314-320, 2007.
  726. Watson AM, Boyce TG, Wylam ME: Legionella pneumonia: infection during immunosuppressive therapy for idiopathic pulmonary hemosiderosis, Pediatr Infect Dis J 23:82-84, 2004.
  727. Yao TC, Hung IJ, Jaing TH, et al: Pitfalls in the diagnosis of idiopathic pulmonary haemosiderosis, Arch Dis Child 86:436-438, 2002.
  728. Agha BS, Sturm JJ, Simon HK, et al: Pulmonary embolism in the pediatric emergency department, Pediatrics 132:663-667, 2013.
  729. Askegard-Giesmann JR, Caniano DA, Kenney BD: Rare but serious complications of central line insertion, Semin Pediatr Surg 18:73-83, 2009.
  730. Baird JS, Killinger JS, Kalkbrenner KJ, et al: Massive pulmonary embolism in children, J Pediatr 156:148-151, 2010.
  731. Bonduel M, Hepner M, Sciuccati G, et al: Prothrombotic abnormalities in children with venous thromboembolism, J Pediatr Hematol Oncol 22:66-72, 2000.
  732. Chalmers EA: Epidemiology of venous thromboembolism in neonates and children, Thromb Res 118:3-12, 2006.
  733. Chatterjee S, Chakraburty A, Weinberg I, et al: Thrombolysis for pulmonary embolism and risk of all-cause mortality, majority bleeding, and intracranial hemorrhage a meta-analysis, JAMA 311:2414-2421, 2014.
  734. Dijk FN, Curtin J, Lord D, Fitzgerald DA: Pulmonary embolism in children, Paediatr Respir Rev 13:112-122, 2012.
  735. Douma RA, Mos ICM, Erkens PMG, et al: Performance of 4 clinical decision rules in the diagnostic management of acute pulmonary embolism, Ann Intern Med 154:709-718, 2011.
  736. Goldenberg NA, Bernard TJ: Venous thromboembolism in children, Hematol Oncol Clin North Am 24:151-166, 2010.
  737. Goldenberg NA, Knapp-Clevenger R, Durham JD, et al: A thrombolytic regimen for high-risk deep venous thrombosis may substantially reduce the risk of post thrombotic syndrome in children, Blood 110:45-53, 2007.
  738. Goldhaber SZ, Bounameaux H: Pulmonary embolism and deep vein thrombosis, Lancet 379:1835-1844, 2012.
  739. Hochhegger B, Ley-Zaporo zhan J, Marchiori E, et al: Magnetic resonance imaging findings in acute pulmonary embolism, Br J Radiol 84:282-287, 2011.
  740. Holzer R, Peart I, Ciotti G, et al: Successful treatment with rTPA, Pediatr Cardiol 23:548-552, 2002.
  741. Hull RD: Diagnosing pulmonary embolism with improved certainty and simplicity, JAMA 295:213-215, 2006.
  742. Kyrle PA, Eichinger S: New diagnostic strategies for pulmonary embolism, Lancet 371:1312-1314, 2008.
  743. Lapner ST, Kearon C: Diagnosis and management of pulmonary embolism, BMJ 346:f757, 2013.
  744. Lucassen W, Geersing GJ, Erkens PMG, et al: Clinical decision rules for excluding pulmonary embolism: a meta-analysis, Ann Intern Med 155:448-460, 2011.
  745. Meyer G, Vicaut E, Danays T, et al: Fibrinolysis for patients with intermediate-risk pulmonary embolism, N Engl J Med 370:1402-1410, 2014.
  746. Monagle P, Adams M, Mahoney M, et al: Outcome of pediatric thromboembolic disease: a report from the Canadian childhood thrombophilia registry, Pediatr Res 47:763-766, 2000.
  747. Nowak-Gottl U, Bidlingmaier C, et al: Pharmacokinetics, efficacy, and safety of LMWHs in venous thrombosis and stroke in neonates, infants and children, Br J Pharmacol 153:1120-1127, 2008.
  748. Nowak-Gottl U, Janssen V, Manner D, et al: Venous thromboembolism in neonates and children-update 2013, Thromb Res 131:S39-S41, 2013.
  749. Paes BA, Nagel K, Sunak I, et al: Neonatal and infant pulmonary thromboembolism: a literature review, Blood Coagul Fibrinolysis 23:653-662, 2012.
  750. Parker RI: Thrombosis in the pediatric population, Crit Care Med 38:S71-S75, 2010. Patocka C, Nemeth J: Pulmonary embolism in pediatrics, J Emerg Med 42:105-116, 2012. Perrier A, Roy PM, Sanchez O, et al: Multidetector-row computed tomography in suspected pulmonary embolism, N Engl J Med 352:1760-1768, 2005.
  751. Raffini L, Huang YS, Witmer C, et al: Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007, Pediatrics 124:1001-1008, 2009.
  752. Stein P, Kayali F, Olson R: Incidence of venous thromboembolism in infants and children: data from the national hospital discharge survey, J Pediatr 145:563-565, 2004.
  753. Stein PD, Fowler SE, Goodman LR: Multidetector computed tomography for acute pulmonary embolism, N Engl J Med 354:2317-2326, 2006.
  754. Tapson VF: Acute pulmonary embolism, N Engl J Med 358:1037-1052, 2008.
  755. The EINSTEIN-PE Investigators: Oral rivaroxaban for the treatment of symptomatic pulmonary embolism, N Engl J Med 366:1287-1296, 2012.
  756. Van Belle A, Buller HR, Huisman MV, et al: Christopher study investigators: effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography, JAMA 295:172-179, 2006.
  757. Young G, Albisetti M, Bonduel M, et al: Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies, Circulation 118:1373-1382, 2008.
  758. Zoller B, Li X, Sundquist J, et al: Risk of PE in patients with autoimmune disorders: a nationwide follow-up study from Sweden, Lancet 379:244-249, 2012.
  759. Bartyik K, Bede O, Tiszlavicz L, et al: Pulmonary capillary haemangiomatosis in children and adolescents: report of a new case and a review of the literature, Eur J Pediatr 163:731-737, 2004.
  760. Brown CM, Redd SC, Damon SA, Centers for Disease Control and Prevention (CDC): Acute idiopathic pulmonary hemorrhage among infants: recommendations from the working group for investigation and surveillance, MMWR Recomm Rep 53:1-12, 2004.
  761. Centers for Disease Control and Prevention (CDC): Investigation of acute idiopathic pulmonary hemorrhage among infants—Massachusetts, December 2002-June 2003, MMWR Morb Mortal Wkly Rep 53:817-820, 2004.
  762. Coss-Bu JA, Sachdeva RC, Bricker JT, et al: Hemoptysis: a 10-year retrospective study, Pediatrics 100:E7, 1997.
  763. Cottin V, Chinet T, Lavole A, et al: Pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: a series of 126 patients, Medicine (Baltimore) 86:1-17, 2007.
  764. Di Nisio M, van Es N, Buller HR: Deep vein thrombosis and pulmonary embolism, Lancet 388:3060-3069, 2016.
  765. Godfrey S: Pulmonary hemorrhage/hemoptysis in children, Pediatr Pulmonol 37:476-484, 2004.
  766. Grzela K, Krenke K, Kulus M: Pulmonary arteriovenous malformations: clinical and radiological presentation, J Pediatr 158:856, 2011.
  767. Hennelly KE, Baskin MN, Monuteuax MC, et al: Detection of pulmonary embolism in high-risk children, J Pediatr 178:214-218, 2016.
  768. Kearon C, Akl EA, Ornelas J, et al: Antithrombotic therapy for VTE disease, Chest 149(2):315-352, 2016.
  769. Konstantinides SV, Barco S, Lankeit M, Meyer G: Management of pulmonary embolism, J Am Coll Cardiol 67(8):976-990, 2016.
  770. Mismetti P, Laporte S, Pellerin O, et al: Effect of retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism—a randomized clinical trial, JAMA 313(16):1627-1635, 2015.
  771. Ryu JS, Song ES, Lee KH, et al: Natural history and therapeutic implications of patients with catamenial hemoptysis, Respir Med 101:1022-1036, 2007.
  772. van der Hulle T, Dronkers CEA, Klok FA, Huisman MV: Recent developments in the diagnosis and treatment of pulmonary embolism, J Intern Med 279:16-29, 2016.
  773. van der Hulle T, van Es N, den Exter PL, et al: Is a normal computed tomography pulmonary angiography safe to rule out acute pulmonary embolism in patients with a likely clinical probability?, Thromb Haemostasis 117(8):1622-1629, 2017.
  774. Abu-Hasan MN, Chesrown SE, Jantz MA: Successful use of bronchoscopic lung insufflation to treat left lung atelectasis, Pediatr Pulmonol 48:306-309, 2013.
  775. Bilan N, Poorshiri B: The role of chest physiotherapy in prevention of postextubation atelectasis in pediatric patients with neuromuscular diseases, Iran J Child Neurol 7:21-24, 2013.
  776. Lin JA, Madikians A: From bronchiolitis guideline to practice: a critical care perspective, World J Crit Care Med 4:152-158, 2015.
  777. Shaughnessy EE, White C, Shah SS, et al: Implementation of postoperative respiratory care for pediatric orthopedic patients, Pediatrics 136:e505-e512, 2015.
  778. Soyer O, Ozen C, Cavkaytar O, et al: Right middle lobe atelectasis in children with asthma and prognostic factors, Allergol Int 65:253-258, 2016.
  779. Strickland SL, Rubin BK, Drescher GS, et al: AARC clinical practice guideline: effectiveness of nonpharmacologic airway clearance therapies in hospitalized patients, Respir Care 58:2187-2193, 2013.
  780. Thornby K-A, Johnson A, Axtell S: Dornase alfa for Non-cystic fibrosis pediatric pulmonary atelectasis, Ann Pharmacother 48:1040-1049, 2014.
  781. Yang C, Hua R, Xu K, et al: The role of 3d computed tomography (CT) imaging in the diagnosis of foreign body aspiration in children, Eur Rev Med Pharmacol Sci 19:265-273, 2015.
  782. Cogen JD, Swanson J, Ong T: Endobronchial carcinoid and concurrent carcinoid syndrome in an adolescent female, Case Rep Pediatr 2016:2074970, 2016.
  783. Eggli KD, Newman B: Nodules, masses, and pseudomasses in the pediatric lung, Radiol Clin North Am 31:651-666, 1993.
  784. Epstein DM, Aronchick JM: Lung cancer in childhood, Med Pediatr Oncol 17:510-513, 1989.
  785. Eyssartier E, Ang P, Bonnemaison E, et al: Characteristics of endobronchial primitive tumors in children, Pediatr Pulmonol 49:E121-E125, 2014.
  786. Hancock BJ, Di Lorenzo M, Youssef S, et al: Childhood primary pulmonary neoplasms, J Pediatr Surg 28:1133-1136, 1993.
  787. Kaplan KA, Beierle EA, Faro A, et al: Recurrent pneumonia in children: a case report and approach to diagnosis, Clin Pediatr. 45:15-22, 2006.
  788. Keita O, Lagrange JL, Michiels JF, et al: Primary bronchogenic squamous cell carcinoma in children: report of a case and review of the literature, Med Pediatr Oncol 24:50-52, 1995.
  789. McCahon E: Lung tumours in children, Pediatr Respir Rev 7:191-196, 2006.
  790. Roviaro GC, Varoli F, Zannini P, et al: Lung cancer in the young, Chest 87:456-459, 1985. Thomas R, Christopher DJ, Balamugesh T, et al: Clinico-pathologic study of pulmonary carcinoid tumours: a retrospective analysis and review of the literature, Respir Med 102:1611-1614, 2008.
  791. Tian DL, Liu HX, Zhang L, et al: Surgery for young patients with lung cancer, Lung Cancer 42:215-220, 2003.
  792. Bintcliffe O, Hallifax RJ, Edey A, et al: Spontaneous pneumothorax: time to rethink management?, Lancet Respir Med 3:578-588, 2015.
  793. Bintcliffe O, Maskell N: Spontaneous pneumothorax, BMJ 348:g2928, 2014.
  794. Cashen K, Peterson TL: Pleural effusions and pneumothoraces, Pediatr Rev 38(4):170-179, 2017.
  795. Chen JS, Chan WK, Tsai KT, et al: Simple aspiration and drainage and intrapleural minocycline pleurodesis versus simple aspiration and drainage for the initial treatment of primary spontaneous pneumothorax: an open-label, parallel-group, prospective, randomized, controlled trial, Lancet 381:1277-1282, 2013.
  796. Choi SY, Kim YH, Jo KH, et al: Video-assisted thorascopic surgery for primary spontaneous pneumothorax in children, Pediatr Surg Int 29:505-509, 2013.
  797. Gupta N, Sunwoo BY, Kotloff RM: Birt-Hogg-Dube syndrome, Clin Chest Med 37:475-486, 2016.
  798. Hathorn C, Armitage N, Wensley D, et al: Bronchial balloon occlusion in children with complex pulmonary air leaks, Arch Dis Child 98:136-140, 2013.
  799. Hegde S, Prodhan P: Serious air leak syndrome complicating high-flow nasal cannula therapy: a report of 3 cases, Pediatrics 131:3939-3944, 2013.
  800. Lopez ME, Fallon SC, Lee TC, et al: Management of the pediatric spontaneous pneumothorax: is primary surgery the treatment of choice?, Am J Surg 208:571-576, 2014.
  801. Noppen M: Spontaneous pneumothorax: epidemiology, pathophysiology, and cause, Eur Respir Rev 19:217-219, 2010.
  802. Robinson PD, Blackburn C, Babl FE, et al: Management of paediatric spontaneous pneumothorax: a multicenter retrospective case series, Arch Dis Child 100:918-923, 2015.
  803. Abbas P, Akinkuotu A, Peterson M, Mazziotti M: Spontaneous pneumomediastinum in the pediatric patient, Am J of Surg 210:1031-1036, 2015.
  804. Cashen K, Peterson TL: Pleural effusions and pneumothoraces, Pediatr Rev 38(4): 170-179, 2017.
  805. Fitzwater J, Silva N, Knight C, et al: Management of spontaneous pneumomediastinum in children, J Ped Surg 50:983-986, 2015.
  806. Hu M, Green R, Gungor A: Pneumomediastinum and subcutaneous emphysema from bronchial foreign body aspiration, Am J Otolaryngol 34:85-88, 2013.
  807. Kim SH, Huh J, Song J, et al: Spontaneous pneumomediastinum: A rare disease associated with chest pain in adolescents, Yonsei Medl J 56(5):1437-1442, 2015.
  808. Matsumoto T, Matano H: The still lung point: new sonographic evidence for pneumomediastinum, Am J Emerg Med 34:344.e1-344.e2, 2016.
  809. Wong K, Wu H, Lai S, Chiu C: Spontaneous pneumomediastinum analysis of 87 pediatric patients, Ped Emer Care 29(9):988-991, 2013.
  810. Zachariah S, Gharahbaghian L, Perera P, Joshi N: Spontaneous pneumomediastinum on bedside ultrasound: case report and review of the literature, West J Emerg Med 16(2):321-324, 2015.
  811. Chavannes M, Sharma AP, et al: Diagnosis by peritoneal scintigraphy of peritoneal dialysis-associated hydrothorax in an infant, Perit Dial Int 34(1):140-143, 2014.
  812. Jabeen S, Murtaza G, et al: Migration of indwelling central venous catheter and fatal hydrothorax, European J Pediatr Surg Rep 2:32-34, 2014.
  813. Kim J, Roberts D, Bauer D: CSF hydrothorax without intrathoracic catheter migration in children with ventriculoperitoneal shunt, Surg Neurol Int 6(11):330-333, 2015.
  814. Light RW: New treatment for hepatic hydrothorax, Ann Am Thorac Soc 13(6):773-774, 2016.
  815. Saguil A, Wyrwick K, Hallgren J: Diagnostic approach to pleural effusion, Am Fam Physician 90(2):99-104, 2014.
  816. Barua A, Brown R, et al: Spontaneous hemothorax following cardiac surgery, J Card Surg 31:211-213, 2016.
  817. Bradley M, Okoye O, et al: Risk factors for post-traumatic pneumonia in patients with retained hemothorax: results of a prospective, observational AAST study, Injury 44:1159-1164, 2013.
  818. Chou YP, Lin HL, et al: Video-assisted thorascopic surgery for retained hemothorax in blunt chest trauma, Curr Opin Pulm Med 21(4):393-398, 2015.
  819. Dennis B, Gondek S, et al: Use of an evidence-based algorithm for patients with traumatic hemothorax reduces need for additional intervention, J Trauma Acute Care Surg 82(4):728-731, 2017.
  820. Inafuku K, Masuda M, et al: Assessment of spontaneous hemopneumothorax: indications for surgery, Asian Cardiovasc Thorac Ann 23(4):435-438, 2015.
  821. Tay CKJ, Yee YC, Asmat A: Spontaneous hemopneumothorax: our experience with surgical management, Asian Cardiovasc Thorac Ann 23(3):308-310, 2015.
  822. Ichikawa Y, Sato A, Sato K, et al: Chylothorax associated with child abuse, Pediatr Int 57(6):1202-1204, 2015.
  823. Kazanci SY, McElhinney DB, Thiagarajan R, et al: Obstruction of the superior vena cava after neonatal extracorporeal membrane oxygenation: association with chylothorax and outcome of transcatheter treatment, Pediatr Crit Care Med 14:37-43, 2013.
  824. Muniz G, Hidalgo-Campos J, Valdivia-Tapis MD, et al: Successful management of chylothorax with etilefrine: case report in 2 pediatric patients, Pediatrics 141(5): e20163309, 2018.
  825. Tutor JD: Chylothorax I infants and children, Pediatrics 133:722-733, 2014.
  826. Abman SH, Collaco JM, Shepherd EG, et al: Interdisciplinary care of children with severe bronchopulmonary dysplasia, J Pediatr 181:12-28:e1, 2016.
  827. Abman SH, Hansmann G, Archer SL, et al: Pediatric pulmonary hypertension: guidelines from the American heart association and American thoracic society, Circulation 132(21):2037-2099, 2015.
  828. Bott L, Beghin L, Devos P, et al: Nutritional status at 2 years in former infants with bronchopulmonary dysplasia influences nutrition and pulmonary outcomes during childhood, Pediatr Res 60:340-344, 2006.
  829. Jobe AH, Bancalari E: Bronchopulmonary dysplasia, Am J Respir Crit Care Med 163(7):1723-1729, 2001.
  830. Kotecha SJ, Edwards MO, Watkins WJ, et al: Effect of preterm birth on later FEV1: a systematic review and meta-analysis, Thorax 68(8):760-766, 2013.
  831. Sterni LM, Collaco JM, Baker CD, et al: An official American thoracic society clinical practice guideline: pediatric chronic home invasive ventilation, Am J Respir Crit Care Med 193(8):e16-e35, 2016.
  832. Svedenkrans J, Henckel E, Kowalski J, et al: Long-term impact of preterm birth on exercise capacity in healthy young men: a national population-based cohort study, PLoS ONE 8(12):e80869, 2013.
  833. Borowitz D, Cerny F, Zallen G, et al: Pulmonary function and exercise response in patients with pectus excavatum after Nuss repair, J Pediatr Surg 38:544-547, 2003.
  834. Brigato RR, Campos JR, Jatene FB, et al: Pectus excavatum: evaluation of Nuss technique by objective methods, Interact Cardiovasc Thorac Surg 7:1084-1088, 2008.
  835. Chavoin J, Grolleau J, Moreno B, et al: Correction of pectus excavatum by custom-made silicone implants: contribution of computer-aided design reconstruction. A 20-year experience and 401 cases, Plast Reconst Surg 137:860e, 2016.
  836. Daunt SW, Cohen JH, Miller SF: Age-related normal ranges for the Haller index in children, Pediatr Radiol 34:326-330, 2004.
  837. Haller JA Jr, Loughlin GM: Cardiorespiratory function is significantly improved following corrective surgery for severe pectus excavatum: proposed treatment guidelines, J Cardiovasc Surg (Torino) 41:125-130, 2000.
  838. Harrison MR, Gonzales KD, Bratton BJ, et al: Magnetic mini-mover procedure for pectus excavatum III: safety and efficacy in a Food and Drug Administration sponsored clinical trial, J Pediatr Surg 47:154-159, 2012.
  839. Koumbourlis AC: Pectus deformities and their impact on pulmonary physiology, Pediatr Respir Rev 16:18-24, 2015.
  840. Lopez M, Patoir A, Costes F, et al: Preliminary study of efficacy of cup suction in the correction typical pectus excavatum, J Pediatr Surgery 51:183-187, 2016.
  841. Malek MH, Fonkalsrud EW, Cooper CB: Ventilatory and cardiovascular responses to exercise in patients with pectus excavatum, Chest 124:870-882, 2003.
  842. Nuss D, Kelly RE Jr: Minimally invasive surgical correction of chest wall deformities in children (Nuss procedure), Adv Pediatr 55:395-410, 2008.
  843. Ohno K, Morotomi Y, Nakahira M, et al: Indications for surgical repair of funnel chest based on indices of chest wall deformity and psychologic state, Surg Today 33:662-665, 2003.
  844. Rowland T, Moriarty K, Banever G: Effect of pectus excavatum deformity on cardiorespiratory fitness in adolescent boys, Arch Pediatr Adolesc Med 159:1069-1073, 2005.
  845. Swanson JW, Avansino JR, Phillips GS, et al: Correlating Haller Index and cardiopulmonary disease in pectus excavatum, Am J Surg 203:660-664, 2012.
  846. Abramson H, D'Agostino J, Wuscovi S: A 5-year experience with a minimally invasive technique for pectus carinatum repair, J Pediatr Surg 44:118-123, 2009.
  847. Coelho Mde S, Guimaraes Pde S: Pectus carinatum, J Bras Pneumol 33:463-474, 2007. Emil S, Sevigny M, Mopntpetit K, et al: Success and duration of dynamic bracing for pectus carinatum: a four-year prospective study, J Pediatr Surg 52:124-129, 2017.
  848. Engum SA: Embryology, sternal clefts, ectopic cordis, and Cantrell's pentalogy, Semin Pediatr Surg 17:154-160, 2008.
  849. Fonkalsrud EW, Anselmo DM: Less extensive techniques for repair of pectus carinatum: the undertreated chest deformity, J Am Coll Surg 198:898-905, 2004.
  850. Goretsky MJ, Kelly RE, Croitoru D, et al: Chest wall anomalies: pectus excavatum and pectus carinatum, Adolesc Med Clin 15:455-471, 2004.
  851. Ohye RG, Rutherford JA, Bove EL: Congenital sternal clefts, Pediatr Cardiol 23:472-473, 2002.
  852. Williams AM, Crabbe DC: Pectus deformities of the anterior chest wall, Paediatr Respir Rev 4:237-242, 2003.
  853. Davis JT, Long FR, Adler BH, et al: Lateral thoracic expansion for Jeune syndrome: evidence of rib healing and new bone formation, Ann Thorac Surg77:445-448, 2004.
  854. Kajantic E, Anderson S, Kaitila I: Familial asphyxiating thoracic dysplasia: clinical variability and impact of improved neonatal intensive care, J Pediatr 139:130-133, 2001.
  855. Keppler-Noreuil KM, Adam MP, Welch J, et al: Clinical insights gained from eight new cases and review of reported cases with Jeune syndrome (asphyxiating thoracic dystrophy), Am J Med Genet 155A:1021-1032, 2001.
  856. Phillips JD, van Aalst JA: Jeune's syndrome (asphyxiating thoracic dystrophy): congenital and acquired, Semin Pediatr Surg 17:167-172, 2008.
  857. Sharoni E, Erez E, Chorev G, et al: Chest reconstruction in asphyxiating thoracic dystrophy, J Pediatr Surg 33:1578-1581, 1998.
  858. Wiebicke W, Pasterkamp H: Long-term continuous positive pressure in a child with asphyxiating thoracic dystrophy, Pediatr Pulmonol 4:54-58, 1988.
  859. Boulet S, Althuser M, Nugues F, et al: Prenatal diagnosis of achondroplasia: new specific signs, Prenat Diagn 29:697-702, 2009.
  860. Julliand S, Boule M, Baujat G, et al: Lung function, diagnosis, and treatment of sleep-disordered breathing in children with achondroplasia, Am J Med Genet 158A:1987-1993, 2012.
  861. Tasker RC, Dundas I, Laverty A, et al: Distinct patterns of respiratory difficulty in young children with achondroplasia: a clinical, sleep, and lung function study, Arch Dis Child 79:99-108, 1998.
  862. Trotter TL, Hall JG, American Academy of Pediatrics Committee on Genetics: Health supervision for children with achondroplasia, Pediatrics 116:771-783, 2005.
  863. Barrios C, Perez-Encinas C, Maruenda JI, Laguia M: Significant ventilatory functional restriction in adolescents with mild or moderate scoliosis during maximal exercise tolerance test, Spine 30:1610-1615, 2005.
  864. Hedequist D, Emans J: Congenital scoliosis, J Am Acad Orthop Surg 12:266-275, 2004.
  865. Koumbourlis AC: Scoliosis and the respiratory system, Paediatr Respir Rev 7:152-160, 2006.
  866. Martinez-Llorens J, Ramirez M, Colomina MJ, et al: Muscle dysfunction and exercise limitation in adolescent idiopathic scoliosis, Eur Respir J 36:393-400, 2010.
  867. McNicholas WT: Impact of sleep in respiratory failure, Eur Respir J 10:920-933, 1997. Yaszat B, Jazayeri R, Lonner B: The effect of surgical approaches on pulmonary function in adolescent idiopathic scoliosis, J Spinal Disord Tech 22:278-283, 2009.
  868. Yuan N, Skaggs DL, Dorey F, et al: Preoperative predictors of prolonged postoperative mechanical ventilation in children following scoliosis repair, Pediatr Pulmonol 40:414-419, 2005.
  869. Campbell RM Jr, Smith MD, Mayes TC, et al: The characteristics of thoracic insufficiency syndrome associated with fused ribs and congenital scoliosis, J Bone Joint Surg Am 85-A:399-408, 2003.
  870. Mayer OH: Chest wall hypoplasia—principles and treatment, Pediatr Respir Rev 16:30-34, 2015.
  871. McPhail GL, Ehsan Z, Howells SA, et al: Obstructive lung disease in children with idiopathic scoliosis, J Pediatr 166:1018-1021, 2015.
  872. Mehta MH, Patel RV, Mehta LV, et al: Congenital absence of ribs, Indian Pediatr 29:1149-1152, 1992.
  873. Nishibayashi A, Tomita K, Yano K, et al: Correction of complex chest wall deformity in Poland's syndrome using a modified Nuss procedure, J Plast Reconstr Aesthet Surg 66:353-355, 2013.
  874. Tsirikos AI, McMaster MJ: Congenital anomalies of the ribs and chest wall associated with congenital deformities of the spine, J Bone Joint Surg 87:2524-2536, 2005.
  875. Agarwal A, Willis D, Tang X, et al: Transition of respiratory technology dependent patients from pediatric to adult pulmonology care, Pediatr Pulmonol 50:1294-1300, 2015.
  876. Amin R, Sayal P, Syed F, et al: Pediatric Long-term home mechanical ventilation: twenty years of Follow-up from one Canadian center, Pediatr Pulmonol 49:816-824, 2014.
  877. Baker CD, Martin S, Thrasher J, et al: A standardized discharge process decreases length of stay for Ventilator-dependent children, Pediatrics 137(4):e20150637, 2016.
  878. Benneyworth BD, Gebremariam A, Clark SJ, et al: Inpatient health care utilization for children dependent on Long-term mechanical ventilation, Pediatrics 127:e1533-e1541, 2011.
  879. Carnevale FA, Alexander E, Davis M, et al: Daily living with distress and enrichment: the moral experience of families with Ventilator-assisted children at home, Pediatrics 117:e48e60, 2006.
  880. Chatwin M, Tan H-L, Bush A, et al: Long term Non-invasive ventilation in children: impact on survival and transition to adult care, PLoS ONE 10(5):e0125839, 2015.
  881. Com G, Kuo DZ, Bauer ML, et al: Outcomes of children treated with tracheostomy and Positive-pressure ventilation at home, Clin Pediatr (Phila) 52:54-61, 2013.
  882. Cristea AI, Ackerman VL, Swigonski NL, et al: Physiologic findings in children previously ventilator dependent at home due to bronchopulmonary dysplasia, Pediatr Pulmonol 50:1113-1118, 2015.
  883. Cristea AI, Carroll AE, Davis SD, et al: Outcomes of children with severe bronchopulmonary dysplasia who were ventilator dependent at home, Pediatrics 132: e727-e734, 2013.
  884. Edwards JD, Kun SS, Graham RJ: End-of-life discussions and advance care planning for children on Long-term assisted ventilation with Life-limiting conditions, J Palliat Care 28:21-27, 2012.
  885. Edwards JD, Kun SS, Keens TG, et al: Children with corrected or palliated congenital heart disease on home mechanical ventilation, Pediatr Pulmonol 45:645-649, 2010.
  886. Edwards JD, Kun SS, Keens TG: Outcomes and causes of death in children on home mechanical ventilation via tracheostomy: an institutional and literature review, J Pediatr 157:955-959, 2010.
  887. Gowans M, Keenan HT, Bratton SL: The population prevalence of children receiving invasive home ventilation in Utah, Pediatr Pulmonol 42:231-236, 2007.
  888. Graham RJ, Rodday AM, Weidner RA, et al: The impact on family of pediatric chronic respiratory failure in the home, J Pediatr 175:40-46, 2016.
  889. Keilty K, Cohen E, Ho M, et al: Sleep disturbance in family caregivers of children who depend on medical technology: a systematic review, J Pediatr Rehabil Med 8:113-130, 2015.
  890. Kun SS, Edwards JD, Davidson Ward SL, et al: Hospital readmissions for newly discharged pediatric home mechanical ventilation patients, Pediatr Pulmonol 47:409-414, 2012.
  891. Rose L, McKim DA, Katz SL, et al: Home mechanical ventilation in Canada: A national survey, Respir Care 60:695-704, 2015.
  892. Sobotka SA, Hird-McCorry LP, Goodman DM: Identification of fail points for discharging pediatric patients with new tracheostomy and ventilator, Hosp Pediatr 6:552-557, 2016.
  893. Sterni LM, Collaco JM, Baker CD, et al: An official American thoracic society clinical practice guideline: pediatric chronic home invasive ventilation, Am J Respir Crit Care Med 193:e16-e35, 2016.
  894. Bachetti T, Parodi S, Di Duca M, et al: Low amounts of PHOX2B expanded alleles in asymptomatic parents suggest unsuspected recurrence risk in congenital central hypoventilation syndrome, J Mol Med 89(5):505-513, 2011.
  895. Basu SM, Bchir MB, Chung FF, et al: Anesthetic considerations for patients with congenital central hypoventilation syndrome: a systematic review of the literature, Anesth Analg 124:169-178, 2017.
  896. Carroll MS, Patwari PP, Kenny AS, et al: Residual chemosensory response to exogenous ventilatory challenges in paired-like homeobox 2b mutation-confirmed congenital central hypoventilation syndrome, J Appl Physiol 116:439-450, 2014. PMID: 24381123.
  897. Charnay AJ, Antisdel-Lomaglio JE, Zelko FA, et al: Congenital central hypoventilation syndrome (CCHS): neurocognition already reduced in preschool-age children, Chest 149(3):809-815, 2016.
  898. Chin AC, Shaul DB, Patwari PP, et al: Diaphragmatic pacing in infants and children with congenital central hypoventilation syndrome (CCHS). In Kheirandish-Gozal L, Gozal D, editors: Sleep disordered breathing in children: a clinical guide, New York, NY, 2012, Springer Press, pp 553-573. doi:10.1007/978-1-60761-725-729. 2012.
  899. Gronli JO, Santucci BA, Leurgans SE, et al: Congenital central hypoventilation syndrome: PHOX2B genotype determines risk for sudden death, Pediatr Pulmonol 43:77-86, 2008.
  900. Healy F, Marcus CL: Congenital central hypoventilation syndrome in children, Pediatr Respir Rev 12:253-263, 2011.
  901. Jennings LJ, Yu M, Rand CM, et al: Variable human phenotype associated with novel deletions of the PHOX2B gene, Pediatr Pulmonol 47(2):153-161, 2012. PMID: 21830319.
  902. Jennings LJ, Yu M, Zhou L, et al: Comparison of PHOX2B testing methods in the diagnosis of congenital central hypoventilation syndrome and mosaic carriers, Diagn Mol Pathol 19(4):224-231, 2010.
  903. Kinney HC: Structural abnormalities in the brainstem and cerebellum in congenital central hypoventilation syndrome, Pediatr Res 64:226-227, 2008.
  904. Kumar R, Lee K, Macey P, et al: Mammillary body and fornix injury in congenital central hypoventilation syndrome, Pediatr Res 66:429-434, 2009.
  905. Kumar R, Macey PM, Woo MA, et al: Diffusion tensor imaging demonstrates brainstem and cerebellar abnormalities in congenital central hypoventilation syndrome, Pediatr Res 64:275-280, 2008.
  906. Lijubic K, Fister I Jr, Fister I: Congenital central hypoventilation syndrome: a comprehensive review and future challenges, J Respir Med 1-8, 2014. Article ID 856149.
  907. Marazita ML, Maher BS, Cooper ME, et al: Genetic segregation analysis of autonomic nervous system dysfunction in families of probands with congenital central hypoventilation syndrome, Am J Med Genet 100:229-236, 2001.
  908. Moreira TS, Takakura AC, Czeisler C, Otero JJ: Respiratory and autonomic dysfunction in congenital central hypoventilation syndrome, J Neurophysiol 116:742-752, 2016.
  909. Nobuta H, Cilio MR, Danhaive O, et al: Dysregulation of locus coeruleus development in congenital central hypoventilation syndrome, Acta Neuropathol 130(2):171-183, 2015.
  910. Rand CM, Yu M, Jennings LJ, et al: Germline mosaicism of PHOX2B mutation accounts for familial recurrence of congenital central hypoventilation syndrome (CCHS), Am J Med Genet A 158A(9):2297-2301, 2012. PMID: 22821709.
  911. Straus C, Trang H, Becquemin MH, et al: Chemosensitivity recovery in Ondine's curse syndrome under treatment with desogestrel, Respir Physiol Neurobiol 171(2):171-174, 2010.
  912. Todd ES, Weinberg SM, Berry-Kravis EM, et al: Facial phenotype in children and young adults with PHOX2B-determined congenital central hypoventilation syndrome: quantitative pattern of dysmorphology, Pediatr Res 59:39-45, 2006.
  913. Weese-Mayer DE, Berry-Kravis EM, Ceccherini I, et al: An official ATS clinical policy statement. Congenital central hypoventilation syndrome: genetic basis, diagnosis, and management, Am J Respir Crit Care Med 181:626-644, 2010.
  914. Weese-Mayer DE, Marazita ML, Berry-Kravis EM: Congenital central hypoventilation syndrome. In Pagon RA, Bird TC, Dolan CR, et al, editors: GeneReviews, Seattle, 1993, University of Washington.
  915. Weese-Mayer DE, Patwari PP, Rand CM, et al: Congenital central hypoventilation syndrome (CCHS) and PHOX2B mutations. In Robertson D, Biaggioni I, Burnstock G, et al, editors: Primer on the autonomic nervous system, Oxford, UK, 2012, Academic Press, pp 445-450.
  916. Weese-Mayer DE, Rand CM, Berry-Kravis EM, et al: Congenital central hypoventilation syndrome from past to future: model of translational and transitional autonomic medicine, Pediatr Pulmonol 44:521-535, 2009.
  917. Weese-Mayer DE, Rand CM, Zhou A, et al: Congenital central hypoventilation syndrome (CCHS): a bedside-to-bench success story for advancing early diagnosis and treatment and improved survival and quality of life, Pediatr Res 81(1-2):192-201, 2017. PMID: 27673423. [50th anniversary success stories]Weese-Mayer DE, Silvestri JM, Huffman AD, et al: Case/control family study of ANS dysfunction in idiopathic congenital central hypoventilation syndrome, Am J Med Genet 100:237-245, 2001.
  918. Amaddeo A, Moreau J, Frapin A, et al: Long term continuous positive airway pressure (CPAP) and noninvasive ventilation (NIV) in children: initiation criteria in real life, Pediatr Pulmonol 51(9):968-974, 2016.
  919. Bach JR, Chiou M, Saporito LR, Esquinas AM: Evidence-based medicine analysis of mechanical Insufflation-exsufflation devices, Respir Care 62(5):643, 2017.
  920. Bach JR, Martinez D: Duchenne muscular dystrophy: continuous noninvasive ventilatory support prolongs survival, Respir Care 56(6):744-750, 2011.
  921. Bidiwala A, Volpe L, Halaby C, et al: A comparison of high frequency chest wall oscillation and intrapulmonary percussive ventilation for airway clearance in pediatric patients with tracheostomy, Postgrad Med 129(2):276-282, 2017.
  922. Chatwin M, Tan HL, Bush A, et al: Long term non-invasive ventilation in children: impact on survival and transition to adult care, PLoS ONE 10(5):e0125839, 2015.
  923. Cristea AI, Carroll AE, Davis SD, et al: Outcomes of children with severe bronchopulmonary dysplasia who were ventilator dependent at home, Pediatrics 132(3):e727-e734, 2013.
  924. Fauroux B, Quijano-Roy S, Desguerre I, Khirani S: The value of respiratory muscle testing in children with neuromuscular disease, Chest 147(2):552-559, 2015.
  925. Fine-Goulden MR, Ray S, Brierley J: Decision making in long-term ventilation for children, Lancet Respir Med 3(10):745-746, 2015.
  926. Finkel RS, Chiriboga CA, Vajsar J, et al: Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study, Lancet 388(10063):3017-3026, 2016.
  927. Hull J, Aniapravan R, Chan E, et al: British thoracic society guideline for respiratory management of children with neuromuscular weakness, Thorax 67(Suppl 1):i1-i40, 2012.
  928. Katz SL, Barrowman N, Monsour A, et al: Long-term effects of lung volume recruitment on maximal inspiratory capacity and vital capacity in duchenne muscular dystrophy, Ann Am Thorac Soc 13(2):217-222, 2016.
  929. Khirani S, Ramirez A, Delord V, et al: Evaluation of ventilators for mouthpiece ventilation in neuromuscular disease, Respir Care 59(9):1329-1337, 2014.
  930. Lacombe M, Del Amo Castrillo L, Bore A, et al: Comparison of three coughaugmentation techniques in neuromuscular patients: mechanical insufflation combined with manually assisted cough, insufflation-exsufflation alone and insufflation-exsufflation combined with manually assisted cough, Respiration 88(3): 215-222, 2014.
  931. Liptzin DR, Connell EA, Marable J, et al: Weaning nocturnal ventilation and decannulation in a pediatric ventilator care program, Pediatr Pulmonol 51(8):825-829, 2016.
  932. MacIntyre EJ, Asadi L, McKim DA, Bagshaw SM: Clinical outcomes associated with home mechanical ventilation: a systematic review, Can Respir J 2016:6547180, 2016.
  933. Mack DL, Poulard K, Goddard MA, et al: Systemic AAV8-Mediated gene therapy drives Whole-body correction of myotubular myopathy in dogs, Mol Ther 25(4):839-854, 2017.
  934. Martinez EE, Smallwood CD, Bechard LJ, et al: Metabolic assessment and individualized nutrition in children dependent on mechanical ventilation at home, J Pediatr 166(2):350-357, 2015.
  935. Mellies U, Goebel C: Optimum insufflation capacity and peak cough flow in neuromuscular disorders, Ann Am Thorac Soc 11(10):1560-1568, 2014.
  936. Prickett KK, Sobol SE: Inpatient observation for elective decannulation of pediatric patients with tracheostomy, JAMA Otolaryngol Head Neck Surg 141(2):120-125, 2015.
  937. Simonds AK, Hare A: New modalities for non-invasive ventilation, Clin Med (Lond) 13(Suppl 6):s41-s45, 2013.
  938. Sterni LM, Collaco JM, Baker CD, et al: An official American thoracic society clinical practice guideline: pediatric chronic home invasive ventilation, Am J Respir Crit Care Med 193(8):e16-e35, 2016.
  939. Wilfond BS: Tracheostomies and assisted ventilation in children with profound disabilities: navigating family and professional values, Pediatrics 133(Suppl 1): S44-S49, 2014.

Труды отечественных авторов при подготовке статей по педиатрии для пользователей сайта - не использовались, так как их вы всегда можете найти в библиотеках.

- Вернуться в раздел "Педиатрия"

Редактор: Искандер Милевски. Дата обновления публикации: 14.5.2024

Медунивер Мы в Telegram Мы в YouTube Мы в VK Форум консультаций врачей Контакты, реклама
Информация на сайте подлежит консультации лечащим врачом и не заменяет очной консультации с ним.
См. подробнее в пользовательском соглашении.